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Abstract 
 
The use of Diels Alder cycloaddition chemistries to access a diverse range of 
useful cyclic structures is well established throughout literature. However, the 
value of the product may be enhanced further still by linking this reaction with 
subsequent (biocatalytic) steps to create novel, structurally demanding, optically 
pure compounds. This project investigates the linking of Diels Alder (DA) 
chemistry to the enzyme, transketolase (TK) as a model integration pathway of a 
chemical syntheses and a biological transformation. The two-step process aims to 
provide a framework to synthesise small structurally diverse compounds with high 
enantiomeric excess. The demand for optically pure compounds is becoming a 
necessity due to the adverse affects frequently introduced by racemic compounds 
and the cost implications of the material possessing often only 50% active 
compound. 
 
Recombinant wild type Eschericha coli transketolase (EC 2.2.1.1) (WT-TK) was 
overexpressed in E. coli for the biocatalytic step of this two step synthesis. A 
substrate walking approach whereby a range of sequentially linked cyclic 
aldehydes, were applied to wild type transketolase and potential activity detected. 
Transketolase mutants, previously constructed based on information derived from 
the structural position within the active site of the dimeric enzyme were 
subsequently screened for activity with the cycloadduct of the Diels Alder 
reaction as aldehyde acceptor substrate for TK. Following identification, 
selection, culturing and sequencing of variants indicating enhanced activity 
towards the novel, bulky, hydrophobic, cyclic aldehyde the enantioselectivity and 
absolute stereochemistry of the product were determined. Activity displayed by 
wild type transketolase indicated an 18,000 fold activity improvement. Michaelis-
Menten kinetic parameters were subsequently determined to have an apparent Km 
of 69.9 mM, kcat of 17.5 s-1 and a vmax of 0.07 mM.min-1 and preliminary process 
compatibility including product and substrate inhibition issues were highlighted.  
 
 
 
 5
Acknowledgements 
 
I would like to thank my supervisors, Dr. Paul Dalby, Dr. Helen Hailes and 
Professor John Woodley for their guidance throughout my project. The interesting 
multi-disciplinary discussions provided both motivation and inspiration for the 
topics.   
 
A big thank you is also due to Dr. Mark Smith, James Galman and Dr. Kirsty 
Smithies for the invaluable advice, assistance and kindness in all aspects of 
molecular chemistry, organic chemistry and analytical chemistry.  The support 
received from the chemistry department throughout my entire project was very 
much appreciated. 
 
I am also very grateful to everyone within the Biochemical Engineering 
department at UCL, in particular those within the BiCE programme for the very 
useful advice and constructive discussions. I would like to thank Adam Stonier, 
Sandro Matosevic, Nina Remtulla and James Galman not only for help with IT 
quandaries and practical assistance but on a personal level, making this journey an 
enjoyable one.  
 
Finally, I would like to thank my family for their love, support and 
encouragement always.  And to my lovely husband, Ritchie Crago whom without 
his support and understanding, this would have been impossible.  
 
 
 
 
 
 
 
 6
Abbreviations 
 
ABT    2-amino-1,3,4-butanetriol 
ACN   Acetonitirile  
AmpR   Ampicillin resistant 
AP   Acetophenone 
BSA   Bovine serum albumin 
CO2   Carbon dioxide 
DA   Diels Alder reaction 
DCHCA  3,4-dimethyl-3-cyclohexene-1-carboxaldehyde 
DCDHP 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one 
DHP   1,3-dihydroxypentan-2-one 
DNA   Deoxynucleic acid 
DOT    Dissolved oxygen tension (%) 
E.C.   Enzyme commission 
E. coli    Escherichia coli 
EDTA   Ethylenediaminetetraacetic acid 
L-ery    L-erythrulose 
EtOAc   Ethyl acetate 
GA    Glycolaldehyde 
GC   gas chromatography 
His-tag   Histidine-tag 
HPA    Hydroxypyruvic acid 
HPLC    High Performance Liquid Chromatography 
IPTG   Isopropyl-β-D-thiogalactosidase 
ISPR   in situ product removal 
kDa   kilo dalton 
Km   Michaelis constant 
kcat   Enzyme turnover rate 
LB    Luria -Bertani 
Li-HPA   Lithium hydroxypyruvate 
MBA   Methylbenzylamine 
MeOH   Methanol 
mg   milligrams  
mL   millilitre 
MgCl   Magnesium chloride 
 7
MPTA   2-methoxy-2-(trifluoromethyl) phenylacetic acid 
NaOH   Sodium Hydroxide 
Ni-NTA   Nickel – Nitriloacetic acid 
OD    Optical Density 
PA   Propanal 
PCR   Polymerase chain reaction  
PLP    Pyridoxal phosphate 
PMP   Pyridoxamine phosphate 
PMA    Phosphomolybdic Acid 
RO    Reverse osmosis 
rpm   revolutions per minute 
[S]   Substrate concentration 
SDS-PAGE  Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis 
SFPR   substrate feed product removal 
SRW    Standard round well 
TAm    Transaminase 
TEMED   Tetramethylethylenediamine 
TFA    Trifluoroacetic Acid 
TLC   Thin Layer Chromatography 
THF   Tetrahydrofuran 
TK    Transketolase 
TPP   Thiamine Pyrophosphate 
TPTC   2,3,5-tripheyltetrazolium chloride 
Tris-HCl   Tris(hydroxymethyl)aminomethane-hydrochloric acid 
UCL    University College of London 
UV  Ultraviolet 
v/v  volume by volume 
vmax   Maximal velocity 
WT   Wild type 
X5P   xylulose-5-phosphate 
µmax   Maximal specific growth rate 
µL   microlitre 
µg   microgram 
 
 
 8
Contents 
 
Abstract ........................................................................................................................ 4 
Acknowledgements ...................................................................................................... 5 
Abbreviations ............................................................................................................... 6 
Contents ........................................................................................................................ 8 
List of figures ............................................................................................................. 15 
List of Tables .............................................................................................................. 18 
List of schemes ........................................................................................................... 18 
 
1 Introduction ....................................................................................................... 19 
1.1 Chemoenzymatic synthesis: Integrating chemistry and biology ................. 19 
1.2 Chirality ....................................................................................................... 24 
1.2.1 Optically pure pharmaceuticals ........................................................... 25 
1.2.2 Enantioselectivity ................................................................................ 29 
1.3 Carbon-carbon bond forming ...................................................................... 29 
1.4 Biocatalysis ................................................................................................. 30 
1.4.1 Advantages and disadvantages of biocatalysis .................................... 31 
1.4.2 Ideal biocatalysts ................................................................................. 33 
1.4.3 Biocatalysts in Industry ....................................................................... 34 
1.4.4 Transketolase (TK) .............................................................................. 35 
1.4.4.1 Synthetic potential of transketolase .................................................. 37 
1.4.4.2 TK function In vivo .......................................................................... 38 
1.4.4.3 Transketolase mechanism ................................................................. 38 
1.4.4.3.1 Thiamine pyrophosphate (TPP) ................................................. 41 
1.4.4.4 Sources of TK ................................................................................... 41 
1.4.4.5 TK production .................................................................................. 42 
1.4.4.5.1 TK purification .......................................................................... 42 
1.4.5 Enzyme modification .......................................................................... 44 
1.4.5.1 Enzyme evolution ............................................................................. 44 
1.4.5.2 Directed evolution ............................................................................ 45 
1.4.6 TK biotransformation .......................................................................... 47 
1.4.6.1 Reactants and products ..................................................................... 47 
 9
1.4.7 TK stereoselectivity ............................................................................. 49 
1.5 Diels Alder reaction ..................................................................................... 51 
1.5.1 Diels Alder reaction substrates ............................................................ 51 
1.5.2 DA cycloadducts ................................................................................. 52 
1.5.3 Solvents and catalysts for Diels Alder reaction ................................... 53 
1.6 Enzyme kinetics .......................................................................................... 55 
1.6.1 Detection methods ............................................................................... 58 
1.6.1.1 Colorimetric assay ............................................................................ 60 
1.7 Summary, aims and objectives .................................................................... 61 
 
2 General Materials and Methods ...................................................................... 63 
2.1 General ........................................................................................................ 63 
2.2 Reagent and Protein sources ........................................................................ 64 
2.3 Biocatalyst preparation ................................................................................ 64 
2.3.1 LB-agar plates and streaking ............................................................... 64 
2.3.2 Luria Bertani (LB) media .................................................................... 65 
2.3.3 Ampicillin ............................................................................................ 65 
2.3.4 Overnight culture ................................................................................. 65 
2.3.5 Shake flask fermentation ..................................................................... 66 
2.3.6 20 L fermentation of D469T-TK ......................................................... 66 
2.3.7 Glycerol stocks .................................................................................... 67 
2.3.8 Sonication for clarified lysate .............................................................. 67 
2.3.9 Sonication for purified enzyme ........................................................... 68 
2.4 Biocatalysis quantification .......................................................................... 68 
2.4.1 SDS-PAGE and densitometry ............................................................. 68 
2.4.2 Bradford assay ..................................................................................... 68 
2.4.3 Spectrophotometry for pure TK .......................................................... 69 
2.5 Transketolase activity test ........................................................................... 69 
2.5.1 Tris-HCl buffer .................................................................................... 69 
2.5.2 Cofactor solution ................................................................................. 70 
2.5.3 Substrate solutions ............................................................................... 70 
2.5.4 Activity assay with GA and HPA ........................................................ 70 
2.6 Synthetic chemistry ..................................................................................... 71 
2.6.1 Lithium hydroxypyruvate .................................................................... 71 
 10
2.6.2 1,3-dihydroxypentan-2-one (DHP) ..................................................... 71 
2.7 Detection and quantification ....................................................................... 72 
2.7.1 Flash chromatography ......................................................................... 72 
2.7.2 Thin layer chromatography ................................................................. 72 
2.7.3 HPLC ................................................................................................... 72 
2.6.2.1 HPLC Standards ............................................................................... 73 
2.6.2.2 HPLC assay for GA and L-erythrulose ............................................ 75 
2.6.2.3 HPLC assay for DHP and HPA ........................................................ 75 
 
3 Aldehyde design, library screening and mutant selection ............................. 76 
3.1 Introduction ................................................................................................. 77 
3.1.1 Natural substrates for transketolase ..................................................... 77 
3.1.2 Non-natural substrates for transketolase ............................................. 78 
3.1.3 Substrate walking ................................................................................ 80 
3.1.4 Cyclic aldehyde series ......................................................................... 82 
3.1.5 Aldehyde design for a chemoenzymatic reaction cascade .................. 83 
3.1.6 Aldehyde synthesis .............................................................................. 85 
3.1.7 Diels Alder reaction ............................................................................. 86 
3.1.8 TK structural mutant library D469 ...................................................... 87 
3.1.9 Mutant library selection ....................................................................... 90 
3.2 Materials and methods ................................................................................. 91 
3.2.1 TK reaction with cyclic aldehydes ...................................................... 91 
3.2.2 Ionic liquid [Me3NC2H4OH]Cl-ZnCl2 (1:2) preparation ..................... 91 
3.2.3 Ionic liquid recycling ........................................................................... 91 
3.2.4 3,4-Dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA) 
synthesis using Diels Alder reaction in RTIL ..................................... 92 
3.2.5 (1R)-3,4-Dimethyl-3-cyclohexen-1-carboxaldehyde (DCHCA 1R 
isomer) synthesis ................................................................................. 92 
3.2.6 Diels Alder cyclo-adduct distillation purification ............................... 93 
3.2.7 D469X library screening assay ............................................................ 93 
3.2.8 Colorimetric assay for screening ......................................................... 93 
3.2.9 Sequencing .......................................................................................... 94 
3.2.10 TK mutant production ......................................................................... 94 
3.2.11 TK purification (His-tagged pQR412) ................................................ 95 
 11
3.3 Results and discussion ................................................................................. 96 
3.3.1 TK wt on GA, PA and cyclic aldehydes.............................................. 96 
3.3.2 New aldehyde synthesis .................................................................... 102 
3.3.2.1 Ionic Liquid .................................................................................... 102 
3.3.2.2 DA reaction optimisation ............................................................... 105 
3.3.2.2.1 Ionic liquid recycling ............................................................... 107 
3.3.3 WT-TK on DA product ..................................................................... 109 
3.3.4 TK library on propanal and cyclic aldehydes .................................... 109 
3.3.5 TK D469X library on DA cycloadduct ............................................. 112 
3.3.6 TK sequencing and mutant identification ......................................... 116 
3.3.7 Fermentation scale up and synthesis at scale .................................... 117 
3.3.7.1 Bioedit ............................................................................................ 125 
3.3.8 Summary ........................................................................................... 126 
 
4 Synthesis of 1,3-Ketodiol and enantiomeric excess ...................................... 128 
4.1 Introduction ............................................................................................... 129 
4.1.1 TK reaction with complex substrates ................................................ 129 
4.1.2 TK catalysed reaction conditions ...................................................... 130 
4.1.3 Biomimetic TK reaction .................................................................... 131 
4.1.4 Substrate solubility in biocatalysis .................................................... 132 
4.1.5 Enantioselectivity of wild-type-TK and its variants .......................... 133 
4.1.5.1 Methods of enantiomeric excess (ee) determination ...................... 136 
4.2 Materials and Methods .............................................................................. 137 
4.2.1 TK Catalysed synthesis of 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-
dihydroxypropan-2-one (DCDHP) .................................................... 138 
4.2.2 D469T-TK reaction pH dependence ................................................. 138 
4.2.3 D469T-TK reaction temperature dependence ................................... 138 
4.2.4 Biomimetic reaction for propanal to give product 1,3-
dihydroxypentan-2-one (DHP) .......................................................... 139 
4.2.5 Biomimetic synthesis of 4-isomer mixture of (1RS,1'RS)-1-(3',4'-
dimethylcyclohex-3'-enyl)-3-hydroxy-2-oxo-propyl ester ................ 139 
4.2.6 Enantioselectivity of D469T – TK .................................................... 140 
4.2.6.1 Synthesis of (1R)-3,4-Dimethyl-3-cyclohexen-1-carboxaldehyde 
((1R-3)-DCHCA) ............................................................................ 140 
 12
4.2.6.2 Benzoylation of DCDHP for chiral HPLC (benzoic acid 
(3'RS,1''RS)-3'-(3'',4''-dimethylcyclohex-3''-enyl)-3'-hydroxy-2          
-oxo-propyl ester) ........................................................................... 140 
4.2.6.3 Mosher’s acid ................................................................................. 142 
4.3 Results and discussion ............................................................................... 142 
4.3.1 D469T-TK catalysed reaction with DCHCA .................................... 142 
4.3.1.1 Determination of optimum reaction conditions .............................. 143 
4.3.1.1.1 D469T-TK pH optimum .......................................................... 143 
4.3.1.1.2 Investigation of temperature optimum .................................... 144 
4.3.1.1.3 Reaction component stabilisation ............................................ 147 
4.3.1.1.3.1 Biocatalyst stability .......................................................... 147 
4.3.1.1.3.2 HPA .................................................................................. 148 
4.3.1.1.3.3 DCHCA and R-isomer-DCHCA ...................................... 150 
4.3.1.1.4 Reaction vessels, plastic eppendorf or glass vials? ................. 151 
4.3.1.1.5 Impact of reaction scale for D469T-TK and WT-TK activity 153 
4.3.1.1.5.1 Kinetic assays at low reaction volumes (300 µl -1.2 mL) 153 
4.3.1.1.5.2 Kinetics at preparative reaction scale (90 mL-500 mL) ... 155 
4.3.1.2 Investigation into improving substrate solubility ........................... 156 
4.3.1.2.1 Co-solvent addition to water ................................................... 156 
4.3.1.2.2 Comparison of shaking and non-shaking D469T reaction ...... 156 
4.3.2 Biomimetic reaction for racemic ketodiol synthesis ......................... 157 
4.3.2.1 Co-solvent addition to the biomimetic reaction ............................. 158 
4.3.2.2 Scale ............................................................................................... 159 
4.3.3 Enantioselectivity of TK-D469T with DCHCA ................................ 159 
4.3.3.1 Cyclic aldehyde enantioselectivity and absolute configuration ..... 159 
4.4 Summary ................................................................................................... 163 
 
5 D469T-TK and WT-TK kinetics .................................................................... 164 
5.1 Introduction ............................................................................................... 165 
5.1.1 Wild-type-TK kinetics ....................................................................... 165 
5.1.2 TK variant kinetics ............................................................................ 165 
5.1.3 Colorimetric assay ............................................................................. 166 
5.2 Materials and methods ............................................................................... 168 
5.2.1 TK activity at various substrate concentrations ................................ 168 
 13
5.2.2 TK Kinetic assay reaction quenching methods ................................. 168 
5.2.3 Colorimetric assay for kinetic analysis ............................................. 168 
5.2.3.1 Carbonate resin quenching ............................................................. 168 
5.2.3.2 Colorimetric assay .......................................................................... 169 
5.2.3.3 Calibration curve ............................................................................ 169 
5.2.4 TK Kinetics assay .............................................................................. 169 
5.3 Results and discussion ............................................................................... 171 
5.3.1 Kinetic assay development ................................................................ 171 
5.3.1.1 Kinetic assay optimisation .............................................................. 171 
5.3.1.2 Reaction quenching methods .......................................................... 173 
5.3.1.3 Resin quenching ............................................................................. 175 
5.3.1.4 Colorimetric assay development for kinetic analysis ..................... 177 
5.3.1.4.1 Colorimetric assay calibration curve ....................................... 179 
5.3.1.4.2 Limit of detection and control assay ....................................... 180 
5.3.2 D469T kinetic parameters ................................................................. 181 
5.4 Summary ................................................................................................... 192 
 
6 Product inhibition, substrate inhibition and product extraction ................ 194 
6.1 Introduction ............................................................................................... 195 
6.1.1 Enzyme substrate inhibition .............................................................. 195 
6.1.2 Enzyme product inhibition ................................................................ 196 
6.1.3 Approaches to overcome inhibition issues ........................................ 197 
6.1.3.1 Substrate feeding strategies ............................................................ 197 
6.1.3.2 Product removal ............................................................................. 199 
6.1.3.2.1 Transaminase ........................................................................... 200 
6.1.3.2.2 Boronates ................................................................................. 202 
6.1.4 Compatibility between biological and chemical processes ............... 203 
6.2 Materials and Methods .............................................................................. 204 
6.2.1 Substrate inhibition studies ............................................................... 204 
6.2.1.1 Addition of neat aldehyde .............................................................. 204 
6.2.1.2 Increased substrate concentrations of 200 mM DCHCA ............... 204 
6.2.2 Product inhibition study .................................................................... 205 
6.2.2.1 D469T-TK reaction spiked with product at t0 ................................ 205 
6.2.2.2 D469T-TK reaction spiked with product at t5 ................................ 205 
 14
6.2.2.3 Enzyme product complex experiment ............................................ 206 
6.2.3 Transaminase (TAm) preparation and purification ........................... 207 
6.2.4 Transaminase reaction ....................................................................... 207 
6.2.5 Transaminase HPLC analysis ............................................................ 207 
6.2.6 Phenylboronic acid reaction with ketodiol products ......................... 208 
6.2.6.1 L-erythrulose and phenylboronic acid ............................................ 208 
6.2.6.2 DCDHP and phenylboronic acid .................................................... 208 
6.2.7 Compatibility studies ......................................................................... 208 
6.3 Results and discussion ............................................................................... 210 
6.3.1 Investigation into substrate inhibition ............................................... 210 
6.3.2 Investigation into product inhibition ................................................. 212 
6.3.3 Product Removal ............................................................................... 214 
6.3.3.1 Phenylboronic acid ......................................................................... 214 
6.3.3.2 Transaminase (TAm) ...................................................................... 215 
6.3.4 Compatibility studies between DA and TK reactions ....................... 216 
6.4 Summary ................................................................................................... 218 
 
7 Summary and final discussion ........................................................................ 220 
 
8 Future work ..................................................................................................... 226 
 
References ................................................................................................................ 229 
Appendix .................................................................................................................. 250 
 
 
 
 
 
 
 
 
 
 15
List of figures 
 
Figure 1.1: Products from chemoenzymatic synthesis involving transketolase.. .. 20 
Figure 1.2. Process development for integration. .................................................. 23 
Figure 1.3. Enantiomers of an amino acid. ............................................................ 24 
Figure 1.4: Thalidomide enantiomers ................................................................... 26 
Figure 1.5: Thiamine pyrophosphate (TPP). ......................................................... 41 
Figure 1.6: Enantioselectivity of E . coli towards D-, L- and DL-glyceraldehyde .. 50 
Figure 1.7: Diels Alder cycloaddition reaction. .................................................... 51 
Figure 1.8: Good dienophiles. ............................................................................... 52 
Figure 1.9: Lewis acid: nobium pentachloride . .................................................... 55 
Figure 1.10: Linked enzyme assay for TK catalysed reaction product detection. 59 
Figure 1.11: Tetrazolium red colour assay. ........................................................... 60 
Figure 2.1: Li-HPA calibration curve .................................................................... 73 
Figure 2.2: L-erythrulose calibration curve ........................................................... 74 
Figure 2.3: 1,3-dihydroxypentan-2-one (DHP). .................................................... 74 
Figure 3.1: Natural transketolase substrates. ......................................................... 77 
Figure 3.2: Substrate walking. ............................................................................... 81 
Figure 3.3: Potential target aldehydes ................................................................... 83 
Figure 3.4: Dienes ................................................................................................. 85 
Figure 3.5: Target Diels Alder reaction ................................................................. 87 
Figure 3.6: Transketolase active site. .................................................................... 88 
Figure 3.7: Structural TK library residues. ............................................................ 88 
Figure 3.8: Transketolase dimer ............................................................................ 90 
Figure 3.9: GA reaction profile ............................................................................. 96 
Figure 3.10: GA and HPA activity assay .............................................................. 97 
Figure 3.11: Transketolase reaction profile ........................................................... 99 
Figure 3.12: Colorimetric assay photograph ......................................................... 99 
Figure 3.13: Substrate walking TLC ................................................................... 100 
Figure  3.14: Mechanical stirring of large volume RTIL and DA reactants ....... 102 
Figure 3.15: Effect of ionic liquid volume .......................................................... 104 
Figure 3.16: Diels Alder reaction in RTIL. ......................................................... 106 
Figure 3.17: Room temperature ionic liquid recycling ....................................... 108 
Figure 3.18: Propanal screen of library D469X .................................................. 110 
Figure 3.19: Cyclohexanecarboxaldehyde screen of library D469X .................. 111 
Figure 3.20: 3-cyclohexene-1-carboxaldehyde screen of library D469X ........... 111 
 16
Figure 3.21: 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde screen of library 
D469 ............................................................................................... 113 
Figure 3.22: Correlation of cyclic aldehyde D469 screens ................................. 114 
Figure 3.23: D469 Library screen, using 3,4-dimethyl-3-cyclohexene-1-
carboxaldehyde (DCHCA) ............................................................. 115 
Figure 3.24: Intensity spots ................................................................................. 116 
Figure 3.25: Comparison of top performing TK-mutants and WT-TK............... 117 
Figure 3.26: Typical fermentation growth curve of WT-TK and TK-Mutants ... 118 
Figure 3.27: 20 L fermentation growth curve of D469T ..................................... 120 
Figure 3.28: TK purification process. ................................................................. 122 
Figure 3.29: SDS-PAGE gel photograph ............................................................ 123 
Figure 4.1: Mosher Conformers .......................................................................... 137 
Figure 4.2: MS data for monobenzoylated DCDHP and Mosher’s acid. ............ 141 
Figure 4.3: D469T-TK pH optimum investigation ............................................. 144 
Figure 4.4: Effect of temperature on D469T-TK activity ................................... 146 
Figure 4.5: Storage stability of D469T-TK His-tagged pQ412.. ......................... 148 
Figure 4.6: HPA stabilization during short time scale reactions ......................... 149 
Figure 4.7: HPA stabilization during long time scale reactions. ......................... 149 
Figure 4.8: Mass spectrometry of DCHCA ......................................................... 150 
Figure 4.9: Comparison of reaction vessel effect on DCDHP synthesis ............. 151 
Figure 4.10: Comparison of propanal depletion within screw top glass vials and 
microwells with plate lid ................................................................ 152 
Figure 4.11: Comparison of activity of D469T-TK at small assay scales........... 153 
Figure 4.12: Comparison of enzyme concentration on product formation ......... 154 
Figure 4.13: Comparing effect of scale on initial rate of D469T-TK ................. 155 
Figure 4.14: Four possible ketodiol product diastereomers. ............................... 157 
Figure 4.15: Tetrahydrofuran, THF ..................................................................... 158 
Figure 4.16: Reaction pathway for chiral HPLC and ee assay ............................ 160 
Figure 4.17: Chiral HPLC spectra. ...................................................................... 161 
Figure 4.18: Stereochemistry of the major diastereoisomer formed by D469T-
transketolase (1'R,1S)-(3,4-dimethylcyclohex-3-enyl)-1,3-
dihydroxypentan-2-one (DCDHP). ................................................ 162 
Figure 5.1: Calibration curve for formazane after addition of 1-
(3’,4’dimethylcyclohex-3’enyl)-1,3-dihydroxypentan-2-one      
DCDHP ............................................................................................. 170 
Figure 5.2: Optimisation of dilutions in the colorimetric assay. ......................... 172 
 17
Figure 5.3: Enzyme reaction quenching methods ............................................... 174 
Figure 5.4: MP-Carbonate resin (Biotage) .......................................................... 176 
Figure 5.5: Time-dependence of Li-HPA quench using MP carbonate resin ..... 177 
Figure 5.6: Effect of addition of methanol into colorimetric assay samples ....... 179 
Figure 5.7: Evaluation of the colorimetric assay on TK reaction control 
experiments ....................................................................................... 180 
Figure 5.8: Colorimetric assay validation ........................................................... 182 
Figure 5.9: Comparison of colorimetric assay wells from different TK catalysed 
reactions ............................................................................................. 183 
Figure 5.10: Comparison of TK reaction profiles for WT-TK and D469T-TK 
towards DCHCA ............................................................................ 184 
Figure 5.11: Typical TLC plate for the conversion of DCHCA to DCDHP by 
transketolase ................................................................................... 185 
Figure 5.12: Initial rate of WT-TK against DCHCA .......................................... 186 
Figure 5.13: Initial reaction progress curves for D469T-TK catalysed reactions   
of DCHCA ...................................................................................... 186 
Figure 5.14: Michaelis Menten Model. ............................................................... 188 
Figure 5.15: Colorimetric assay for pure D469T-catalysed conversion of   
different concentrations of DCHCA ............................................... 189 
Figure 5.16: Lineweaver-Burk Plot for the D469T catalysed reaction of HPA    
and DCHCA ................................................................................... 191 
Figure 5.17: Hanes-Woolf Plot............................................................................ 191 
Figure 6.1: SFPR concept (substrate feeding product removal). ........................ 200 
Figure 6.2: Phenylboronic acid ........................................................................... 202 
Figure 6.3: Micro-dialysis ................................................................................... 206 
Figure 6.4: Varying reaction conditions of TK catalysed DCHCA and HPA 
reaction .............................................................................................. 211 
Figure 6.5: Enzyme spike reaction ...................................................................... 212 
Figure 6.6: Effect of reaction product on reaction .............................................. 213 
Figure 6.7: Effect of spiking TK reaction with product at 5 hours ..................... 213 
Figure 6.8: Effect of ionic liquid on D469T-TK reaction ................................... 218 
Figure 6.9: Amino acid side chains……………………………………………..223 
 
 
 
 
 18
 
List of Tables 
 
Table 1.1: Enantiomeric compounds with differing biological activity between  
enantiomers. .............................................................................................. 25 
Table 1.2: Examples of racemic mixtures and the corresponding single-
enantiomer products that have been marketed.. ........................................ 28 
Table 1.3: Aldehyde substrates and conversion levels reported in literature. ............. 48 
Table 1.4: TK Activities towards various substrates relative to glycolaldehyde. ....... 50 
Table 2.1: Luria-Burtani (LB) media components. ..................................................... 65 
Table 3.1: Specific activity of D469T against cyclic aldehydes compared to PA. ... 101 
Table 3.2: Effect of ionic liquid volume on yield.. ................................................... 103 
Table 3.3: TK-Mutant Characterisation. ................................................................... 125 
Table 4.1: Highly enantioselective biocatalysts. ....................................................... 135 
Table 6.1: Control reactions for compatibility studies. ............................................. 209 
 
 
List of schemes 
 
Scheme 1: Natural TK Reactions. ............................................................................... 35 
Scheme 2: The transketolase catalysed reaction. ........................................................ 36 
Scheme 3. Transketolase mechanism .......................................................................... 40 
Scheme 4: Transketolase catalysed reaction ............................................................... 79 
Scheme 5: Transketolase catalysed reaction of Propanal and HPA for DHP ............. 98 
Scheme 6: Transketolase catalysed reaction of DCHCA and HPA for DCDHP ...... 130 
Scheme 7: The mimetic of the TK reaction in the presence of a tertiary amine, N-
methylmorpholine ................................................................................... 132 
Scheme 8: Colorimetric assay mechanism ................................................................ 178 
Scheme 9: Model TAm reaction ............................................................................... 201 
Scheme 10: Two step reaction pathway…….……….………………...………...………..216 
 
 
 
 
 
 19
 
 
 
 
 
 
 
 
 
 
 
 
1 Introduction 
 
1.1 Chemoenzymatic synthesis: Integrating chemistry and biology 
 
Chemoenzymatic synthesis is a flexible approach to synthesising complex 
intermediates where the yield and knowledge of powerful conventional chemistry 
is combined with the potentially high enantio- regio- and chemo- selectivity of 
biocatalysts. Integrating the ‘best’ of two disciplines is a powerful tool for 
synthesising novel, structurally complex, chiral synthons, where demand for 
optically pure pharmaceuticals alongside greener more efficient processes is ever 
increasing (Dalby et al., 2005). Whilst biotransformations are particularly elegant 
at selective conversions and atom efficiency, chemistry often affords high 
productivities. In order to truly impact drug intermediate synthesis at industrial 
scale in terms of productivity, cost effectiveness and environmental burden, 
biocatalysis and chemical synthesis must be integrated (Tao et al., 2007).  
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An example of a process utilising a transferase enzyme, transketolase (TK) within 
a chemoenzymatic system is the production of the glycoside inhibitors, fagomine 
and natural compound 1,4-dideoxy-1,4-imino-D-arabinitol shown in Figure 1.1 
(Hecquet et al., 1994).  
 
 
 
 
 
 
                               
 
 
 
 
 
 
Figure 1.1: Products from chemoenzymatic synthesis involving transketolase. 
Glycoside inhibitors (a) synthetic fagomine and (b) natural 1,4-dideoxy-1,4-
imino-D-arabinitol. 
 
 
 
 
 
 
 
(a) (b) 
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The demand for more complex, optically pure compounds calls for alternative 
routes and novel pathways, such as chemical synthesis coupled with biocatalytic 
steps. The integration of the two steps requires process design consideration and 
the investigation of compatibility, such as the toxicity of components likely to 
interact and optimal reaction conditions. The presence of activating or toxic 
reactive groups on intermediates within the chemical synthesis will affect the 
kinetics of the biocatalyst, potentially damaging productivity (Kim et al., 2007). 
Recent reviews demonstrate the application of biology and chemistry interfacing 
in highly significant fields, for instance the development of cancer therapeutics 
via a drug discovery process involving chemical biology and structural biology 
(Collins and Workman, 2006). Targeting novel compounds for new drugs often 
demands an efficient synthetic route in order to provide the quantities required for 
clinical trials, however, this can prove difficult and sometimes impossible for 
more complex small molecules. Utilising the knowledge from chemistry, 
chemical biology and structural biology, novel predictive and innovative 
technologies for pharmaceuticals may be developed with greater ease (Sawyer, 
2006). A chemoenzymatic approach to the synthesis of non-ribosomal peptides 
and polyketides were previously reported where the combination of synthetic 
chemical tools and recombinant metabolic enzymes aimed to generate the 
structurally demanding compounds (Kopp and Maraheil, 2007). This illustrates 
not only the advantages of integration being to produce optically pure compounds 
more efficiently and to develop more direct, environmentally friendly routes but 
also  to improve accessibility to more structurally demanding compounds.  
 
A number of issues arise with the true integration of chemistry and biology. The 
impact that each process may have on the other, requires consideration and 
characterisation, such as the toxic effect of chemical reagents on enzymes or the 
presence of proteins inhibiting chemical reactions (Hailes et al., 2007). 
Additionally, compatibility issues, such as reaction rates, reactant concentrations, 
optimal pH and optimal temperatures require consideration. Approaches to 
overcome the problems, may involve compromisation, whereby lower optimal 
reaction conditions are utilised to enable both reactions to occur. This however, is 
not ideal with regard to yield and productivity and therefore, approaches to alter 
 22
the steps to improve compatibility are considered. For instance, the modification 
of an enzyme at the genetic level, to withstand the presence of organic solvents or 
to accept substrates synthesised directly from a chemical reaction, without the 
need for purification processing (Bruggink et al., 2003).  The concept of a ‘one-
pot synthesis’ is defined by the lack of intermediate purification processes 
required within a cascade reaction system, needless to say within a single reactor 
vessel (Koeller and Wong, 2000). Ultimately this further addresses the advantages 
associated with reducing the number of steps within a process, potentially 
reducing cost and environmental burden. Further more the linking of additional 
reactions such as a second biotransformation enhances the product potential 
tremendously.  
 
The development of a process for the synthesis of chiral compounds with high 
enantiomeric excess is crucial with current regulatory demands within industry 
including pharmaceutical industry. It is rational to develop a pathway from 
components that are well established throughout the literature such as a well 
characterised enzyme with available structural data and activity profiles (Schorken 
and Sprenger, 1998). Transketolase has been extensively studied, providing 
excellent access to TK enzymes and established detection methods (Littlechild et 
al., 1995; Brocklebank et al., 1996; Hobbs et al., 1996; Mitra and Woodley 1996; 
Mitra et al., 1998; Morris et al., 1996; Hibbert et al., 2007; Hibbert et al., 2008). 
Also, the synthetic potential of TK has been demonstrated by coupling with a 
further biotransformation involving aminotransferase enzyme, Transaminase 
(Tam) (Ingram et al., 2007). Similarly, the chemistry component of the pathway 
should be well examined and known to be commercially useful, such as the 
valuable Diels Alder (DA) cycloaddition, which is well reported in a variety of 
reaction systems with a huge array of potential cycloadducts (Kagan and Riant, 
1992; Griffiths and Previdoli, 1993; Nicolaou et al., 2002). The reaction should 
possess considerable future potential and be particularly applicable for 
exploitation with the ability to generate intermediates with extensively differing 
architectures.  
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Figure 1.2. Process development for integration.  
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1.2 Chirality 
 
Chirality is a significant feature of many biologically active molecules requiring 
much consideration during process design. As early as 1815, Jean-Baptiste Biot, a 
French physicist, whilst studying the polarisation of light, discovered optical 
purity. Using liquids such as turpentine and essential oils, he determined that light 
could be rotated clockwise or counter clockwise, dependent on the optical axis of 
the organic substance being penetrated.  Later on in 1948, Louis Pasteur, rather 
crudely with a microscope and pair of tweezers isolated two enantiomer crystal 
forms, recognised by their mirror image of each other.  The next era, saw Jacobus 
van’t Hoff and Joseph Achille Le Bel, in 1874 proposing a theory of molecular 
asymmetry explaining the isomerization phenomenon by the configuration of 
groups on the tetravalent atom being tetrahedral (Meijer, 2001). This is 
demonstrated by the enantiomers of an amino acid in Figure 1.3. 
 
The ‘handedness’ of a molecule can have a dramatic effect on the activity of a 
drug, where one enantiomer is active towards its target protein, and the other may 
be inadvertently active elsewhere causing potentially devastating side reactions. 
Although in many cases the second enantiomer is inactive, the demand for 
optically pure pharmaceuticals is greater then ever. It is reported that 80% of the 
compounds currently in development by the pharmaceutical industry are single 
isomer compounds (Breuer et al., 2004). 
 
C
COOH
H3C
HH
H2N
C
NH2
CH3
HOOC
 
 
 
Figure 1.3. Enantiomers of an amino acid. The two molecules have the same 
components but may not be superimposed onto each other, they are mirror 
images.  
D-amino acid                           L-amino acid 
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In addition to pharmaceuticals, chiral technology is important to biochemicals, 
pesticides, aroma and flavourings, dyes and pigments, nonlinear optical materials, 
and polymers shown in Table 1.1.  
 
 
Table 1.1: Enantiomeric compounds with differing biological activity 
between enantiomers.  
Industry Enantiomeric 
compound 
Biological Activity 
Pharmaceuticals amphetamine  
 
 
 
epinephrine  
 
 
propranolol 
D-isomer acts as a potent central nervous 
system stimulant, L-isomer has no effect 
 
L-isomer is up to 10 times more potent as a 
vasoconstrictor than D-isomer  
 
S-isomer acts by blocking beta-adrenergic 
receptors  
 
Aroma/Flavourings limonene 
 
 
asparagine  
 
 
carvone 
S-limonene smells like lemons, while R-
limonene smells like oranges 
 
D-asparagine tastes sweet, while L-
asparagine tastes bitter 
 
S-carvone smells like caraway, while R-
carvone smells like spearmint 
 
Vitamins ascorbic Acid L-isomer is good ascorbic acid (vitamin C), 
while D-isomer has no such properties 
 
Insecticides bermethrine D-isomer is much more toxic than L-isomer 
 
 
 
 
1.2.1 Optically pure pharmaceuticals 
  
Chirality becomes highly significant when the two optical isomers exhibit 
different chemical behaviours. In the early 1900s, Cushny, saw importance of 
chirality in pharmaceuticals come to light, where one of the Atropine enantiomers, 
L-hyoscyamine, possessed significantly greater potency than its D-isomer 
 26
(Cushny, 1904). Then, during the 1950s the drug thalidomide, a sedative 
antimuscurinic agent, was distributed to pregnant women as a drug to alleviate 
morning sickness. However it was soon realised that the two enantiomers of the 
compound behaved differently once administered. One remedied morning 
sickness whilst the other was teratogenic, causing malformation to the foetus, a 
somewhat devastating example of the administration of a racemic drug without 
the knowledge of the action of enantiomers.  
 
 
 
 
 
 
Figure 1.4: Thalidomide enantiomers (Rouhi, 2005).  
 
 
 
This problem cannot be resolved by the administration of the single, effective, 
positively acting enantiomer however, due to the action whereby thalidomide 
isomers are reversibly converted into each other in vivo.  This characterisation is 
therefore critical in the production of pharmaceuticals. Ethambutol, a 
bacteriostatic antimycobacterial drug prescribed for the respiratory disease, 
tuberculosis is also known to possess adverse side effects. One enantiomer of the 
drug successfully inhibits bacterial growth, whilst the other acts on the optic nerve 
causing, optic neuritis and potentially partial or complete blindness (Kanther, 
1970; Tugwell and James, 1972). A further example of extreme differences in the 
activity of two enantiomers of a drug is amphetamine and methamphetamine. The 
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D-enantiomer acts on the central nervous system with stimulant effects, whilst the 
L-enantiomer acts on the peripheral nervous system having drastically differing 
effects (Tocco et al., 1985).  
 
The administration of drugs is highly dependant on the knowledge of correct 
doses and upper and lower limitations associated with the biological effects of the 
drugs. With racemic mixtures, where both enantiomers act identically but exhibit 
varying potencies, especially in cases where one enantiomer is inactive, 
theoretically larger doses than required are administered (Cannarsa, 1996), to 
compensate for the lesser acting enantiomer. The pain killing drug, Ibuprofen 
(iso-butyl-propanoic-phenolic acid), is an example of such a chiral 
pharmaceutical, where it is not economically feasible with the current process to 
isolate the active isomer but to simply double the recommended dose (Stinson, 
1994). It becomes of particular consideration where side effects are observed, 
where increasing the dose may increase the possibility of these side effects and 
their intensities. Optically pure drugs would see an improvement in the control of 
pharmacokinetics (Caner et al., 2004).   
 
Apart from increased risk of adverse effects, and possibility that the other 
enantiomer is toxic, racemic mixtures also possess other undesirable properties. 
Such properties include the possible interaction with other commonly 
administered drugs, the lack of specificity of the other enantiomer, and the 
possible competitive nature between the two enantiomers which could reduce the 
effectiveness of the drug. The lack of control over the two different enantiomers is 
commercially unattractive and consequently being more and more closely 
regulated by agencies (i.e. FDA), which further creates the great demand for 
enantiomerically pure drugs and other chemical intermediates (Stinson, 1998).  
The Food and Drug Administration (FDA) of the USA have reported 
recommendations to provide patients with enantiopure pharmaceuticals and not 
racemic forms where available (FDA, 1992).  
 
The production of biologically active molecules for use in pharmaceuticals, where 
restraints have been placed with regard to their optical activity and specificity has 
therefore instigated the demand and manufacture of more structurally complex 
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intermediates (Lye and Woodley, 1999). Many drugs that are now in production 
and use, are chiral and many possess multiple chiral centres. Chirality is 
increasingly important for pure, valuable compounds such as pharmaceuticals 
(Caner et al., 2004).  
 
 
 
Table 1.2: Examples of racemic mixtures and the corresponding single-
enantiomer products that have been marketed. (The marketed brand is in 
brackets, data collected from numerous internet sources).  
Racemic drug Single enantiomer drug 
amphetamine (Benzedrine) dextroamphetamine (Dexedrine) 
salbutamol (Ventolin) levabuterol (Xopenex) 
bupivacaine (Marcain) levobupivacaine (Chicaine) 
omeprazole (Prilosec) esomeprazole (Nexium) 
zopiclone (Imovane) eszopiclone (Lunesta) 
cetirizine (Zyrtec / Reactine) levocetirizine (Xyzal) 
ofloxacin (Floxin) levofloxacin (Levaquin) 
 
 
 
 
In simple terms, two general options are available for consideration, namely, the 
‘chiral approach’ and the ‘racemic approach’. The chosen approach is dependent 
largely on the target intermediates and the planned development time frame, costs 
and scale up feasibility of specific processes (Francotte, 2001; Francotte and 
Linder, 2006). The chiral approach involves the synthesis of the single enantiomer 
through specifically designed methodologies such as stereoselective catalysis 
using synthetic chiral transition metal complexes, organocatalysts, enzymes and 
chiral pool synthesis.  
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1.2.2 Enantioselectivity 
 
On synthesis of a chiral compound it is necessary to determine the optical purity.  
The enantiomers of a compound will each rotate plane, polarized light in opposite 
directions and when a compound contains an equal mixture of enantiomers, 
termed ‘racemic’ no optical activity is exhibited, (the net rotation of plane-
polarized light is zero). When the balance of enantiomers in a compound is 
unequal, light is rotated in relation to the proportions and is known as the 
enantiomeric excess (ee).   
 
Enzymes which are chiral, often distinguish between the two enantiomers of a 
chiral molecule. There has been an increasing awareness of the potential of both 
microorganisms and enzymes for the transformation of synthetic compounds with 
high chemo, regio- and enantio- selectivity (Roberts et al., 1995). Cyanohydrins, 
acyloins (α-hydroxy ketones), α- hydroxy acids and aldols (β-hydroxy ketones) 
were very efficiently synthesised enantioselectivity using carbon-carbon bond 
forming enzymes (Sukumaram and Hanefield, 2005).  
 
 
1.3 Carbon-carbon bond forming 
 
Carbon-carbon bond formation is a significant process in the synthesis of 
intermediates for the production of pharmaceuticals, and lies at the heart of 
organic synthesis. Synthetic carbon-carbon bond forming reactions include a well 
utilised Diels Alder reaction, which has been well studied and numerous processes 
are well established within industry (Nicolaou et al., 2002).  
 
Several enzymes are capable of carbon-carbon bond forming reactions, and many 
are involved in important industrial processes. N-acetylneuraminic acid aldolase 
(NcuA: EC 4.1.3.3) catalyses the carbon-carbon bond forming synthesis of sialic 
acid through the reversible addition of pyruvate to N-acetyl-D-mannosamine 
(Fessner, 1998). The importance of utilising such enzymes is recognised by the 
large range of processes involving compounds like sialic acids, such as cell-cell 
recognition during development and differentiation and tumour metastasis. The 
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ability of NcuA to accept a variety of substrates enables the synthesis of a whole 
host of derivatives. It demonstrates the significance of the development of 
enzymes for the synthesis of complex, multifunctional compounds that are 
otherwise difficult to achieve.  
 
An enzymatic carbon-carbon bond synthesis is also demonstrated by the 
transferase class enzyme, transketolase, which has become a key enzyme within 
rational engineering and directed molecular evolution studies (Morris et al., 1996; 
Woodley et al., 1996; Hibbert et al., 2007). The high stereoselectivity of 
transketolase reported, and the relatively low substrate specificity describe the 
characteristics of a potentially viable biocatalyst for asymmetric carbon-carbon 
bond synthesis of structurally diverse compounds (Littlechild et al., 1995; Morris 
et al., 1996; Koeller and Wong, 2001).  
 
  
1.4 Biocatalysis 
 
Biochemical catalysts providing the appropriate kinetic environment for a 
chemical reaction to be initiated and proceed are suitably named biocatalysts.  
Thousands of biocatalytic processes go on within living organisms, enabling the 
formation of essential compounds from the substrates that are consumed, for 
example, as food. Biocatalysis having been used for some of the oldest chemical 
transformations known to man, including fermentation for production of beer, are 
now being realised for their huge potential in a numerous variety of areas. More 
recent uses for biocatalysts are being studied for structurally complex 
pharmaceuticals where they have been either impossible or extremely difficult to 
develop via conventional chemical synthesis. ‘Biocatalysis can be defined as the 
application of a biocatalyst to achieve a desired conversion under controlled 
conditions in a bioreactor’ (Krieger et al., 2004).  
 
Application in industry of biocatalysts has become widespread with the demand 
for complex products including pharmaceuticals, agrochemicals and plastic 
materials (Schmid et al., 2001; Schmid et al., 2002; Pollard and Woodley, 2007). 
For example, the synthesis of an optically pure carbonic anhydrase inhibitor 
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TRUSOPT, by Merck for the treatment of glaucoma, employed two biocatalytic 
steps instead of a complex chemical synthesis (Kim et al., 2007). The further 
demand for enzymes with characteristics able to act on alternative substrates, and 
the demand for more complex molecules such as chiral products provides a 
greater need for biocatalysts due particularly, to their exquisite enantioselective 
ability (Adam et al., 1999; Caner et al., 2004). The development of processes 
integrating biocatalysis is therefore, essential for the next generation of greener, 
more efficient, industrial processes and requires improvement of product yield to 
become feasible. The development of biocatalysts with respect to the 
environments that reactions may be performed, i.e. organic solvents, pH, 
temperature, that were previously detrimental to the catalyst, have increasingly 
benefitted biocatalytic processes and therefore facilitated the progression of more 
sophisticated synthetic systems (Adams et al., 1995; Schmid et al., 2001).  
 
Biocatalysts can take the form of isolated, purified enzymes, enzyme complexes, 
or whole cells (lysate or intact whole cells) (Krieger et al., 2004). Within industry, 
isolated biocatalysts are mainly hydrolytic or isomerisation enzymes, whereas 
whole cells are utilised for synthetic reactions which necessitate the need for 
cofactors that may be regenerated in a whole cell system, eradicating the need for 
continual feeding of cofactors, thereby reducing costs (Schmid et al., 2001).  
 
 
 
1.4.1 Advantages and disadvantages of biocatalysis 
  
A particularly useful characteristic of a biocatalyst is the ability to take part in a 
reaction and remain unchanged and therefore be available for further substrate 
conversion. Regenerated cofactors create an advantageous system reducing both 
costs and process time by eliminating purification and washing steps and the need 
for new cofactors for each batch.  
 
Biocatalysts provide a process that may be a single or two step scheme, whereas 
the alternative chemical synthesis may require a multitude of stages with complex, 
costly separation, cleaning and purification protocols. The need for protection and 
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deprotection steps required in chemical synthesis is often eliminated with the use 
of biocatalysts (Lye et al., 2002; Sheldon and Rantwijk, 2004). As a consequence 
of fewer steps in biocatalytic processes compared to conventional chemical 
syntheses there may be less waste and lower emissions, potentially reducing 
environmental burden.  
 
Biocatalysts also boast an environmentally friendly nature, compared to their 
conventional chemical counterparts (Pereira et al., 2005). This is due to the mild 
conditions the enzymes are able to perform in, relating to the biological origin of 
the catalyst (Sheldon and Rantwijk, 2004) resulting in a reduction in the use of 
organic solvents and an increased use of renewable resources (Schmid et al., 
2001). For example, a particular reaction within the body where fatty acids are 
oxidised to form carbon dioxide and water, the reaction conditions are mild i.e. 
body temperature and pH, and the reaction runs efficiently and rapidly. However, 
when the reaction is performed synthetically, high temperatures, extremes of pH 
and hazardous chemicals are required. There also remains the advantage that the 
enzyme is less likely to produce undesirable and/or toxic by-products that may be 
seen regularly in the chemical synthesis (Schmid and Verger, 1998).  
 
The mild conditions associated with biocatalysts, also provide a means of 
eliminating problems that often afflict conventional methods. These problems 
include undesirable side reactions such as isomerisation, racemisation, 
epimerisation and rearrangement, which will affect the product yield and therefore 
the efficiency of the reaction (Burton et al., 2002). Improved environmental 
impact may also be attributed to the fact that the enzyme, through conformational 
change in the protein structure, lowers the activation energy required for a 
reaction to occur, whereas chemical synthesis requires an external source of 
energy, such as heat.  
 
A significant advantage associated with the use of biocatalysts is the ability to 
produce optically pure, enantioselective products. The enzyme preferentially 
discriminates between enantiomers during a reaction, related to the shape of the 
molecule and specific interactions within the enzyme active site. This is another 
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factor that afflicts the chemical synthesis, which would require further 
racemisation and/or kinetic resolution steps.  
 
An important feature which many enzymes inherit from their natural environment 
is the sensitivity to both substrates and products, in particular at critical 
concentrations. Often, high product concentrations within a reactor will become 
toxic or inhibitory to the enzyme. This may be due to a feedback mechanism of 
the cell of origin to switch off the enzyme when the product is at optimal 
concentrations within the cell. This feature inevitably causes limitations within a 
process and therefore often requires solutions to realise optimal productivity.  
 
Drawbacks of the use of biocatalysts are associated largely with the production of 
the enzyme and their stability. The production of the enzyme becomes difficult 
with particularly labile enzymes. The reputation remains that the immobilization 
to stabilise enzymes is effective yet costly, and the stability of the enzymes is 
‘inherent to their complex structure’ (Llanes, 2001).  
 
 
1.4.2 Ideal biocatalysts 
 
Designer biocatalysts are becoming increasingly commonplace throughout 
industry, enabled by the use of recombinant DNA technology. Further to the 
advantages associated with the use of enzymes in synthesis, is the potential held 
by enzymes to be adapted and manipulated genetically (Burton et al., 2002). The 
development of several techniques such as directed mutagenesis, has provided, 
and will continue to do so, the numerous industries with an increasing supply of 
specific, process-compatible biocatalysts. The observation that the range of 
reactants is not limited by the original metabolism of the biocatalyst signify that 
they are able to transform both natural and non-natural compounds is amplified by 
such processes (Held et al. ,2000). The alteration of specific amino acid residues 
within an enzyme gene, based on a particular approach, such as phylogenetic or 
structural, followed by screening and characterisation is a useful tool for the 
development of the biocatalyst pool. An expanding repertoire of enzymes with a 
large range of capabilities and characteristics is hugely valuable.  
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‘Ideal’ biocatalysts for industry would possess high specific activity, high storage 
and process stability, and would also be unaffected to issues such as substrate and 
product inhibition (Hibbert et al., 2005). Enzyme specific activity may be 
quantified by kcat and specificity kcat/Km and are significant parameters requiring 
characterisation for the determination of the applicability of a reaction.  The 
degree of substrate specificity is a significant parameter requiring characterisation 
to realise its potential for synthetic transformations (Woodley, 2006). Together 
with these parameters, the cost of effectiveness of the biocatalyst largely 
determines its synthetic utility at industrial scale, determined by the kinetic 
parameters and its production.  
 
 
1.4.3 Biocatalysts in Industry 
 
The transfer of techniques established in the laboratory to industrial scales 
involves a number of considerations. The effectiveness of a biocatalyst in terms of 
selectively and activity, must remain as high as possible with the scale up of 
substrate and subsequent product concentrations. Many processes to date have 
been engineered successfully and are currently in use for production of a wide 
range of fine chemicals (Shulze and Wubbolts, 1999; Panke et al., 2004), 
including those used in the food industry (Hecquet et al., 1996), pharmaceuticals 
(Hecquet et al., 1994), agriculture and paper and dye production among many 
more. The wide range of enzymes available, i.e. oxidoreductases, transferases, 
hydrolases, lyases, isomerases, and ligases has enabled this flexibility, providing a 
means for many syntheses. The synthesis of aspartame, an artificial sweetener, is 
an example of a bioprocess within the food industry employing biocatalysts, 
where the precursor, L-phenylalanine, an aromatic amino acid, is synthesised by a 
thermolysin catalysed reaction (Oyama, 1985). The pharmaceutical industry, of 
particular relevance here, utilises biocatalysis for numerous drug synthesis 
processes, such as anticancer, antiviral, antihypertensive, anti-Alzheimer’s drugs 
and for example the synthesis of semi-synthetic β-lactam antibodies with the use 
of acylases (Schoemaker et al., 2003). A further example of the production of 
chiral products for the pharmaceutical industry includes the generation of S-
ibuprofen by Sepracor, using a lipase biocatalyst from Candida cylindracea 
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(Krieger et al., 2004). The increasing use of biocatalysts within the food industry 
is instigated by the demand for natural flavourings, i.e. not compounds made 
synthetically (Schrader et al., 2004; Cheetham, 1997). Vanillyl-alcohol oxidase 
(VAO) is a versatile biocatalyst used in the enantioselective production of the 
flavouring vanillin (van den Heuvel et al., 2001; van den Heuvel et al., 2004).  
 
 
1.4.4 Transketolase (TK) 
 
Transketolase, (TK; E.C. 2.2.1.1) a thiamine dependant enzyme, catalyses the 
formation of carbon-carbon bonds within the non-oxidative branch of the pentose 
phosphate pathway in animals and the Calvin cycle in plants. In addition to the 
cofactor thiamine diphosphate, transketolase also requires divalent metal ions 
such as  Ca2+, Co2+ and Mg2+ (Racker et al., 1953).  
 
 
 
Scheme 1: Natural TK Reactions. TK catalysed reactions of the oxidative 
pentose phosphate pathway.   
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A broad range of substrates have been reported for TK’s from yeasts, plants 
(Kobori et al., 1992) and bacteria (Sprenger et al., 1995) and, since the products 
of these enzymes have been seen to serve as precursors for a number of synthetic 
compounds, the enzyme is being exploited for industrial application (Wohlgemuth 
et al., 2009). TK catalysed reactions have been seen as dominant tools in the 
toolbox of routes to sugars, sugar analogs, glycoprocessing enzyme inhibitors and 
carbohydrate probes (Takayama et al., 1997). The compounds produced using TK 
are also useful building blocks for conversion to other chiral synthons such as 
aminodiols (Schmid et al., 2001; Ingram et al., 2007).   
 
E. coli TK was successfully overexpressed (Lilly et al., 1996) and an irreversible 
reaction was made possible by the use of ketone donor, hydroxypyruvate, due to 
the release of CO2 driving the equilibrium to completion (Srere et al., 1958). 
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Scheme 2: The transketolase catalysed reaction using hydroxypyruvate 
(HPA) in the presence of cofactors, thiamine pyrophosphate (TPP) and Mg2+.  
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1.4.4.1 Synthetic potential of transketolase 
 
The synthesis of carbohydrates and sugars and important intermediates for the 
investigation of metabolic diseases are a significant example of the synthetic 
potential of transketolase (Shaeri et al., 2006). The conventional chemical 
synthesis of the particular metabolite, D-xylulose-5-phosphate (X5P) requires 
numerous steps including protection and deprotection processing causing low 
product yields (Breuer and Hauer, 2003), instigating alternative routes of 
production (Sprenger et al., 1995; Sprenger and Pohl, 1999; Zimmerman et al., 
1999; Faber and Patel, 2000;). A two step enzymatic pathway utilising 
transketolase and triosephosphate isomerase has been characterised and 
operational guidelines determined (Shaeri et al., 2008).   
 
The synthesis of aromatic amino acids L-tryptophan, L-tyrosine and L-
phenylalanine from D-glucose by TK-catalysed reactions (Frost and Draths, 
1995), are examples of its use within a range of industries L-tryptophan is useful 
in the medical, food and animal feed industries, and also used as a precursor in the 
synthesis of the dye, indigo (Draths and Frost, 1991). L-tyrosine is used as a 
precursor for a UV-absorbing substance, eumelanin and L-phenylalanine is further 
transformed within the food industry for the production of aspartame, an artificial 
sweetener, and is also used within the pharmaceutical industry (Shenck et al., 
1998).  
 
TK has also been employed within the flavour and aroma industries, due 
particularly to the demand for ‘natural’ flavourings and aromas. The use of 
biocatalysts for the synthesis of these compounds is stoked by this demand and 
the premium price allocated to such food additives. A compound with a caramel-
like flavour, furaneol, is made though a chemoenzymatic synthesis involving a 
TK-catalysed reaction forming the furaneol precursor, 6-deoxy-L-sorbose (Schenk 
et al., 1998; Turner, 2000).   
  
Chiral amino alcohols are potentially synthesised by a multi-enzyme pathway of 
transferase enzymes, transketolase and transaminase. The products of the 
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transketolase catalysed reaction have been seen to be accepted by transaminase for 
optically active chiral amines with multiple chiral centres (Ingram et al., 2007). 
The demand for both amino acids and optically pure non-proteinogenic amines 
from the nutrition and pharmaceutical industry is ever increasing in line with the 
demand for optically pure compounds in general. The large scale synthesis of 
single enantiomer peptidomimetic drugs calls for the synthesis of chiral amines as 
precursors, for example, L-tert-leucine in an HIV protease inhibitor as part of 
AIDS therapy (Kempf et al., 1991) and D-phenylalanine in a remedy for 
thrombosis (Bajusz et al., 1990).  
 
 
1.4.4.2  TK function In vivo 
 
In vivo, TK catalyses two reactions of the metabolic pathway which utilises free 
energy of metabolite oxidation in order to generate NADPH for reductive 
biosynthesis. The pathway also serves to synthesise ribose-5-phosphate for the 
synthesis of both nucleotides and nucleic acids. 
 
In the first reaction a thiamine diphosphate-mediated reversible transfer of a 2-
carbon unit from D-xylulose-5-phosphate to D-ribose-5-phosphate affords 
sedoheptulose 7-phosphate. In the second reaction, also thiamine diphosphate 
mediated, the transfer of a 2-carbon unit from D-xyulose-5-phosphate to the 
aldose erythrose-4-phosphate, affording fructose-6-phosphate and 
glyceraldehydes-3-phosphate.  
 
 
1.4.4.3  Transketolase mechanism 
 
The catalytic mechanism of transketolase, particularly TK from yeast, has been 
well studied including subunit interactions and cofactor binding (Datta and 
Racker, 1961, Nilsson et al., 1997, Fiedler et al., 2001). The apo-enzyme of TK 
requires two cofactors, TPP and divalent metal ions to become the holo-enzyme 
which exists as a dimer. The active sites of the enzyme are formed at the interface 
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of the monomers and TK is therefore only active as a dimer. Each monomer or 
subunit has a molecular weight of 73 kDa (Brocklebank et al., 1999).  
 
X-ray studies of the transketolase structure indicated each subunit consisting of 
three domains, the N-terminus or PP-domain (residues 3-332), the middle or Pyr-
domain (residues 323-538), and the C-domain (residues 539-680). Whilst reports 
suggest the N-terminus and Pyr-domain are involved in cofactor binding, it is 
unclear of the function of the C-domain (Kochetov, 2001).   
 
Transketolase binds TPP in a ‘V’ conformation, which is energetically less 
favourable and is activated by the deprotonation of the C2 atom of the thiazolium 
ring of TPP which has been indicated as necessary for catalysis (Schenk et al., 
1998). This C2 deprotonation yields a carbanion which then attacks the carbonyl 
group of the ketol donor (nucleophilic attack). The C-C bond cleavage yields the 
aldose molecule and an enzyme bound TPP with a two carbon fragment attached 
(a resonance stabilised C2 carbanion). A new C-C bond is formed by the 
subsequent attack of the C2 carbanion on the terminal carbon of the acceptor 
aldehyde substrate. The TPP is subsequently available for the next reaction (See 
scheme 3).  
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Scheme 3. Transketolase mechanism. (E) transketolase enzyme (Voet & Voet, 
2004). 
 
 
 
 
 
 
 
 
 41
 
1.4.4.3.1 Thiamine pyrophosphate (TPP) 
 
Transketolase is dependent upon the presence of the cofactor thiamine 
pyrophosphate (TPP) also known as thiamine diphosphate (ThDP) shown in 
Figure 1.5. Thiamine diphosphate consists of an aromatic methylaminopyrimidine 
ring which is connected to a methylthiazolium ring via a methylene bridge. The 
thiazole ring contains nitrogen and sulphur atoms with a diphosphate functional 
group bound to the hydroxyethyl side chain. The nitrogen and sulphur within the 
thiazole ring portion of TPP, act by donating a proton and forming a carbanion. 
 
Previously, studies involving the catalytic activity of thiamine pyrophosphate 
demonstrated that the thiazolium ring alone can in fact catalyse reactions similar 
to TPP dependent enzymes, however at much slower rates (Krampitz, 1969; 
Schenk et al., 1998).  
 
 
 
 
 
 
Figure 1.5:  Thiamine pyrophosphate (TPP). 
 
 
 
1.4.4.4 Sources of TK 
 
Transketolase has been located in varying quantities within all organisms to date. 
Sources include yeast (Kotchetov, 1982), rat and pig liver (Paoletti and Aldinucci, 
1986; Kotchetov, 1982), E .coli (Sprenger, 1991) and spinach (Demuynck et al., 
1990).  Previously, for scientific purposes TK was sourced mainly from spinach 
 42
and Saccharomyces cerevisiae until more recently when the TK gene was 
successfully overexpressed in recombinant E. coli (Draths and Frost, 1990; French 
and Ward, 1995). This allowed for the production of TK in large quantities and at 
a relatively low cost in fermentations up to 1000 L scale (Hobbs et al., 1996). 
 
 
1.4.4.5 TK production 
 
The large scale production of TK though fermentation of E. coli has been 
successfully implemented and bench scale fermentations are possible to yield 
sufficient quantities of biocatalyst. DNA technology has enabled high protein 
productivity utilising fermentation where the micro-organism is manipulated to 
over produce (over-express) a target enzyme. A recombinant micro-organism 
often consists of a host organism, such as E. coli and a vector, such as a plasmid. 
The plasmid, a DNA molecule, is modified by the insertion of a specific gene 
encoding the target protein, for instance an enzyme such as transketolase. 
Analogous to naturally occurring processes, the micro-organism replicates in the 
correct conditions along with the plasmid vector, of which the organism is 
hosting. Over-expression of the inserted gene is amplified by the ability of the 
plasmid to replicate up to 1000 times more than the host.  The cost and simplicity 
of producing the enzyme is therefore attractive for industrial processes.  
 
Release of the enzyme from the intracellular environment of the bacterium has 
been demonstrated by sonication (Bonsignore et al., 1962) for smaller processes 
and homogenisation (Gray et al., 1972) for larger volumes for improved 
consistency.   
 
 
1.4.4.5.1 TK purification 
 
In order to purify the enzyme from contaminants and other native enzymes 
potentially acting in similar ways to the target enzyme, a specific procedure is 
required. A number of methods exist, such as, ammonium sulphate fractionation, 
protein specific antibodies, SDS-PAGE and size exclusion chromatography. A 
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more specific and somewhat simpler method however, involves affinity 
chromatography. A method whereby a  polyhistidine-tag (his-tag or his6-tag) 
which is an amino acid sequence in proteins consisting of up to 6 histidine 
residues is attached to the N- or C-terminus of the protein. The procedure is often 
used for affinity purification of recombinant proteins that are expressed in E. coli 
or other prokaryotic expression systems. The process works by the specific 
binding of the his-tag to nickel groups of Ni-NTA (nickel-nitrilotriacetic acid) 
resins within a column, followed first by washing and then elution from the 
column providing a purified enzyme solution.  
 
 
The application of the his-tag / Ni-NTA technology also lends itself well to 
enzyme immobilisation, a process used within biochemical engineering to 
overcome an array of process limitations (Krenkova and Foret, 2004). Such as, 
increased biocatalyst stability, increased durability, potential re-use of the 
biocatalyst, optimal control of the biocatalyst within solution, where it may be 
removed rapidly from contaminants and simplified removal from product 
solutions (Chibata, 1978). The stability of enzymes within industrial processes is a 
problem being faced more widely, as the advantages of biocatalysts become 
recognized. During industrial processes where high substrate concentrations are 
required and high ionic environments are concerned, proteins become denatured 
and processes become unfeasible. Immobilisation has been investigated and in 
many cases found to increase operational stability of the biocatalyst. The 
attachment of the protein to solid interfaces of films or coatings can result in a 
more stable protein structure and therefore more active and efficient biocatalysts. 
Several studies have reported reduced thermal denaturation of immobilised 
enzymes (Brocklebank, 1999) and is often thought to be due to the rigidification 
of the proteins tertiary structure.  
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1.4.5 Enzyme modification 
 
The application of enzymes within industrial processes for synthesis of specific 
intermediates relies upon the ability of the enzyme to act on desired substrates and 
within certain reaction conditions.  To enable the continued growth of biocatalysis 
application within further disciplines and a wider range of industries, the pool of 
available enzymes must be augmented. An alternative to searching for or creating 
enzymes with specific properties for target compound synthesis is the 
enhancement of existing enzymes. Modifying enzyme characteristics such as 
activity, substrate specificity or selectivity, pH optimum, stability in organic 
solvents and thermostability are ways in which the advantages of biocatalysis can 
be better suited to reactions conditions and requirements that are commercially 
useful. A number of approaches currently exist to take advantage of the capacity 
of enzymes to embrace modification for improvement.  
 
 
1.4.5.1  Enzyme evolution 
 
In biology, enzymes successfully evolve, and adapt at the molecular level.  
Evolution is a natural process within an organism’s population, where inherited 
traits change from one generation to the next on the basis of improvement with 
regard to survival and reproduction. The evolution of enzymes has created a huge 
array of diverse proteins capable of performing within a diverse range of 
environments. This diversity provides a reservoir of enzymes to choose from for 
industrial applications that may require, for example high temperatures or acidic 
process conditions. Some enzymes will possess these characteristics naturally and 
may be known as extremozymes (Kirk et al., 2002; Straathof et al., 2002; 
Robertson and Steer, 2004). These enzymes have successfully adapted to extreme 
environments such as temperatures (hyperthermophiles), high salt (halphiles), pH 
(acidophiles and alkaliphiles) and pressure (barophiles).   
 
The natural evolution of enzymes may be exploited and performed within the 
laboratory, providing enzymes with often specific properties. Powerful 
recombinant DNA technology and enzyme-screening technology enable the 
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development of ‘designer biocatalysts’ providing ‘ideal biocatalysts’ (Cowan et 
al., 2004; Kourist et al., 2008).  
 
 
1.4.5.2 Directed evolution 
 
Directed evolution is a powerful algorithm aiming to modify proteins, introducing 
mutations at the molecular level potentially introducing desirable properties, not 
otherwise found naturally (Schmidt-Dannert and Arnold, 1999; Schmid et al., 
2001; Zhao et al., 2002; Dalby, 2003). This powerful tool may be implemented 
within the laboratory, where recombinant organisms are utilised and their amino 
acid sequence modified though alteration of the DNA sequence.  Within a short 
period of time compared to the lengthy process of natural evolution, just a matter 
of days, a generation of mutants can be made, screened and selected.  
 
It is true, however, that the complexity of a protein amino acid sequence holds 
back the process of simply changing a sequence for a target property. The stability 
of enzymes, for example relies upon the well orchestrated folding and specific 
arrangement of amino acids. The successful improvement of one characteristic 
such as enhanced activity, may be detrimental to this protein stability. 
Mutagenesis studies enable the identification of protein structure and function and 
the involvement of particular amino acid residues. It subsequently enables DNA, 
RNA and protein design with specifically altered stabilities, activities, 
enantioselectivities and tolerance to organic solvents to name but a few (Miyazaki 
and Arnold, 1999).  
  
Directed evolution is based upon the generation of diversity proceeded by the 
screening of target characteristics, such as substrate acceptance and the selection 
of these mutants.  The technology has been exploited as a more general approach 
to the alteration and improvement of enzyme characteristics, through random 
mutagenesis and recombination (Arnold et al., 2001; Sylvestre et al., 2006). 
Indeed saturation mutagenesis of selected sites has also proven to be a successful 
strategy for improving enzyme properties (Miyazaki and Arnold, 1999; Shinkai et 
al., 2001; Goud et al., 2001; Hayes et al., 2002; Santoro and Schultz, 2002; 
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Peimbert and Segovia, 2003; Mullegger et al., 2005; Ashworth et al., 2006; 
Hibbert et al., 2007). 
 
The directed evolution process begins with the selection of an enzyme with the 
ability to catalyse a required reaction system for synthesis of target compounds. 
Appropriate reaction conditions may then be optimized, and the enzyme is then 
subjected to an in vitro directed evolution cycle. Through screening of the 
generated mutants for improved or new activity, mutants are selected and further 
directed evolution cycles may be applied to create a more stable and robust 
biocatalyst (Schmidt-Dannert, 2001; Walsh, 2001; Dalby, 2003).  
 
The enantioselectivity of an enzyme is a significant target characteristic for 
enhancement using such processes as directed evolution. For instance, a directed 
evolution process applied to a lipase-catalysed hydrolytic kinetic resolution of a 
chiral ester improves the enantioselectivity of 2% ee to >90% ee (Reetz and 
Jaeger, 2000). The use of enzymes such as TK for studies involving mutagenesis 
is beneficial due to the considerable knowledge already reported. Several 
transketolase protein sequences in conjunction with a number of crystal structures 
are available including transketolase from S. cerevisiae both with and without the 
substrate bound and also from E. coli (Littlechild et al., 1995).  
 
‘Site specific’ mutagenesis (rational design) is used to describe the method where 
a single base is targeted within a very small known sequence of DNA (Reetz and 
Carballeira, 2007) as opposed to random base mutations throughout the coding 
gene (Kazlauskas, 2005; Paramesvaran, 2009). This method is used for the 
determination of protein structure and function as well as altering or improving 
enzyme function. The basic procedure relies upon the design of a sequence 
specific oligonucleotide or primer containing the desired base change. This primer 
is hybridized to a single stranded DNA containing the target protein gene, and the 
primer extended enzymatically with DNA polymerase. The subsequent double 
stranded gene containing the base change is inserted into a chosen host cell and 
cloned. A significant advantage associated with site directed mutagenesis is the 
relatively small number of mutant libraries required for the identification of 
improved properties in well known protein structures (O’Fagain, 2003). 
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Polymerase chain reactions, known as PCR, methods are now used increasingly 
for the amplification of DNA strands containing specific mutations.  
 
 
1.4.6 TK biotransformation 
 
 
1.4.6.1 Reactants and products 
 
In vivo, ribose-5-phosphate is the readily accepted α-hydroxyaldehyde donor 
molecule by TK within the pentose phosphate pathway. The synthesis of both 
phosphorylated carbohydrates (structurally homologous to its natural substrates) 
(Srere et al., 1958; Mocali et al., 1985) and non-phosphorylated carbohydrates 
(Villafranca and Axelrod, 1971; Demuynck et al., 1990) have been reported. 
Many acceptor aldehydes were investigated for activity with transketolase, 
predominantly α-hydroxyaldehydes (Effenberger et al., 1992; Kobori et al., 1992) 
until a broader range of aldehydes were investigated (Demuynck et al., 1991). The 
subsequent investigation into substrate tolerance using E. coli Transketolase, 
highlighted the ‘promiscuity’ of the enzyme by its notable lack of specificity for 
aldehyde acceptor substrates compared to Yeast TK.  
 
Preliminary studies using yeast and spinach TK with a variety of aldehydes 
enabled some conclusions to be drawn with regard to the acceptor aldehyde. It 
was seen that the presence of a hydroxyl group or an oxygen atom at the α-carbon 
or/and β-carbon enhanced relative rates. Also, steric hindrance near the aldehyde 
group causes a reduction in relative activity. In addition, α,β-unsaturated aldehyde 
are accepted as TK substrates, benzaldehyde is a poor substrate but the presence 
of hydroxyl-groups on C2 leads to higher activities. Finally, heterocyclic 
aldehydes are accepted better than benzaldehyde but low initial velocities were 
still observed (Demuynck et al., 1991).  
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Table 1.3: Aldehyde substrates and conversion levels reported in literature.  
Acceptor aldehyde 
substrate 
Reaction product (Ketol donor is 
HPA) 
Conversion 
% 
Reference 
 
Glycolaldehyde  
L-erythrulose 
74 
Morris et 
al., 1996 
and Hobbs 
et al., 
1993. 
Glyceraldehyde Xylulose 
37 
(racemic 
substrate) 
Hobbs et 
al., 1993 
 
Propanal dihydroxypentan-2-one 
29 
Hobbs et 
al., 1996 
and Morris 
et al., 1996 
3-O-
benzglyceraldehyde 
 
             5-o-benzyl-D-xylulose 
80 
Humphrey 
et al., 2000 
benzaldehyde 
 
   5-benz-1,3-dihydroxypentan-2-one 
33:18 
Morris et 
al., 1996 
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The transketolase catalysed conversion of carbohydrates is a reversible reaction 
shown in Scheme 2. It was previously demonstrated (Srere et al., 1958), that β-
hydroxypyruvic acid (HPA) was accepted as a ketol donor substrate by TK, 
driving the equilibrium to completion. The decarboxylation of β-hydroxypyruvate 
and the subsequent release of CO2 from the reaction render it an irreversible 
condensation reaction. This creates a commercially viable reaction and therefore 
HPA has since been used as a substrate in many transketolase reactions as an 
alternative to ketose sugars. As one of the TK substrates, measuring HPA 
depletion is a method of analysing activity, HPLC is a useful technique for this. 
 
Where HPA is utilized for its irreversible quality, a disadvantage stands that a pH 
change occurs due to the consumption of the substrate, although this is offset by 
the by-product CO2 reacting with water to produce H+ ions, therefore the 
monitoring and subsequent addition of acid is required (Brocklebank et al., 1996; 
Lilly et al., 1996). 
 
 
1.4.7 TK stereoselectivity  
 
Previous studies examined the enantioselectivity of TK-catalysed reactions and 
found the condensation of α-hydroxyaldehydes with HPA to be specific to 
aldehyde acceptor molecules with the α-hydroxyl group in the D (i.e. 2R)-
configuration (Hobbs et al., 1993; Humphrey et al., 1995). Preceding experiments 
indicated the preference of TK for the D-enantiomer of glyceraldehydes by 
demonstrating similar activity with this enantiomer to achiral glycolaldehyde, 
whilst no activity was seen at all with the L-enantiomer. Furthermore, racemic 
glyceraldehyde (D/L-glyceraldehyde) indicated half the activity exhibited by the 
stereospecific D-enantiomer substrate shown in Figure 1.6 (Morris et al., 1996). In 
summary, 1,2-diols in the D-threo configuration are synthesised by TK in the 
presence of TPP by transfer of a hydroxyketo group from a donor substrate to an 
acceptor aldehyde.  
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Figure 1.6: Enantioselectivity of E . coli towards D-, L- and DL-
glyceraldehyde. Activity indicated by the consumption of HPA over time (Taken 
from, Morris et al., 1996).  
 
 
 
Table 1.4: TK Activities towards various substrates relative to 
glycolaldehyde. (Adapted from, Bolte et al., 1987). 
 
Substrates Vsubstrate/Vglycolaldehyde Products 
D-glyceraldehyde 3-phosphate 44 D-xylulose-5-p 
D-erythrose 4-phosphate 33 D-fructose-6-p 
D-arabinose 5-phosphate 24 D-octulose-8-p 
D-glucose 6-phosphate 9 L-erythrulose 
D-glyceraldehyde 78 D-xylulose 
L-glyceraldehyde <0.01 - 
DL-glyceraldehyde 56 D-xylulose 
D-erythrose 56 D-fructose 
D-glucose 4 D-octulose 
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1.5 Diels Alder reaction  
 
The ‘Diels Alder reaction’ (DA) was discovered by Kurt Alder and Otto Paul 
Hermann Diels, and earnt them the Chemistry Nobel prize in 1950 (Diels and 
Alder, 1928).  The discovery and subsequent development of this cycloaddition 
reaction has become an invaluable tool for organic chemists and has since been 
adopted as the standard method of six-membered ring formation. The reaction is 
widely used in industry for the construction of cyclic and heterocyclic compounds 
from simple materials.  
 
The organic chemical reaction, involves the addition of a conjugated diene and a 
dienophile, forming a cycloadduct more commonly known as a substituted 
cyclohexene system, giving six new stereocentres in a single step. The most basic 
of the Diels Alder reactions occurs between the simplest conjugated diene, 1,3-
butadiene and the simplest alkene (dienophile), ethene to form cyclohexene 
shown in Figure 1.7. The variety of starting materials that can be used, leads to an 
array of useful cycloadducts.  
 
 
 
 
 
 
Figure 1.7: Diels Alder cycloaddition reaction proposed mechanism.  
 
 
 
1.5.1 Diels Alder reaction substrates  
 
The driving force behind the reaction involves the formation of two new δ-bonds 
replacing two π-bonds. The mechanism of the reaction involves a single step with 
no intermediate. The reaction is concerted and almost synchronous, and is largely 
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favoured by the presence of electron withdrawing groups on the dienophile and 
the corresponding presence of an electron-donating group on the diene.  
 
The diene component of the reaction is an intermediate between an alkene (with a 
single bond) and polyenes (with multiple double bonds). Dienes suitable for the 
Diels Alder reaction are conjugated (two double bonds separated by a single 
bond). The diene is reactive in the s-cis conformation for the efficient addition to 
a conjugated dienophile. The corresponding s-trans diene is relatively unreactive.  
 
Ethene is the simplest dienophile that has been utilised for the Diels Alder 
reaction. Acrolein is a commonly used dienophile and is a substrate for the 
production of cyclohexenecarboxaldehyde. Simply, dienophile means ‘diene 
loving’ and therefore shows reactive tendencies in the presence of appropriate 
conjugated dienes.   
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                         Ethene    Conjugated carbonyls (aldehydes, ketones and esters) 
 
 
Figure 1.8: Examples of good dienophiles as substrates for DA reactions.  
 
 
 
1.5.2 DA cycloadducts  
 
Cyclohexenecarboxaldehyde is a possible product of the Diels Alder reaction, and 
is also a potential substrate for the transketolase reaction. Although it has been 
reported that cyclic-aldehydes (Hobbs et al., 1993) were not good substrates for 
transketolase, advances in enzyme engineering can now aim to broaden the 
substrate range including these bulky aldehydes thought to cause steric hindrance. 
Some Diels Alder reactions may be performed enantioselectively providing a 
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means of supplying stereoselective biocatalysts with chiral starting materials for 
the potential of 100% conversion with no waste (i.e. unreactive enantiomer) 
(Thadani et al., 2004).  
 
 
1.5.3 Solvents and catalysts for Diels Alder reaction 
 
Several studies have looked at the effects of solvents on reaction rate of the DA 
reaction, in order to determine the actual mechanisms behind the observed kinetic 
changes. Many solvents have been used to improve reaction rates, however it has 
been concluded that many of these unusual media were not the cause of the 
enhanced reaction rate, it was due to the involvement of a Lewis acid catalyst.  
 
It has been well observed over the years that DA reactions performed in aqueous 
media can vastly increase the reaction rate (Breslow and Guo, 1988; Pindur et al., 
1993; Li, 1993). Although this discovery occurred early on in the DA reaction life 
time, it was not fully exploited and did not receive much attention. However, 
more recent studies have examined the effect of the media on the reaction rates 
and much has been considered, including the substituents of the substrates, such 
as the hydrophobicity of the dienophiles resulting in increased reaction rates 
(Pindur et al., 1993). The use of water as a solvent for the DA reaction has been 
largely reported and accelerations of up to 13,000 times compared to organic 
solvents have been seen (Otto et al., 1996). Proposed mechanisms for this 
outstanding reaction rate enhancement consist of 1) enforced hydrophobic 
interaction and 2) hydrogen bonding to the activating group of the dienophile. The 
evidence that water acts as a powerful catalytic media even without the presence 
of a catalyst, for the DA reaction prompted experiments using water as the 
solvent. It has also been observed that selectivity was enhanced when reactions 
were performed in aqueous media compared to similar reactions in organic 
solvents (Lubineau and Queneau, 1987; Lubineau et al., 1994). 
 
There are a number of systems used widely to catalyse the DA reaction, in 
particular, the well known acid catalysts. The acid catalysts act on the dienophile 
component of the reaction. Protonation or complexation of the dienophile by the 
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acid catalysts result in an energy decrease and is thought to cause the acceleration 
and improved selectivity of the DA reaction. Other, more recent systems such as 
TADDOL (α,α,α’,α’-tetraaryl-1,3-dioxolane-4,5-dimethanol), a ‘simple, 
commercially available chiral alcohol’,  has been developed for specific dienes 
and without the use of metal substituents, enhances the Diels Alder reaction 
similarly to the metal-based Lewis acid catalysts (Thadani et al., 2004).  
 
In 1942, the Brønsted acid catalyzed Diels Alder reaction was reported by 
Wasserman (Wasserman, 1942) however has received less attention than the well 
established Lewis-acid catalysts (Nakashima and Yamamoto, 2005). A Brønsted 
acid is a molecular entity that, in the presence of a base or corresponding 
molecule, is able to donate a proton. This protonating ability causes an activation 
of the dienophile and has a subsequent catalytic affect. Brønsted catalysts include 
acetic acid, bromoacetic acid, dichloroacetic acid and trichloroacetic acid. 
 
Utilising chiral Lewis acids for the asymmetric catalysis of Diels Alder reactions 
is well established in literature (Aggarwal et al., 1995). Lewis acids such as zinc 
chloride (ZnCl2) and aluminium chloride (AlCl3) act by coordinating to the 
dienophile substrate, resulting in a more electrophilic complex more reactive 
towards the diene substrate. The rate of the reaction is often therefore increased. 
The majority of studies associated with the catalysis of the Diels Alder reaction 
with Lewis acids, are limited to the use of organic solvents. This is surprising, 
when in the past it has been observed that the reaction is superior in aqueous 
media with Lewis acids when compared to organic solvents (Otto et al., 1996). An 
example of a Lewis acid is nobium pentachloride (Figure 1.9), where previously 
unreactive dienes and dienophiles are activated by the compound and undergo the 
Diels Alder mechanism. 
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Figure 1.9: Lewis acid: nobium pentachloride structure. 
 
 
 
 
Ionic liquids are also reported as a useful component for the catalysis and solvents 
simultaneously of DA reactions (Chen et al., 2004). In this project I have used a 
moisture stable, Lewis acidic, room temperature ionic liquid containing a 
quaternary ammonium salts and functionalised side chain, [Me3NC2H4OH]Cl 
(Abbott et al., 2001). The development of this ionic liquid attempted to both 
improve moisture stability and reduce costs, where aluminium containing 
imidazolium-based liquids were particularly costly and difficult to make due to 
the water insensitivity of the aluminium anions. Also, the alteration of the ionic 
liquid freezing point was investigated so as to reduce it and therefore create a 
simple and easy to make ionic liquid. The variation of metal anions and use of 
functionalised side chains successfully produced ionic liquids at 23-25 °C. 
 
 
1.6 Enzyme kinetics 
 
The investigation of reactions catalysed by enzymes involves the determination of 
the enzyme kinetics and the effect of reaction conditions such as pH, temperature 
and ionic strength on reaction rate. Enzyme kinetic mechanisms are generally 
described by the Michaelis-Menten theory, named after Leonor Michaelis and 
Maude Menten (Michaelis and Menten, 1913). In simple terms the theory 
proposes that the reaction proceeds in two steps, the first, a reversible binding of 
the substrate and enzyme followed by the irreversible reaction (whereby the 
product does not bind to the enzyme) of the enzyme-substrate complex to form 
the product and release the enzyme. An additional assumption that the rate of 
binding is more rapid than the rate of reaction describing that the enzyme-
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substrate (ES) complex is in equilibrium with the concentration of free enzyme 
(E) and substrate (S) at all times.  
 
  
 
 
Where, k1 represents the rate of the forward reaction of E and S,  k-1 represents the 
rate of dissociation of ES to E and S and k2 represents the rate of formation of 
product (P) and subsequent release of E.  
 
The first assumption of the mechanism describing the more rapid change in 
concentration of P and S than ES can be written as: 
 
 
 
 
 
 
The second assumption of the theory that the total enzyme concentration ([E]0) 
does not change over time and can therefore be written as: 
 
 
 
[E]0  = [E] + [ES] = const. 
 
Due to the concentration of substrate changing as the reaction proceeds, the initial 
reaction rate (v0) is analysed for simplicity (as it is approximately linear) and can 
be defined as: 
 
vo = k2 [ES] 
 
 
 
E + S           ES        E + P 
k -1 
k1 k2 
d[ES] 
   dp 
= k1 [E][S] – [ES] (k -1 + k2) = 0 
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And therefore maximum velocity (Vmax) can be defined as: 
 
 
Vmax = k2 [E]0 
 
 
The rate of reaction may then be expressed as:  
 
 
 
 
 
 
 
 
Where the Michealis-Menten constant, Km be written as: 
 
 
 
 
 
 
 
 
 
 
The determination of enzyme kinetics largely rely on the determination of the 
Michaelis-Menten constants Km and vmax (or kcat). Enzyme assays are often 
performed with small quantities of enzyme, a range of substrate concentrations 
and detection of product formation over time and characterised using calibration 
curves with substrate concentrations that exceed the Km. 
 
Enzyme inhibition issues may also be characterised by Michaelis Menten theory, 
such as competitive and non-competitive, product and substrate inhibition. The 
mechanism behind such inhibitory effects is an inherent ability of enzymes for 
complex control of reaction within natural environment. Reflecting their 
involvement in complex biochemical pathways in vivo for control of homeostasis, 
enzymes are often inhibited by their own substrates or products, either of which 
may severely limit the productivity of a biocatalytic process.  
v 0  =  
Vmax[S] 
Km + [S] 
k -1 +  k2 
k1 
Km = 
 58
 
1.6.1 Detection methods 
 
Enzyme activity may be detected using many methods of analysis such as 
chromatography methods including HPLC, GC and TLC. Other methods include 
NMR, where sequential spectra of the metabolites provide a reaction profile, 
potentially of both reaction substrates and products and calorimetry, based on the 
proportionality between the rate of a reaction and the thermal power (heat/time) 
generated (Todd and Gomez, 2001).  
 
Some enzymatic reactions are detected colorimetrically or fluorometrically where 
absorbance/fluorescence or optical density is measured by a spectrophotometer. 
For example, the detection of carbonic anhydrase by carbon dioxide hydration 
(Livesey, 1977) and an assay for amino acids using ninhydrin (Schwert, 1948). 
Many reactions involve a colorimetric component attached to the substrate or one 
of the substrates of the reaction being measured. Such as, a functionality that once 
reacted emits a specific colour that may then be measured. The amount of colour 
is then proportional to the amount of product directly.  
 
A reaction may also be detected microbiologically, where the reaction product is 
used as a subsequent substrate for the growth of a microorganism, and organism 
growth is measured by optical density. The amount of growth is proportional to 
the amount of reaction product present.  
 
Traditionally, TK activity was measured using a spectrophotometric assay, 
involving an NADH dependent enzyme, a method based on a system used by 
Heinrich and co-workers in 1972 (Figure 1.10). Additionally a pH indication 
assay using para-nitrophenol was used, and also importantly an HPLC assay based 
on the detection of residual substrates and formation of product (Mitra et al., 
1996; Miller et al., 2007).  
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Figure 1.10: Linked enzyme assay for transketolase catalysed reaction 
product detection.   
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1.6.1.1 Colorimetric assay 
 
A tetrazolium-red colour assay, shown in Figure 1.11, was developed for the 
detection of ketodiol products of the transketolase catalysed reaction (Smith et al., 
2006). Studies regarding the screening of a large number of novel mutant libraries 
made though directed evolution techniques, required a simple, sensitive and high-
throughput assay (Hibbert et al., 2007). Efforts were targeted to generate TK 
mutants with enhanced rate of reaction with a variety of acceptor aldehyde 
substrates including propanal (Hibbert et al., 2008). The assay was developed to 
quantitatively distinguish between mutants that had improved activity compared 
to WT-TK. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Colourimetric assay for TK. The assay ustilises the reduction of 
colourless tetrazolium red in the presence of non-α-hydroxyaldehydes forming red 
coloured compound formazane.   
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1.7 Summary, aims and objectives 
 
The main objective of this project was to establish and present a model 
chemoenzymatic pathway for the synthesis of structurally diverse compounds 
with the potential for optical purity. Whilst aiming to explore the compatibility of 
a compound synthesized chemically and applied directly to a biotransformation, 
but also providing preliminary indications of a potential ‘one-pot synthesis’. The 
use of a valuable Diels Alder reaction and well studied transketolase reaction 
provided good model components for integration and subsequent characterization. 
Determining the kinetic parameters of a substrate relatively far removed from the 
natural substrates of TK with possible TK mutants is significant for understanding 
such a system. In addition, due to the demand of optically pure pharmaceuticals 
the determination of enantiomeric purity is a significant aim of the project. The 
challenges highlighted, include increasing substrate complexity and therefore 
synthesizing more interesting and complex products. Also, identifying issues such 
as low substrate solubility in aqueous media and enzyme inhibition, for instance 
product toxicity at critical concentrations.  
 
Chapter two provides general materials and methods paramount to this 
investigation including E. coli fermentation and TK isolation. Chapter three aims 
to investigate the target acceptor aldehyde substrate for the transketolase reaction 
and address the synthesis using a potentially compatible chemical method. The 
screening and subsequent identification of a TK mutant with the ability to accept 
the novel substrate is presented. Chapter four continues with the highlighted TK-
mutants and determination of reaction rates and yields at preparative scales, where 
optimal conditions are analysed including the study of cosolvent addition where 
substrate solubility in aqueous media is limited. Chapter five presents the 
determination of the Michaelis-Menten kinetic parameters, Km, kcat and vmax for the 
mutants of TK with the cyclic aldehyde and compared to WT-TK kinetics 
utilising a modified colorimetric detection assay validated by HPLC. Chapter six, 
provides preliminary investigation into product and substrate inhibition associated 
with the pathway together with initial compatibility limitations. Prospective 
solutions are discussed. Chapter seven summarises the findings throughout the 
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investigation and offers a final discussion of the topics highlighted. Chapter eight 
continues by describing potential extensions and the future implications to this 
work.  
 
 
The overall aims of the project: 
 
♦ To establish a novel model pathway demonstrating chemoenzymatic 
synthesis of novel compounds.  
 
♦ To identify new TK mutant enzymes with desired substrate specificity 
and preserved high selectivity.  
 
♦ To demonstrate substrate walking which will allow the substrate 
specificity of an enzyme to be evolved beyond currently perceived 
limitations. 
 
♦ To extend the synthetic repertoire of TK bioconversions by 
introducing a novel, cyclic aldehyde substrate. 
 
♦ To determine the kinetic parameters and enantioselectivity of the novel 
transketolase reaction.  
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2 General Materials and Methods 
 
 
2.1 General  
 
Unless otherwise noted, solvents and reagents were reagent grade from 
commercial suppliers (Sigma-Aldrich) and used without further purification. Dry 
CH2Cl2 was obtained using anhydrous alumina columns. All moisture-sensitive 
reactions were performed under a nitrogen or argon atmosphere using oven-dried 
glassware. 1H NMR and 13C NMR spectra were recorded at the field indicated 
using Bruker AMX300 MHz, Avance-500 MHz and Avance-600 MHz machines. 
Coupling constants are measured in Hertz (Hz) and unless otherwise specified, 
NMR spectra were recorded at 298 K. Mass spectra were recorded on a Thermo 
Finnegan MAT 900XP and Micro Mass Quattro LC electrospray mass 
spectrometers VG ZAB 2SE. Infrared spectra were recorded on a Shimadzu 
FTIR-8700 and Perkin Elmer Spectrum 100 FTIR spectrometer. Optical rotations 
were recorded on a Polarimeter Perkin Elmer model 343 polarimeter at 589 nm, 
quoted in deg cm2.g–1 and conc (c) in g.100 mL-1.  
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2.2 Reagents 
 
Proteins were made in house by fermentation of glycerol stocks of E. coli 
pQR412:XL10-gold AmpR made for previous study. The D469T-TK mutant and 
WT-TK was expressed with a His6 tag from pQR412:XL10-gold (AmpR) as 
described previously (Hibbert et al., 2008) (previously cloned from expression 
construct pQR706 obtained by Dr John Ward, Department of Biochemistry and 
Molecular Biology, UCL and transformed by Dr Christine Ingram). RO water was 
used in all experiments. All other reagents including cyclic aldehydes were of 
analytical grade and were obtained from Sigma-Aldrich (Gillingham, UK), apart 
from the following: acetophenone (Acros Organics, Geel, Belgium), β-
hydroxypyruvic acid lithium salt (Fluka, UK) and pyridoxal-5-phosphate 
(Calbiochem/Merch Chemicals, Nottingham, UK). (5S)-2,2,3-Trimethyl-5-
phenylmethyl-4-imidazolidinone monohydrate chloride was purchased (Sigma-
Aldrich). 
 
2.3 Biocatalyst preparation 
 
2.3.1  LB-agar plates and streaking 
 
LB-agar was prepared by adding 15 g.L-1 select agar to LB-media. The agar 
solution was then autoclaved at 121 °C. Once cooled to approximately 40 °C, 
ampicillin (150 µg.mL-1) was added and dissolved by gentle mixing and 20 mL of 
the media was poured into standard-sized petri dish, being careful not to introduce 
bubbles. LB-agar plates were streaked with cells (XL10 pQr412) from glycerol 
stocks (50% v/v glycerol stored –80 °C) and incubated for 16 hours at 37 °C. 
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2.3.2 Luria Bertani (LB) media 
 
All media components shown in Table 2.1, are weighed, added to RO water, 
stirred and autoclaved at 121 °C in fermentation shake flasks (ampicillin is added 
after autoclaving).  Fresh media was made for each fermentation batch.  
 
 
 
Table 2.1: Luria Burtani (LB) media components.  
Component Concentration (g.L-1) 
Yeast extract 25.0 
Tryptone 10.0 
Glycerol 10.0 
NaCl 10.0 
Ampicillin 0.15 
 
 
 
2.3.3 Ampicillin 
 
Fresh solutions of ampicillin for bacterial selection were prepared for each 
fermentation at a concentration of 150 µg.mL-1 in RO water. The antibiotic 
solution is added to the autoclaved media through a 0.2 µm filter (Pall, MI, USA).  
 
 
2.3.4 Overnight culture 
 
A single colony was picked from streaked and cultured agar plates (described 
above) and used to inoculate 250 mL shake flasks containing 25 mL LB-glycerol 
media (containing ampicillin 150 µg.mL-1) and incubated overnight at 37 °C and 
200 rpm using an SI 50 orbital shaker (Stuart Scientific, Redhill, UK).  
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2.3.5 Shake flask fermentation 
 
The overnight culture was used to inoculate a 1 L flask containing 100 mL LB-
glycerol Amp media (10% v/v) , and incubated at 37 °C and 200 rpm. The 
fermentation was monitored by OD600 in triplicate using Unicam UV2 UV/vis 
spectrometer (Cambridge, UK) and related to dry cell weight of previous 
calibration until stationary phase was reached. The samples were diluted with 
fresh LB-media to keep concentrations within visible range (0.1-0.3 A.U). No 
induction was necessary due to the constitutive nature of the recombinant strain.  
 
 
2.3.6 20 L fermentation of D469T-TK 
 
A 20 L fermentation of E. coli pQR412:XL10-gold (AmpR) expressing TK 
mutant D469T was performed in a LH20L01/02 fermenter (LH Engineering Ltd 
2000 Series) with 3000 Series instrumentation and Adaptive Biosystems PC 
software. Temperature was controlled via cold water circulation in the external 
jacket of the glass vessel bioreactor and maintained at 37 °C using a temperature 
probe and heating element (Bioprocess Engineering Services Ltd, Kent, UK). pH 
was measured by a sterilisable Ingold pH probe (Ingold Messtechnik, Urdorf, 
Switzerland) and controlled at a constant value of pH 7.0 (±0.05) by the metered 
addition of 5 M H3PO4. DOT was measured by a polarographic oxygen electrode 
(Ingold Messtechnik, Urdorf, Switzerland) and maintained above 40 %. PPG 
(polypropylene glycol) was added automatically to suppress formation of foam to 
a final concentration in the bioreactor of approximately 0.2 mL.L-1. The in-going 
air flow was set at 0.5 vvm and dispersed through a membrane filter and sparger 
at the base of the bioreactor. Out going air was filtered with a Domnick Hunter 
tetpor air filter cartridge in housing on the exhaust air line. Online data logged, 
e.g. impeller speed, pH, DOT, temperature and exhaust gas measurements were 
recorded with the RT−DAS program (real-time data acquisition system) 
(Acquisition Systems, Guildford, Surrey, UK). 
 
Overnight cultures (250 mL shake flasks) 2 x 20 mL broth were used to inoculate 
larger 2 L shake flasks (100 mL culture) and incubated at 37 °C for 8 hours. The 4  
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x 200 mL cultures were then used to inoculate the bioreactor grown from single 
colonies of AmpR agar plates incubated for 16 hours. The bioreactor contained 
two Rushton turbines for stirring and was sterilised in situ for 30 minutes at 121 
°C and ampicillin added (150 µg.mL-1) once cooled to 37 °C. The fermentation 
was performed until the end of the exponential phase, approximately 10 hours. 
The cells were harvested and centrifuged using CARR P-6 centrifuge and 
homogenised (APV CD60 homogeniser) in cold phosphate buffer (5 mM, pH7.0) 
and clarified by centrifugation (4000 rpm for 10 minutes at 4 °C) in 500 mL 
centrifuge bottles and stored at -20 °C.  
 
 
2.3.7 Glycerol stocks 
Overnight growth culture with shaking at 200 rpm was added to 50% v/v of sterile 
filtered glycerol and mixed in aseptically. Aliquots of 1 mL eppendorfs were 
frozen at -80 °C and used for plate streaking. 
 
 
2.3.8 Sonication for clarified lysate 
 
For clarified lysate preparations used in biotransformations, the culture broth was 
thawed, centrifuged for 10 minutes at 4000 rpm at 4 °C on a Hettich Universal 
320R mid-bench centrifuge (DJB Labcare, Newport Pagnell, UK) and the 
supernatant discarded. The cell pellet was resuspended in cold phosphate buffer (5 
mM) and sonicated (on ice) in a Soniprep 150 (MSE, Sanyo, Japan) with 6 cycles 
of 10 second 8 µ pulses with 15 second pauses. The sonicate was clarified by 
centrifugation as above and the supernatant decanted and filtered (0.45 µm GD/X 
PVDF syringe filters; Whatman, UK) to remove excess cell debris, and used 
immediately or frozen at -20 °C.  
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2.3.9 Sonication for purified enzyme 
 
For lysis of cells in preparation for purification the culture broth was thawed and 
the broth (in 50 mL Falcon tubes) was centrifuged for 10 minutes at 4000 rpm on 
a Hettich Universal 320R mid-bench centrifuge (DJB Labcare, Newport Pagnell, 
UK) and the supernatant discarded. The cell pellet was resuspended in binding 
buffer (500 mM NaCl, 20 mM Tris-HCl, 5 mM imidazole; pH 7.0), with a v/v 
ratio of 1:10 buffer to broth. The resupended cell pellet sonicated with an ice 
jacket, using 6 cycles of 10 seconds 8 µ pulses with 15 seconds intervals for each 
50 mL of culture broth using a Soniprep 150 sonicator (MSE, Sanyo, Japan). The 
lysate was clarified by centrifugation at 4000 rpm at 4˚C as above. The 
supernatant was decanted and filtered (0.45 µm GD/X PVDF syringe filters; 
Whatman, UK) to remove excess cell debris, and purified immediately or frozen 
at -20 °C. 
 
 
2.4  Biocatalysis quantification 
 
2.4.1 SDS-PAGE and densitometry 
 
Protein analysis was determined by SDS gel electrophoresis using a Mini-Protean 
II system (Bio-Rad Laboratories Inc., Hemel Hempstead, UK) with 7.5% w/v 
acrylamide gels (prepared with Protogel® stacking and resolving buffers 
(National Diagnostics, Atlanta, GA). with 10% ammonium persulphate and 
TEMED and a 0.05% w/v Coomassie brilliant blue stain. After destaining, the 
protein was visualised and quantified on a GEL-Doc-It bioimaging system with 
labworks 4.5 software (Bioimaging systems, Cambridge) with a marker lane of 
known concentration.  
 
 
2.4.2 Bradford assay 
 
Quantification of total protein concentration was measured additionally using a 
Bradford assay (Bradford, 1977). A protein assay kit was used (Bio-Rad Labs  
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Inc., UK) and protein concentration calibrated with a BSA (bovine serum 
albumin) standard curve. Absorbance was measured at 595 nm using a UV/Vis 
spectrophotometer (Spectronic, Leeds, UK). The Beer-Lambert law was used to 
determine protein concentrations from absorbance measurements.  
 
 
 
A = ελc 
 
 
 
Where, A=absorbance at 280 nm, ε = extinction coefficient (93,905 M. cm-1 for 
transketolase) λ = path length (1 cm) and c = protein concentration (mol.L-1).   
2.4.3 Spectrophotometry for pure TK 
 
Pure transketolase preparations were quantified by UV absorbance at 280 nm 
using a UV/VIS spectrophotometer (Spectronic Leeds, UK) and also with a 
NanodropTM 1000 UV/Vis spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA,USA) and blanked with Tris-HCl buffer (50 mM, pH 7.0) and 
cofactors (TPP, 2.4 mM and MgCl2, 9 mM).  The Beer-Lambert law was also used 
here to determine protein concentration from absorbance measurements.  
 
 
2.5 Transketolase activity test 
 
2.5.1 Tris-HCl buffer  
 
50 mM Tris-HCl (hydroxymethylaminomethane) buffer with a pH of 7.0 was 
prepared by dissolving 6.35 mg mL-1 Tris hydrochloride and 1.18 mg mL-1 Tris 
base in RO water and adjusted to pH 7.0 using HCl and NaOH if necessary.  
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2.5.2 Cofactor solution  
 
Cofactor stock solution for GA and HPA activity tests were as follows: TPP (2.4 
mM, 5.854 mg) and MgCl2 (9 mM, 4.536 mg) were dissolved in 3 mL Tris-HCl 
buffer and pH adjusted to pH 7.0 whilst stirring (Reaction 300 µL total volume, 
10 % enzyme (30 µL), 170 µL cofactor solution, 100 µL substrate solution).  
 
Cofactor stock solution for PA and HPA reaction were as follows: TPP (2.4 mM) 
and MgCl2 (9 mM) were dissolved in 1 mL Tris-HCl buffer and pH adjusted to pH 
7.0 whilst stirring (Reaction: 600 µL total volume, 30% enzyme (200 µL), 200 µL 
cofactor stock solution, 200 µL substrate solution).  
 
Cofactor stock solutions for DCHCA and HPA were made as follows: TPP (2.4 
mM, 6.635mg) and MgCl2 (9 mM, 5.141mg) were dissolved in 1 mL Tris-HCl 
buffer and adjusted to pH 7.0 whilst stirring. (Reaction: 600 µL total volume, 50% 
enzyme (300 µL), 100 µL c factor stock solution and 200 µL substrate solution).  
 
 
2.5.3 Substrate solutions 
 
All substrate stocks were prepared as fresh solutions for each reaction as a 
mixture of lithium hydroxypyruvate (HPA) and aldehyde. All activity assays 
performed maintained equimolar substrate concentrations of 50 mM, unless 
otherwise stated. Lithium hydroxypyruvate was synthesised as described and used 
for all substrate solutions.  
 
 
2.5.4 Activity assay with GA and HPA 
 
The enzyme (30 µL pure or lysate) was pre-incubated with cofactor solution (170 
µL, TPP, 2.4 mM, and MgCl2, 9 mM) to reconstitute the holoenzyme (Sprenger et 
al., 1995). Substrate solution, glycolaldehyde and HPA (100 µL, 50 mM each) 
were added and incubated at 20 °C in SRW 96 microwell plates. Samples were 
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taken at regular intervals, quenched and diluted with 0.2% v/v TFA and analysed 
by HPLC for HPA depletion and L-erythrulose production.  
 
 
2.6 Synthetic chemistry 
 
2.6.1 Lithium hydroxypyruvate 
 
Bromopyruvic acid (0.06 mol) was dissolved in water (100 mL) and carefully 
added 1 M LiOH solution at such a rate that the pH does not exceed 9.5. Glacial 
acetic acid was added dropwise in solution to pH 5. The mixture was concentrated 
in vacuo to approximately 20 mL final volume. The concentration was left to 
crystallise overnight. The crude product was washed with ethanol and filtered off. 
The crude product was suspended in ethanol (50 mL) at 40 °C for 30 minutes. 
White solid was filtered and washed with more ethanol affording a white powder 
(46%). Vmax (KBr/ cm -1) 3462-2619 (broad,O-H from hydrogen bond dimers), 
1608 (strong, C=O, 1244 (strong, C-O). 1H NMR (300 MHz; D2O) δH = 3.60 (2H, 
s, methylene protons), 4.64 (2H, s, OH) 13C NMR (75 MHz; MeOD) δC = 65.8 
(CH2), 66.5 (CH2), 94.8 (gem-diol), 167.9 (C=O), 177.0 (C=O, 203.0 (C=O).  MS: 
m/z (ES+) (%): 220 (100) [2M]+, 152 (20) [M+Na]+  (See appendix).  
 
 
2.6.2 1,3-dihydroxypentan-2-one (DHP)  
 
In a 500 mL round bottomed flask, dissolve lithium hydroxypyruvate (HPA) (1.10 
g, 10 mmol) and propanal (720 µL, 10 mmol) in RO water (200 mL). To this 
solution, 4-methylmorpholine (1.10 mL, 10 mmol) was added and stirred at room 
temperature for 17-24 hours. Silica (1 g) is added to the mixture and concentrated 
to dryness under vacuum on a rotary evaporator (avoiding temperatures of more 
than 50 oC). Flash chromatography was performed as described to give the desired 
product as an oil in approximately 350 mg (28%) yield (an impurity was eluted 
just prior to the desired product and this was thought to be a related triol). The 
product was stored at 4 °C and overtime appears to solidify.   
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2.7 Detection and quantification 
 
2.7.1 Flash chromatography 
 
Silica gel (BDH silica beads 40-63 µm) columns were prepared with a layer of 
sand for neat separation and resolution of components. The columns were 
equilibrated with mobile phase EtOAc:hexanes (2:1) prior to dry loading of the 
silica bound compounds (dried previously on a rotavap). After dry loading the 
product (absorbed onto silica) onto a flash silica column, pure DHP was obtained 
by chromatography eluting with EtOAc:hexane (2:1), fractionation of the eluent is 
analysed by TLC (visualised by PMA and heat) and dried on a rotavap (avoiding 
temperatures of more than 50 °C).  
 
 
2.7.2 Thin layer chromatography 
 
Reactions were monitored by pre-coated aluminium backed silica (TLC) plates 
(Kieselgel 60 F254) with detection by UV (254 nm and 297 nm), potassium 
permanganate and phosphomolybdic acid (PMA), PMA hydrate (12 g) dissolved 
in ethanol (250 mL) stains. Mobile phase solvents system consisted of a 1:1 ratio 
of ethyl acetate and hexanes. Stained plates were visualised by heating with a heat 
gun.   
 
 
2.7.3 HPLC 
 
All HPLC analysis were performed on a Dionex (Camberley, Surrey, UK) 
microbore HPLC system and controlled by Peaknet 5.1 software. A multiwell 
plate autosampler (Spark, Emmen, The Netherlands) was integrated into the 
Dionex system with a GP40 gradient pump, and LC30 column oven, a PC10 
pneumatic controller NaOH addition unit and an AD20 UV detector or ED40 
electrochemical detector (ECD). Chiral HPLC analysis was performed on a 
Varian Prostar instrument equipped with a Chiralcel AD chiral column (Diacel) 
25 cm x 0.46 cm. 
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2.7.3.1 HPLC Standards 
 
Calibration curves were used to quantify absorbance responses for the reaction 
substrates and products. Standards of L−erythrulose, HPA and DHP were prepared 
to a range of concentrations in triplicate and detected by HPLC as described 
(Section 2.7.3.3). Standards of acetophenone and MBA were prepared separately 
and analysed by HPLC in order to obtain standard curves for calibration of the 
TAm reaction also (See appendix).  
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Figure 2.1: Li-HPA calibration curve. Stock solutions of HPA synthesised as 
described, were made ranging 0-50 mM in pH7.0 Tris-HCl buffer (50 mM, 
pH7.0).  
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Figure 2.2: L-erythrulose calibration curve. Stock solutions of L-erythrulose 
(Sigma-Aldrich) ranging 0-40 mM were made in Tris-HCl buffer (50 mM, 
pH7.0).  
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Figure 2.3: 1,3-dihydroxypentan-2-one (DHP) calibration curve. Stock 
solutions of DHP (synthesized as described in Section 2.6.2) ranging 0-50 mM 
were made in Tris-HCl buffer (50 mM, pH7.0). 
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2.7.3.2 HPLC assay for GA and L-erythrulose 
 
A 15 minute isocratic assay was adapted from the existing HPLC assay for the TK 
reaction components glycolaldehyde, HPA and L-erythrulose (Mitra and 
Woodley, 1996). An Aminex 87H column (Bio-Rad, Hemel Hempstead, Herts., 
UK) at 60 °C using a mobile phase of 0.1% (v/v) trifluoroacetic acid (TFA) in 
water at 0.6 mL.min-1. Detection was via a UV detector at 210 nm. Retention 
times were 8.40 min HPA, 11.40 min erythrulose, 12.28 min glycolaldehyde.  
 
 
2.7.3.3 HPLC assay for DHP and HPA 
 
An 8 minute isocratic assay was adapted from the existing HPLC assay for the TK 
reaction components HPA and DHP (Mitra and Woodley, 1996). An Aminex 87H 
column (Bio-Rad, Hemel Hempstead, Herts., UK) at 60 °C using a mobile phase 
of 0.1% (v/v) trifluoroacetic acid (TFA) in water at 0.4 mL.min -1 . Detection was 
via an electrochemical detector (ECD40), set to a standard triple potential, 
following adjustment of pH to above pH 12.0 by post column addition of NaOH.  
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3 Aldehyde design, library screening and mutant 
selection 
 
 
This chapter investigates the initial design and synthesis of a new target aldehyde 
substrate for transketolase that is also the product of a Diels Alder reaction, and 
can therefore be used to demonstrate a chemoenzymatic process. The design of an 
appropriate acceptor aldehyde had to balance both the selection from ‘the best of’ 
conventional chemical synthesis options with the requirement of the chemical 
product to have activity with at least one mutant in a TK biocatalyst library. This 
would then provide a basis for a more in-depth investigation of the full 
chemoenzymatic synthesis in Chapter 4. This chapter also describes the process of 
TK-mutant library screening for enhanced activity with the target acceptor 
aldehyde, sequencing the top performing mutants and then producing pure 
enzyme preparations.  
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3.1 Introduction 
 
3.1.1 Natural substrates for transketolase 
 
TK catalyses a reaction that is stereospecific, whereby the (S)-configuration at the 
C3 of the natural ketol donor is maintained within the new chiral centre of the 
product. The enzyme is also stereoselective, whereby TK selects α–
hydroxyaldehydes with the (R) - configuration at C2 over other configurations. 
Characteristics such as these are particularly attractive for the synthesis of 
commercial compounds, such as pharmaceuticals. 
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Figure 3.1: Natural transketolase substrates.  
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Natural substrates of in vivo TK catalysed reactions, shown in Figure 3.1, include 
phosphorylated sugars, including D-xylose-5-Phosphate, D-erythrose-4-phosphate, 
D-sedoheptulose-7-phosphate and D-fructose-6-phosphate. The phosphate group 
provides a platform for stabilising the substrates through hydrogen bond 
interactions between the phosphate group and residues within the active site 
(Nilsson et al., 1997). Reports have demonstrated that residues 359, 528 and 469 
were highly conserved in TK sequences and lay close to the phosphate group of 
the substrate. These studies concluded that the replacement of these residues with 
alanine caused considerable residual activity but with large increases in Km for 
phosphorylated substrates (Schneider and Lindqvist, 1998). However, recent 
investigations regarding the use of non-phosphorylated substrates have provided 
evidence that reaction can occur without the presence of a phosphate group (Bolte 
et al., 1987; Turner et al., 2000; Hobbs et al., 1993; Hibbert et al., 2007). For 
industrial syntheses it is favourable to eliminate phosphate groups from substrates 
due to the complication they cause in product isolation and also to the subsequent 
removal from reaction products (Schenk et al., 1998; Turner, 2000). The 
application to further non-phosphorylated substrates provides a greater repertoire 
of industrially useful compounds. 
 
 
3.1.2 Non-natural substrates for transketolase 
 
Initially, non-phosphorylated substrates were demonstrated as having limited 
activity and suggested to be due to the reduced substrate binding stability within 
the active site (Villafranca and Axelrod, 1969; Nilsson et al 1997). More recent 
studies have concentrated on providing directed evolution strategies to improve 
this limitation, in order to gain the benefits of increased activity towards 
phosphate free substrates (Hibbert et al., 2007).  The same strategies may be used 
to gain the further benefits of introducing more activity towards non-natural 
substrates into TK, particularly for the synthesis of target compounds that are 
otherwise difficult or impossible to synthesise with conventional chemistry.  
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Hydroxypyruvate has been well demonstrated throughout literature as a 
particularly useful donor substrate, due to the evolution of CO2 creating an 
irreversible reaction (Scheme 4). This reaction system makes the industrial use of 
TK as a biocatalyst very favourable (Bolte et al., 1987).  
 
 
 
 
 
 
  
 
 
 
 
Scheme 4: Transketolase catalysed reaction. Transketolase, in the presence of 
cofactors TPP and Mg2+, catalyses the transfer of a 2-carbon ketol group from 
ketol donor, HPA to acceptor substrate, glycolaldehyde, forming an asymmetric 
carbon-carbon bond in end product L-erythrulose. Carbon dioxide is consequently 
produced, rendering the reaction irreversible.  
 
 
 
Glycolaldehyde (R=CH2OH) (GA), alongside glyceraldehyde has been well 
reported as non-phosphorylated, acceptor aldehyde substrate for analysis of the 
model TK catalysed reaction (Datta and Racker, 1961; Mitra et al., 1996; Hibbert 
et al., 2007). Furthermore, the ketose product, L-erythrulose, of the TK-catalysed 
reaction with GA and HPA is synthesised as a bulk intermediate within several 
industries (Shaeri et al., 2008). The cosmetic industry utilises L-erythrulose as a 
self tanning agent, and the pharmaceutical industry as an intermediate for the 
production of Nelfinavir™, an antiretroviral drug acting on HIV-1 and HIV-2 
proteases (Kaldor et al., 1997). 
 
O
OH
O
OH
O
OH
HOOC
+
TPP, Mg
Hydroxypyruvate
Transketolase
2+
Glycolaldehyde OH
OH
+ CO2
L-erythrulose
Amine
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Approximately 60 aldehydes have previously been identified as acceptor 
substrates for TK indicating its ‘promiscuous’ nature, although certain 
characteristics of the aldehydes have been seen to be crucial for TK activity. In 
particular, the (R)-configuration of a hydroxyl group at position C2, despite the 
acceptance of substrates without a hydroxyl group at position C2.  
 
 
 
3.1.3 Substrate walking 
 
Applying increasingly diverse substrate acceptance into TK in a stepwise fashion 
described as ‘substrate walking’ gives a greater potential understanding of the 
versatility of both native and mutant TK enzymes. Catalysis by WT-TK with a 
previously reported substrate such as glycolaldehyde at well established reaction 
conditions (Gyamerah and Willetts, 1997), indicates the potential activity that 
might be achieved by directed evolution towards new substrates for which the 
current activity is poor or undetectable. For example, exploring the scope of TK 
by directed (or forced) evolution has led to the application of a slightly more 
complex and hydrophobic aliphatic substrate, propanal, which is no longer 
hydroxylated at the C2 position (Hibbert et al., 2008; Smith et al., 2008). This in 
turn may lead to an increased likelihood for access to substrates with a further 
increment of chemical diversity.  Repeating this in a step-wise manner leads to a 
potential substrate series such as cyclopropane-carboxaldehyde, cyclopentane-
carboxaldehyde, cyclohexane-carboxaldehyde and cyclohexene-carboxaldehyde. 
Each modification links the natural substrate to the desired, substantially altered, 
industrially useful substrate shown in Figure 3.2, where the desired substrate is 
out of scope at the first or second round of directed evolution. 
 
Sequential evolution of the enzymes, through forced evolution strategies, may be 
required to allow further complex substrates to be applied to the TK-catalysed 
reaction. Where enzyme activity may no longer be detected, further cycles of 
directed evolution alongside the application of increasingly modified substrates 
may prove valuable.  
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Here we apply the substantially altered substrates directly to both WT-TK and a 
range of first generation TK variants, based on the residue associated with 
stereospecificity and better acceptance of a non-alpha hydroxylated aldehyde. The 
aim is to provide a sound principle for the chemoenzymatic synthesis of 
structurally complex intermediates through non-phosphorylated, cyclic, and 
hydrophobic precursors. This analysis also begins to define the boundaries of 
detectable WT and first generation mutant activities towards substrates with 
increased chemical diversities. 
 
 
3.1.4 Cyclic aldehyde series 
 
The sequentially linked cyclic aldehydes shown in Figure 3.2 are particularly 
interesting due to the link back to substrates structurally homologous to natural 
substrates. Screening of these cyclic aldehydes not only provides a link to more 
highly complex aldehydes but highlights mutants with varied activities towards 
each aldehyde and also mutants with enhanced activity towards all screened 
aldehydes. Such mutants may therefore provide knowledge of the effect of 
particular mutations on selectivity and perhaps structural effects on the active site.   
 
Aldehydes containing cyclic structures greatly increase the potential for the 
synthesis of complex intermediate precursors, through a single biotransformation 
step. Alternative methods of synthesis of such cyclic structures would involve 
numerous multi-step chemical transformations using harsh conditions and many 
protection and de-protection steps. The additional introduction of a double bond 
within a cyclic structure not only pushes the boundaries of currently accepted 
substrates, but further broadens the potential for modification of functionality. A 
greater number of intermediates may be synthesised from this precursor owing to 
the greater number of approaches available, including the reactivity of the double 
bond and the dimethyl groups attached to the cyclic ring.  
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Potential candidates meeting these criteria included 6-methyl-3-cyclohexene-1-
carboxaldehyde, 3,4-dimethylcyclohexane-1-carboxaldehyde, and 3,4-dimethyl-3-
cyclohexene-1-carboxaldehyde (Figure 3.3). 
 
 
 
 
 
 
 
Figure 3.3: Potential target aldehydes. A) 6-methyl-3-cyclohexene-1-
carboxaldehyde B) 3,4-dimethylcyclohexane-1-carboxaldehyde, and C)  3, 4-
dimethyl-3-cyclohexene-1-carboxaldehyde.  
 
 
 
3.1.5 Aldehyde design for a chemoenzymatic reaction cascade 
 
The cyclic aldehydes A and C in Figure 3.3, introduce the potential for their 
synthesis using a Diels Alder route in the first step of a chemoenzymatic synthesis 
using TK in the second step. It was decided to study 3,4-dimethyl-3-cyclohexene-
1-carboxaldehyde (C) due to the greater complexity of the aldehyde, therefore 
providing a greater insight to the potential of substrate acceptance by WT-TK, TK 
mutants or both.  
 
OO O
A                      B                 C 
H H H 
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Demonstrating TK activity towards C was the first step to defining such a 
chemoenzymatic cascade reaction. Probing libraries of existing enzyme mutants 
with novel substrates that are bulky, contain functionality for further chemical 
modification, or that are more hydrophobic and relatively far removed from 
currently accepted substrates, would enhance the potential of TK for the synthesis 
of more complex intermediates. 
 
Compound 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA) was also 
targeted as an acceptor aldehyde for TK mutant screening studies due to the 
potential modifications that may be applied subsequent to the TK reaction. 
Employing a substrate with a bulky structure was considered for pushing the 
boundaries of currently perceived limits, whilst maintaining a structural 
relationship with cyclic aldehydes used in preliminary screens. Introducing an 
alkene group provides further potential for synthetic manipulation. In addition, the 
use of a chiral substrate allows for the assessment of TK selectivity, a significant 
feature of ideal biocatalysts.  
 
A symmetrical diene, 2,3-dimethyl-1,3-butadiene was selected, as opposed to 
asymmetrical isoprene, to avoid in this first system problems with DA 
regioisomers being formed. The essential cis-configuration for the Diels Alder 
reaction is however a limiting factor on reaction rate of the cycloaddition. If the 
diene constituent is part of a cyclic compound such as cyclopentadiene, the cis-
configuration is fixed and therefore the reaction (in appropriate conditions) may 
proceed rapidly. The reaction is limited however, when the diene does not have 
the fixed cis-configuration where the single bond connecting the double bonds is 
continually rotating. The cycloaddition may only proceed at a rate allowed by the 
speed of rotation of the diene to the cis-position. The synthesis of further 
complex, bi-cyclic aldehyde substrates may therefore benefit from enhanced DA 
reaction rates.  
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Figure 3.4: Dienes. 1) Dienes considered for application to Diels Alder reaction 
a) 2,3-dimethyl-1,3-butadiene and b) isoprene 2) cis-trans rotation about the single 
bond.  
 
 
Our aim was to use a racemate generated in the DA reaction as a substrate for TK 
initially for simplicity. The use of a well studied reaction such as the DA reaction 
system is beneficial when integration into a novel multistep reaction requires 
characterisation of individual aspects of each step, as well as complications and 
compatibility between them.   
 
 
3.1.6 Aldehyde synthesis 
 
The catalysis of such reactions has received widespread attention due to the 
valuable nature of cyclic compounds and therefore the methods of 6-membered 
ring formation. Countless DA reactions have been investigated with regard to 
catalysis, media and reaction conditions, including microwave irradiation, 
sonication, high pressure and extreme temperatures (Coda et al., 1984; Blokzijl et 
al., 1991; Otto et al., 1994). Noteworthy efforts have seen great success in the 
effective rate acceleration and also selectivity enhancement of DA reactions, 
particularly in water since the 1980s (Rideout and Breslow, 1980; Sauer and 
Sustmann, 1980).  
 
a) b) 1 
2 
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A recyclable organotungsten Lewis acid [O=P(2-py)3W(CO)(NO)2](BF4)2 was 
reported to effectively catalyse synthesis of DCHCA in ionic liquid media 
(bmimPF6.) with a yield of 92% at room temperature within 4 hours (Chen et al., 
2004). The same catalyst was also reported to catalyse the same reaction with an 
80% yield within 30 seconds, when microwave irradiation was applied. The 
preparation of the catalyst involved several process steps including stirring, 
filtration, cooling, washing and drying.  
 
An alternative method for the synthesis of the same cycloadduct was reported, 
where a moisture stable, Lewis acid containing room temperature ionic liquid 
produced yields of 91% within 2 hours. The process included a simple stirring 
step with no complicated or lengthy extraction methods, and also no purification 
steps were necessary. The preparation of the catalyst, [Me3NC2H4OH]Cl-ZnCl2 
(1:2),  required only two, relatively low cost components, choline chloride and 
zinc chloride, to be stirred whilst heated and cooled to room temperature in air.  
The ionic liquid was also reported to be recyclable (Abbott et al., 2001).  
 
 
3.1.7 Diels Alder (DA) reaction 
 
The substrates of the DA reaction are simple to depict from the chosen target 
product as the reaction is a simple cyclic addition reaction. In detail, the three π 
(pi) bonds of the substrates transfer to give two σ (sigma) bonds and one π (pi) 
bond within the cycloadduct or cyclohexene ring of the product. A functional 
group may be attached to the substrates and will not play a role in the DA 
reaction, but remain within the cycloadduct. The substrates elucidated from the 
target cyclic aldehyde, DCHCA, are diene, 2,3-dimethyl-1,3-butadiene and 
dienophile, acrolein shown in Figure 3.5.   
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Figure 3.5: Target Diels Alder reaction. A) 2,3-dimethyl-1,3-butadiene, B) 
acrolein, C) DCHCA (3,4-dimethyl-3-cyclohexene-1-carboxaldehyde).  
 
 
3.1.8 TK structural mutant library D469 
 
Active site targeted directed evolution by saturation mutagenesis was previously 
used on E. coli transketolase in order to improve activity towards non-
phosphorylated substrates. Two separate approaches to residue selection, 
phylogenetic and structural were used (Hibbert et al., 2007). The phylogenetic 
approach realises the evolutionary variation of transketolases throughout an array 
of species. A number of residues were identified as lying within 10 Å of the TPP 
binding site, and 10 of these, K23, A29, N64, M159, S188, D259, A383, P384, 
V409 and L466 were found to vary since the common TK ancestor. The 
structurally defined sites were selected due to their vicinity to the erythrose-4-
phosphate substrate binding position within the active site of yeast transketolase 
(Nilsson et al., 1997). Residues H26, H100, I189, H261, G262, R358, S385, 
H461, D469 and R520, were all located within 4 Å of the defined active site. 
These previously generated phylogenetic and structural TK mutant’s libraries for 
enhanced activity towards propanal were considered for screening with the cyclic 
aldehydes including DCHCA (Hibbert et al., 2007).  
 
The tetrazolium red assay was developed specifically for the screening of these 20 
mutant libraries targeting enhanced activity towards non-α-hydroxylated 
aldehydes. Establishing a rapid and sensitive assay for the identification of new 
mutants with activity towards novel substrates is fundamental considering the 
enormous number of potential mutants required for screening (Smith et al., 2006) 
(Refer to figures 3.6 and 3.7).  
A B C 
O
O
+ DA
Ionic Liquid
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Figure 3.6: Transketolase active site. Highlighted residues selected for directed 
evolution through two separate approaches, structural and phylogenetic, and 
subsequently considered for screening with cyclic aldehydes including DCHCA. 
(Taken from Hibbert et al., 2007).  
 
Figure 3.7: Strutural library residues.  
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3.1.9 Mutant library selection 
 
Directed evolution strategies have proven to be extremely successful in generating 
enzymes with improved catalytic properties (Hibbert et al., 2007). Previously, 
twenty saturation mutagenesis libraries with regard to specific residues were 
found to enhance activity towards both glycolaldehyde and propanal and also 
enhanced specificity towards propanal (Hibbert et al., 2008). Several factors 
indicating involvement with substrate acceptance led us to explore the structural 
library D469 further. In particular, a number of TK-mutants were identified from 
library D469X as having enhanced activity towards propanal, despite the reported 
decrease in activity of D469E towards formaldehyde (R=CH2) and 
glycolaldehyde. Interestingly, a yeast TK structure with erythrulose-4-phosphate 
adjunct, showed the hydrogen bonding of residue D469 (highlighted in orange on 
figure 3.8) with the C-2 hydroxy group of α-hydroxylated aldehyde substrates in 
the active site.  
 
  
 
 
 
Figure 3.8: Transketolase dimer. Residue D469 highlighted in orange 
previously identified as having significant participation in stereospecificity. 
Generated using PyMOL with data from PDB (Littlechild et al., 1995). 
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3.2 Materials and methods 
 
3.2.1 TK reaction with cyclic aldehydes 
 
Substrate solutions were prepared immediately prior the enzyme reaction to 
maintain homogeneity due to the relatively low solubility in water. Stock 
solutions of each cyclic aldehyde were prepared in water and sonicated on ice, for 
3 cycles of 10 second pulses with 20 second intervals. The assay for cyclic 
aldehydes was performed as described in section 2.5.4 and analysed at 24 hours.  
 
 
3.2.2 Ionic liquid [Me3NC2H4OH]Cl-ZnCl2 (1:2) preparation 
 
The room temperature ionic liquid synthesised here, [Me3NC2H4OH]Cl-ZnCl2 
(1:2),  is available commercially, however, is simple, relatively quick and cheap to 
make. To prepare the ionic liquid (IL) a mixture of zinc chloride (5.45 g, 40 
mmol) and choline chloride (2.79 g, 20 mmol) mixture was heated to 150 °C  and 
stirred magnetically or mechanically (120 rpm) for 10 minutes in a paraffin bath 
until no solid remained. It was then cooled to approximately 28 °C and water 
added (0.72 mL, 40 mmol) with continued stirring. The liquid was cooled further 
to ambient temperature or to 26 °C.  Portions of this material were then used in 
the cycloaddition reaction. 
 
 
3.2.3 Ionic liquid recycling 
 
Following use in the Diels Alder cycloaddition reaction the zinc chloride-choline 
chloride-RTIL ([Me3NC2H4OH]Cl- ZnCl2 (1:2)) was washed thoroughly with 
hexanes and dried for at least an hour on a rota-vap. The catalyst was stored in 
glass screw top vials under argon. The catalyst was heated to a viscosity enabling 
magnetic stirring and cooled to ambient temperature. The RTIL was subsequently 
used as described in section 3.2.4.  
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3.2.4 3,4-Dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA) synthesis 
using Diels Alder reaction in RTIL 
 
 
 2,3-dimethyl-1,3-butadiene (1.36 mL, 12 mmol) and acrolein (0.80 mL, 12 
mmol) were added to the zinc chloride-choline chloride RTIL (0.5 mL) and the 
reaction mixture was stirred for 2 hours at ambient temperature. The mixture was 
allowed to separate by ceasing mixing. The upper layer containing the aldehyde 
was decanted or pippetted from the ionic liquid to give DCHCA as a colourless oil 
(1.53 g, 91%). Smaller scale reactions using 0.5 mL IL and 12 mM of 2,3-
Dimethyl-1,3-butadiene and acrolein required a reaction time of 2 hours, however 
for larger scales (> 5 mL IL)  longer reaction times were required (up to 24 hours) 
and the yield was reduced (500 mM 2,3-Dimethyl-1,3-butadiene and acrolein; 5 
mL IL; 65%) while maintaining the high purity of the product.  1H NMR (300 
MHz; CDCl3) δ 1.54 (3H, s, CH3), 1.61 (3H, s, CH3), 1.87–2.44 (7H, m), 9.67 
(1H, s); 13C NMR (75 MHz; CDCl3) δ 18.9 (CH3), 19.1 (CH3), 22.8, 30.1, 30.5, 
46.9, 123.4, 125.8, 204.7 (C=O) (see appendix).  
 
 
3.2.5 (1R)-3,4-Dimethyl-3-cyclohexen-1-carboxaldehyde (DCHCA 1R 
isomer) synthesis  
 
2,3-Dimethyl-1,3-butadiene (1.13 mL, 10 mmol) and acrolein (2.0 mL, 30 mmol) 
were added to a solution of (5S)-2,2,3-trimethyl-5-phenylmethyl-4-
imidazolidinone monohydrate chloride as catalyst  (255 mg, 1 mmol) in 
acetonitrile/water (95:5, 40 mL). The reaction was stirred at 25 °C for 48 hours. 
The reaction was partitioned between diethyl ether (100 mL) and 0.3 M KHSO4 
(100 mL) and the aqueous phase extracted with diethyl ether (2 × 100 mL). The 
combined organics were dried (MgSO4) and the solvent removed in vacuo to give 
(1R)-DCHCA (1.10 g, 80%). [α]20D = +24.0 (c 1.0, CH2Cl2). 
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3.2.6 Diels Alder cyclo-adduct distillation purification 
 
If necessary the DA cycloadduct (DCHCA) was purified though distillation. The 
aldehyde was heated with anti-bumping granules until boiling point was reached, 
and the more highly volatile, DA substrate contaminants evaporated and 
condensed. The remaining liquid was cooled and analysed for purity by TLC and 
+H NMR. However, purification of the aldehyde was rarely required and all 
aldehyde stocks used for kinetic analysis were not purified.   
 
 
3.2.7 D469X library screening assay 
 
TK mutant libaries were previously produced using saturation site-directed 
mutagenesis using Quikchange kit (Stratagene, Netherlands) and plasmid 
transformed into electrocompetent XL10 (Stratagene) E. coli cells. The D469 
mutant library reaction plate was thawed on ice in order to cause freeze-thaw lysis 
of the 100 µl culture in each SRW 96 microwell plate. The lysed cells were then 
incubated with 12× cofactor stock solution (25 µl of 28.8 mM TPP, 108 mM 
MgCl2 in 50 mM Tris-HCl buffer, pH 7.0) and HPA stock (70 µl of 200mM 
LiHPA in 50mM Tris–HCl, pH 7.0) at room temperature for 20 minutes to 
reconstitute the holo-enzyme. Aldehyde substrate (100 µL, 100 mM DCHCA in 
50 mM Tris-HCl buffer, pH 7.0) was sonicated and then added to initiate the 
reaction, and the microwell plate was sealed using a uniseal polypropylene mat 
(Whatman, Brentford UK) and incubated at room temperature for 24 hours. The 
colour assay was performed as described below.  
 
 
3.2.8 Colorimetric assay for screening  
 
Fifty µL of each microwell was transferred to a fresh SRW 96 microwell plate and 
10 mg MP-carbonate resin added and left to incubate for 3 hours. Fifty µL of Tris-
HCl buffer was added to each microwell and pipette mixed. This solution (50 µL) 
was then transferred to a fresh microwell plate. Automated injection of 20 µL 
tetrazolium red solution (0.2% 2,3,5-tripheyltetrazolium chloride in methanol) and 
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10 µL, 3 M NaOH (aq) with shaking by FLUOstar Optima plate reader (BMG 
Labtechnologies GmbH), was followed by immediate measurement at OD485nm.   
 
0.2% solution of 2,3,5-triphenyltetrazolium chloride in methanol (200 mg of 
2,3,5-TPTC in 100 mL of MeOH). 3 M NaOH (aqueous) (12 g of NaOH 
dissolved in water to give 100 mL final volume of solution). 
 
 
3.2.9 Sequencing 
 
Small scale (10 mL culture in 100 mL flasks) overnight cultures were grown from 
single colonies as described in section 2.3. The culture was centrifuged to isolate 
the cell pellet and a QIAprep Spin Mini Prep (QIAGEN, UK) protocol performed 
to isolate DNA samples.  The samples were diluted to within specific range (16-
18 fmol) and sent (12 µL in 1.5 mL eppendorfs) to The Wolfson Institute for 
Biomedical Research, UCL for DNA sequencing. Primers used were: 
 
TKmidSeq 5’- GTATGAAAGGCGAAATGCCGTCTGACT-3’. 
 
Primers were prepared at concentration of 5 pmol.µL-1. Sequences were 
subsequently analysed by Bioedit software available on the internet: 
www.mbio.ncsu.edu/BioEdit/bioedit.html. 
 
 
3.2.10 TK Mutant production 
 
The TK-mutants and WT-TK had been previously expressed in E.coli strain BL21 
(DE3), pQR412. Allowing for the effective purification of the enzyme, the 
transketolase gene was His6-tagged in previous studies (Ingram et al., 2007). The 
selected mutants from microwells F12, B6, B7, F1, D5 and E2 were streaked from 
glycerol stocks of the same libraries which had been stored at -80 °C, onto LB 
agar plates and incubated for 16 hours. Small overnight cultures were inoculated 
with single colonies, which were subsequently used to inoculate larger scale shake 
flasks. Glycerol was used as a carbon source additive to the culture media to 
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support the constitutive expression of the TK gene. Cell growth was monitored by 
measuring OD600 and the fermentation was ceased once log-phase (exponential 
growth) had been observed and stationary phase was evident.  
 
 
3.2.11 TK purification (His-tagged pQR412) 
 
Fresh fermentation broth was centrifuged at 4000 rpm for 10 minutes, to obtain a 
compact cell pellet and clear media supernatant. Cell pellets were immediately re-
suspended in cold binding buffer (500 mM NaCl, 20 mM Tris-HCl, 5 mM EDTA, 
pH 7.95) with gentle pipette mixing and sonicated with a Soniprep 150 on ice to 
counteract any heating generated. Equilibration of His bind Quick 900 cartridges 
with a cellulose matrix an immobilised Ni-NTA was performed prior to sample 
loading, followed by a series of washes using specific wash buffer 1 M EDTA, 
500 mM NaCl and 20 mM Tris-HCl. Loading of each sample was passed through 
the same column twice to maximise protein binding to the Ni2+ cations within the 
column at a rate of 2 drops s–1. The pure TK was then eluted with an EDTA 
elution buffer then dialysed overnight against 50 mM Tris-HCl buffer, pH 7.5, 
and then stored at 4 °C.  
 
In order to improve enzyme stability further, cofactor stock solution was added to 
the dialysis buffer (TPP, 2.4 mM and MgCl2, 9 mM) and two 8 hour dialysis steps 
replaced a single overnight dialysis in fresh buffer for each step to ensure the 
removal of potentially detrimental buffer (EDTA).  
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3.3 Results and discussion 
 
3.3.1 TK wt on GA, PA and cyclic aldehydes 
 
 
The product, L-erythrulose (L-Ery) and donor substrate, HPA concentrations were 
detected by HPLC and compared to previous measurements. The GA reaction was 
used because of its rapid reaction rate, well reported activity with WT-TK (Hobbs 
et al., 1994; Mitra, 1997; Mitra et al., 1998), readily available substrates and 
products and crucially its well established analytical HPLC method (Mitra and 
Woodley, 1996). 
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Figure 3.9: GA and HPA reaction profile. Representative TK catalysed reaction 
using 10% clarified TK-lysate, 50 mM (equimolar) substrate concentration at 22 
°C (see section 2.5.4 for details).  
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The TK catalysed reaction of HPA and glycolaldehyde, synthesising L-
erythrulose, is able to run to completion within 60 minutes. The measurement of 
the depletion of substrate HPA and the formation of product L-erythrulose is 
shown in Figure 3.9 and indicates a good stoichiometric correlation between the 
substrate consumption and product synthesis by the enzyme. The pure WT-TK 
catalysed reaction toward glycolaldehyde and HPA has a specific activity of 0.61 
µmol.mg.min-1. 
 
 
 
 
Figure 3.10: GA and HPA activity assay. A pure TK catalysed glycolaldehyde 
and HPA conversion to L-erythrulose and CO2 based on results shown in Fig. 3.9.  
 
 
 
Propanal (R=CH2CH3) is the next stepping stone of the substrate walking pathway 
and the reaction has been analysed for optimal TK catalysed reaction conditions. 
The use of this non-α-hydroxylated, aliphatic aldehyde with mutants of TK was 
previously described as having improved specific activity of 0.14 µmol.mg.min-1, 
with a 4.9 fold activity improvement relative to WT-TK (Hibbert et al, 2008).  
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Scheme 5: Transketolase (TK) catalysed reaction. Propanal (PA) and HPA 
form 1,3-dihydroxypentan-2-one (DHP) via the transketolase catalysed reaction.  
 
 
 
For identification and subsequent calibration of the propanal and HPA reaction 
product, 1,3-dihydroxypentan-2-one (DHP) was synthesised biomimetically in 
water (discussed further in section Chapter 4), and reaction progression analysed 
by TLC.  The propanal (PA) reaction profile indicates lower specific activity than 
glycolaldehyde, however establishes the ability of WT-TK to accept non-
phosphorylated, aliphatic substrates.  WT-TK activity towards propanal and HPA 
was determined to be 0.056 µmol.min-1.mg-1. 
 
 
 
 
 
 
 
  Hydroxypyruvate               Propanal                                                 DHP 
CO2 
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Figure 3.11: Transketolase reaction profile.  Propanal (50 mM) and HPA (50 
mM) WT- transketolase catalysed reaction in Tris-HCl buffer (50 mM, pH7.0) 
and cofactors TPP (2.4 mM) and MgCl2 (9 mM) at 20 °C. Substrate HPA (●) and 
product DHP (□) detected by HPLC.  
 
 
 
 
     Hours         1                   5      10      24   48  
 
 
Figure 3.12: Colorimetric assay photograph. Propanal (50 mM) and HPA (50 
mM) transketolase catalysed reaction in Tris-HCl buffer (50 mM, pH7.0) and 
cofactors TPP (2.4 mM) and MgCl2 (9 mM) at 20 °C for 48 hours.  
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In order to establish the potential for activity with an aldehyde substrate greatly 
removed from currently reported substrates with respect to its, size, 
hydrophobicity and functionality, initial studies using lesser complex aldehydes 
were done. Screening reactions using WT-TK were subjected to a large range of 
increasingly complex cyclic aldehydes i.e, cyclopropancarboxaldehyde, 
cyclopentanecarboxaldehyde, cyclohexanecarboxaldehyde and 3-cyclohexene-1-
carboxaldehyde. A 50 mM substrate reaction incubated at room temperature for 
24 hours, and visualised on TLC using PMA and heat, indicated some product 
formation from all of the tested aldehydes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Substrate walking TLC. Plate A, mobile solvent 2:1 Ethyl 
acetate/hexane and Plate B Mobile solvents 1:1 Ethyl acetate/hexane, 24 hours, 50 
mM 1. propanal, 2. cyclopropancarboxaldehyde, 3. cyclopentanecarboxaldehyde, 
4. cyclohexanecarboxaldehyde and 5. cyclohexencarboxaldehyde (see section 
2.7.2 for details).  
 
HPA HPA 
product 
product 
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Furthermore, the cyclic aldehydes were analysed for activity with the mutant 
D469T comparing the initial rates of the cyclic aldehydes with propanal shown in 
Table 3.1. Each of the specific activity and initial rates indicate a decrease with 
increasing ring size of the aldehyde. Steric hindrance of the aldehyde within the 
active site of the enzyme may be responsible for the decreasing activity, or 
decreasing conformational flexibility of the ring potentially reducing the 
probability of correct orientation.   
 
 
 
Table  3.1: Specific activity of D469T against cyclic aldehydes compared to 
propanal (TK 0.3 mg.mL-1).  
Aldehyde Initial Rate 
mM.h-1 
Specific activity 
µmol.mg-1.min-1 
Initial relative 
rates 
 
 
 
Propanal 
 
12.5 0.69 1 
 
 
Cyclopropane-
carboxaldehyde 
 
7.45 0.41 0.6 
 
 
Cyclopentane-
carboxaldehyde 
 
4.47 0.25 0.4 
 
 
Cyclohexane-
carboxaldehyde 
 
3.46 0.19 0.4 
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3.3.2 New aldehyde synthesis 
 
3.3.2.1  Ionic Liquid  
 
The production and use of a quarternary ammonium, lewis acidic, moisture stable, 
ionic liquid was reported for the synthesis of cyclic intermediates including this 
aldehyde, 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA) (Abbott et al. 
2001; Abbott et al. 2002). Several volume scales and substrate concentrations 
with and without the addition of water were investigated, stirring both 
magnetically and mechanically, with an overhead anchor type impeller. Using 
previously reported reaction conditions of 12 mmol substrates in 0.5 mL of a 1:2 
ratio of zinc chloride-choline chloride and stirring for two hours at ambient 
temperature, the cycloadduct yield was 91%. 
 
 
 
 
 
Figure  3.14: Mechanical stirring of large volume RTIL and DA reactants. a) 
(10mm used here) This width is significant for the effective stirring of viscous 
liquids, avoiding stagnant areas on the surface of the vessel. b) (60% of the height 
of the reactor used here) The height of the anchor-type impeller is also significant 
for allowing rotational flow throughout the viscous liquid.    
 
125rpm 
DA in RTIL  
a 
b 
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Table 3.2: Effect of ionic liquid volume on yield. All reactions except those 
mechanically stirred had 1 molar equiv. water added. * Mechanically stirred as 
shown in Figure 3.14. Reaction times given are the times maximum yield was 
reached. (Ambient temperature ~20 °C).  
Substrate 
Concentration 
Volume mL 
(Ionic Liquid) 
Temperature 
°C 
Reaction 
Time (h) 
Yield 
% 
12 mM 0.5 Ambient 2 91 
12 mM 5 25 2 90 
24 mM 0.5 Ambient 4 85 
24 mM 0.5 28 4 85 
50 mM 0.5 28 24 84 
0.1M 5 Ambient 24 90 
0.1M 0.5 28 24 55 
0.2M 0.5 Ambient 24 40 
0.5M 5 Ambient 24 65 
0.5M* 100 25 - - 
1 M* 100 Ambient - - 
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Figure 3.15: Effect of ionic liquid volume on DA reaction yield. Ionic liquid 
([Me3NC2H4OH]Cl-ZnCl2 ratio 1:2)  (●) 0.5 mL and (◊) 5 mL, volumes affecting 
aldehyde (DCHCA) yields of the Diels Alder reaction.  
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The addition of water to the ionic liquid was reported to ease stirring due to the 
high viscosity of the solvent and catalyst mixture. It was seen that the addition of 
water to the ionic liquid during its cooling stage was critical for stirring 
magnetically. The viscosity of the ionic liquid as it neared its freezing point of 23-
25 °C was far too high for the magnetic stirrer bar to consistently stir the mixture 
prior to the addition of the substrates. It was observed that the absence of water 
during the late stages of cooling caused the ionic liquid to solidify, disabling the 
substrates from mixing with the solvent and catalyst, therefore no reaction 
occurred.  
 
Maintaining the temperature at just above the reported freezing point of 23-25 °C 
for the ionic liquid proved advantageous for the ease of stirring magnetically and 
mechanically. Mechanical stirring was used at larger scales >5 mL and although 
the addition of water eased stirring it was not necessary at a maintained 
temperature of 28 °C in an oil bath.  However, for both magnetic and mechanical 
stirring without the addition of water at ambient temperature (22 °C) at a scale of 
100 mL ionic liquid, stirring became very difficult and the formation of emulsions 
between the ionic liquid and substrates solution were evident. The emulsion failed 
to separate into the ionic liquid and product phases. It was also observed that the 
mixture turned a vivid orange colour, possibly due to hotspots within the viscous 
emulsion causing adverse reactions.  
 
 
 
3.3.2.2 DA reaction optimisation 
 
 
Acrolein and 2,3-dimethyl-1,3-butadiene were easily depicted through simple 
evaluation of the target compound, due to the reaction being an atom efficient 
cyclo-addition. The uncatalysed reaction between 2,3-dimethyl-1,3-butadiene and 
acrolein was reported to take over 2000 hours (Odenkirk et al., 1992). No reaction 
product was seen, however, after 4 weeks of stirring at room temperature as a neat 
mixture of the two substrates, or as a 0.5 M reaction in water.  
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To a stirred ionic liquid the substrates were added and continued stirring until 
reaction reached completion. The product (cycloadduct) was then allowed to 
separate from the ionic liquid and subsequently removed by decanting. The 
aldehyde product was analysed for purity and found to be >90% pure.  
 
 
 
 
 
 
 
 
 
Figure 3.16: Diels Alder reaction in room temperature ionic liquid (RTIL) 
(See section 3.2.4). 
 
 
Yield dropped as scale increased, possibly due to the increased reaction time 
allowing for side reactions to occur such as acrolein polymerisation. The longer 
reaction periods may have also seen an increased level of substrate loss through 
evaporation. Acrolein possesses a relatively low boiling point of 53 °C and 
similarly for 2,3-dimethylbutadiene at 68 °C. Improved sealing of the reaction 
Acrolein + 2,3-dimethyl-
1,3-butadiene 
Ionic Liquid and DA 
substrates stirred 
magnetically 
Reaction mixture left to separate, 
product (top layer) removed 
directly by pipetting or decanting.  
O 
H * 
DA Cycloadduct 
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vessel may reduce this loss along with more effective temperature control and 
stirring at scale may aid reaction productivity.  
 
It was found that the ratio of ionic liquid to substrate volume was critical with 
regard to overall product yield and reaction time. An increased ratio of substrate 
volume to ionic liquid volume was shown to reduce yield greatly from 91% to 
40% (Table 3.2). Larger scale reactions, where >5 mL of ionic liquid and equal 
volumes of substrates were used required lengthy reaction times, of up to 24 
hours, compared to the 2-4 hours required for completion with smaller scales <5 
mL ionic liquid.  
 
Control reactions were performed to establish any interaction between the 
substrates without the ionic liquid solvent and catalyst. The two DA reaction 
substrates were stirred neat, for 24 hours at room temperature and no product 
formation was observed. The ionic liquid was replaced with water and the 
reaction stirred for up to 24 hours, again no product formation was observed at 
room temperature. It was previously reported that the reaction time without the 
presence of the ionic liquid, or any catalyst was as long as seven weeks (Odenkirk 
et al., 1992). 
 
Removal of the product from the ionic liquid mixture was a particularly simple 
procedure, as it neatly separated from the ionic liquid/water solution as a layer on 
top (Figure 3.15). It was found that reducing the temperature to below the freezing 
point of the RTIL enabled the product to be simply poured from the reaction 
vessel. Subsequent purification of the product was not required, however 
distillation and flash chromatography were performed if necessary.  
 
 
3.3.2.2.1 Ionic liquid recycling 
 
 
It was reported that the ionic liquid was reusable and no drop in yield was seen 
here after 3 uses, however, the ionic liquid appeared to take on a yellow 
colouration. This may be due to an accumulation and subsequent polymerisation 
of the residual acrolein and also the presence of any contaminants post reaction, 
 108
bearing in mind the reaction takes place in air. No yellow colour was seen in ionic 
liquid stored under argon at 4 °C, which had not been used for a reaction over a 
period of 6 months.  A small drop in activity was seen however after 4 cycles of 
use from 90% (±1%) to 88% (±2%) and then further to 79% (±2%) conversion 
after 5 cycles. This may be due to the increased level and therefore contamination 
of acrolein polymers within the ionic liquid despite a thorough washing 
procedure. A report suggests that mass spectrometric analysis of the ionic liquid 
after recycling shows that the alcohol side chain of some ammonium cations may 
have reacted with the carbonyl starting material (Abbott et al., 2002). 
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Figure 3.17: Room temperature ionic liquid recycling. Reaction conditions 
0.5 mL ionic liquid (RTIL) ([Me3NC2H4OH]Cl-ZnCl2 (1:2)), 12 mM substrates, 
ambient temperature with water added. At the end of each cycle the ionic liquid 
was washed in hexanes and stirred at 30 °C for 2 hours to dry the ionic liquid.  
The ionic liquid was stored under argon at 4 °C between uses.  
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3.3.3 WT-TK on DA product 
 
 
Initial activity studies of WT-TK with a range of cyclic aldehydes, although 
relatively low, indicated some acceptance and product synthesis shown in Figure 
3.13. However, in contrast to the previous substrates, WT-TK enzyme showed 
negligible activity towards DCHCA. Of particular interest was the activity 
recorded with 3-cyclohexene-1-carboxaldehyde. As this was the most closely 
related aldehyde structurally to our target substrate, DCHCA, it was interesting to 
see WT-TK accepting an aldehyde with a bulky cyclic ring and also with an 
alkene moiety.  
 
The capability of TK to physically allow the acceptance of larger, bulkier, 
substrates, although with limited activity, may be described by the shape of the 
active site.  The cleft formed between the two enzyme subunits is funnel-shaped 
(French and Ward, 1996), potentially allowing for the substrate structure to be 
larger at the opposing end of the compound to the reactive aldehyde moiety. 
Limitations arise with orientation and proximity of the substrate with cofactors 
within the active site. Modelling experiments have been performed with WT-TK 
and a range of aldehydes, including linear aliphatic acceptor aldehydes (C4-C8) 
and the same cyclic aldehydes presented here (Càzares et al., 2010). The cyclic 
aldehydes were seen to preferentially dock at the lip of a hydrophobic region at 
the opening of the active site of WT-TK, where no product formation was 
possible, providing a possible cause of limited activity with WT-TK.  
 
 
 
3.3.4 TK library on propanal and cyclic aldehydes 
 
 
All previously tested cyclic aldehydes (Figure 3.13) with WT-TK were screened 
with library D469 for enhanced activity and detected using the specifically 
designed tetrazolium red colour assay.  
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The cyclic aldehyde substrates that indicated some activity with WT-TK were 
applied to the library D469 for the possible identification of improved activity and 
production of cyclic ketodiol compounds. The cyclic aldehydes are all non-α-
hydroxylated aldehydes and therefore applicable for the colorimetric assay. It was 
noticed that all 5 aldehydes maintained a common pattern within the microwell 
plate with regard to improved activity compared to WT-TK (Figures 3.18, 3.19, 
3.20). Other cyclic aldehyde screens are shown in the appendix.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Propanal screen of library D469X.  Photograph of microwell plate 
containing structural library D469 TK-mutants with enhanced activity towards 
propanal and HPA. (See section 3.2.7 for details) 
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Figure 3.19: Cyclohexanecarboxaldehyde screen of library D469X. 
Photograph of microwell plate containing structural library D469 TK-mutants 
with enhanced activity towards cyclohexanecarboxaldehyde and HPA.  
 
 
 
 
 
Figure 3.20: 3-cyclohexene-1-carboxaldehyde screen of library D469X. 
Photograph of microwell plate containing structural library D469 TK-mutants 
with enhanced activity towards 3-cyclohexene-1-carboxaldehyde and HPA.  
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3.3.5 TK D469X library on DA cycloadduct 
 
 
Following screening with the commercially available cyclic aldehydes, the DA 
cycloadduct, 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA) was 
applied to the same structural D469 library.  Figure 3.21 shows the colorimetric 
detection assay indicating several mutants with activity towards the bulky, 
hydrophobic, cyclic acceptor aldehyde substrate.  
 
Despite the lack of product formation from the WT-TK catalysed reaction with 
DCHCA, several mutants from library D469 indicted some activity. Figure 3.22 
shows the correlation between active mutants of this library with all the cyclic 
aldehydes screened. All cyclic aldehydes appear to have a relationship with regard 
to mutant hits, with Pearsons correlation ranging from 0.62-0.74 for all cyclic 
aldehydes with respect to propanal.  
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Figure 3.21: 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde screen of library 
D469. Photograph of microwell plate containing structural library D469 TK-
mutants with enhanced activity towards 3,4-dimethyl-3-cyclohexene-1-
carboxaldehyde and HPA.  
 
 
 
 
 
 
 
 
 
 114
 
 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
D469X TK Mutants
O
D
48
5n
m
 (-
)
 
 
 
Figure 3.22: Correlation of cyclic aldehyde D469 screens in relation to 
propanal. Propanal (∆) cyclopropane-carboxaldehyde (♦) cyclopentane-
carboxaldehyde (▲) cyclohexane-carboxaldehyde (■) cyclohexene-
carboxaldehyde (○) 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde (●). OD is 
proportional to formazane production and is relative to ketodiol synthesis. 
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Figure 3.24: Intensity spots. Graph representing the absorbance intensity of 96 
microwell plate containing library D469 active mutants measured towards 
DCHCA and HPA.  
 
 
 
 
3.3.6 TK sequencing and mutant identification 
 
 
The top six performing D469X TK-mutants with activity towards DCHCA on the 
basis of reduction to formazane, relative to ketodiol synthesis were those residing 
microwells F12, B6, B7, F1, D5 and E2 represented in Figure 3.24 and 3.23. 
Figure 3.25 shows the activity development of TK, where WT-TK shows no 
activity at all through the sensitive detection method of TLC and visualisation by 
PMA and heat alongside 2 novel active mutants, F12 and D5 towards a novel 
acceptor substrate. 
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Figure 3.25: Comparison of top performing TK-mutants and WT-TK. Thin 
layer chromatography D469T (F12) D469L (D5) and (WT) over 48 hours. 
Product visualised with phosphomolybdic acid (PMA) and heat.  Residual HPA 
does not migrate and resides at the baseline.  
 
 
 
3.3.7 Fermentation scale up and synthesis at scale 
 
The typical lag phase of approximately one hour was observed on all mutant 
fermentations in line with WT-TK E. coli  BL21 (DE3), indicating the exponential 
growth of the inoculum. All mutant growth profiles followed WT growth except 
that of mutant residing in microwell F1. Fermentation was ceased on 
determination of the end of the linear exponential phase Ln [OD600], allowing for 
the calculation of growth rate for the mutants based on the exponential growth 
rate and linear regression. All fermentations of the same E. coli strain, including 
both WT-TK and all mutants reached the end of exponential growth within 8 
hours (± 1.0 hours).  
 
HPA 
Product 
 F12                D5           WT 
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Figure 3.26: Typical fermentation growth curve of WT-TK and TK-Mutants 
from library D469.  The growth of E. coli expressing WT-TK monitored by 
OD600, (●) was compared to the growth of E. coli expressing selected top 
performing TK-mutants, B6 (), F12 (¨), E2 (○), B7 (▲), F1 (∆) from library 
D469X, E. coli strain BL21(DE3) pQR412. All fermentations were carried out in 
parallel under exactly the same conditions with 10% v/v inoculum, 37 °C, 200 
rpm in 1 Litre baffled shake flasks with 100 mL LB media and 150 µg.mL-1 
ampicillin. Data shown represents an average of 10 fermentations (see section 2.3 
for details).  
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Slight variations in growth curves between the selected 6 TK mutants compared to 
WT-TK are not significant, except microwell F1. The average fermentation of E. 
coli expressing WT-TK and those expressing the top performing mutants 
maintained a specific growth rate of 0.8 h-1. Growth for TK residing in F1, was 
inconsistent and often significantly lower than the other 5 TK mutants and WT-
TK. An average growth rate of 0.12 h-1 (± 0.08) indicated a growth retardation 
possibly caused by the directed evolution processing. The TK levels obtained 
from microwell F1 were also significantly lower than WT-TK and the other TK-
mutants. Potential issues with the cell host may have caused growth inhibition.  
 
 
A 20 L fermentation of E. coli expressing D469T was performed in order to 
establish the stability of the mutant biocatalyst at scale and also to provide 
significant quantities of enzyme for future experiments. The growth of the 
bacteria was excellent reaching OD levels of 18 A.U. compared to the 5-6 A.U. of 
the smaller 1 L bench scale fermentations (Figure 3.27). The activity of the 
biocatalyst however once purified was significantly lower than that measured of 
the smaller scale fermentation preparations. It was considered that the larger scale 
homogenisation was detrimental to the enzyme activity. Centrifugation at large 
scale did not appear to be responsible for the reduced activity due to comparable 
activities from small scale centrifugation of the same 20 L fermentation culture 
broth. Due to the reduced activity, the enzyme preparation was not used for 
kinetic analysis and 1 L shake flask fermentations were used throughout. 
Optimisation of the purification process at scale would inevitably improve 
enzyme activity levels.  
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Figure 3.27: 20 L fermentation growth curve of D469T (Single fermentation 
performed and conditions described in section 2.3.6) 
 
 
The use of pure enzymes for kinetic data is a controversial topic owing to the end 
process utilising a reaction system closer to that of enzyme lysate or whole cells. 
However in order to obtain data that is free of any potential interference from 
other enzymes that may be present in the protein lysate, pure TK has been used 
here. Also the potential presence of WT-TK, despite the lack of activity noted 
with DCHCA, may give false positive data. 
 
The purification process was based upon a small scale nickel chelate affinity 
chromatography method for the binding of histidine-tagged proteins (Zeng et al., 
1999) using His·Bind® Quick 900 affinity columns. A detailed scheme of the 
purification process is shown in Figure 3.28. Samples were taken throughout the 
process for analysis of any TK protein loss by SDS-PAGE, and final 
determination of enzyme concentration measured by spectrophotometric 
wavelength scanning, and confirmation at wavelength 280 nm. Controlling 
temperature during the sonication procedure was found to be significant, 
alongside shorter pulses and longer interval periods, as protein losses reached 
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60% without the use of ice. The sonication procedure was seen to be detrimental 
to the activity of the enzyme if the sample was not cooled sufficiently. Where 
possible fresh buffer was cooled prior to use and at each stage samples were kept 
on ice. Centrifugation was also performed in a pre-cooled centrifuge at 4 °C.  
 
SDS-PAGE was performed to determine enzyme purity and concentration with 
densitometry alongside the Bradford assay for total protein concentration. 
Initially, however, spectrophotometric wavelength scanning at 280 nm was 
performed. The fast, non-consuming, absorbance assay is based upon the 
knowledge that Tyr and Typ in particular, absorb UV absorbance near 280 nm and 
that the relationship between absorbance and concentration is linear. A known 
extinction coefficient of the pure TK, 93905 M.cm-1 is required (Wetlaufer, 1963; 
Martinez-Torres et al., 2007). The value measured, however, must be considered 
for error, in that different proteins maintain greatly varying absorption 
characteristics. Also the presence of any non-protein contaminant may absorb UV 
at 280 nm giving false positive measurements.  Pure TK preparations of both WT 
and mutants were repeatedly measured with concentrations ranging from 0.3-0.9 
mg.mL-1.    
  
SDS-PAGE was subsequently used to measure purity of the enzymes. Figure 3.29 
shows a typical 7.5% gel with a marker lane verifying the position of TK band, at 
just below 75 kDA, as TK monomers have a molecular weight of 72260 Da (72.3 
KDa). Employing densitometry analysis of the gel, also allows for the 
quantification of the proteins separated by the 80-150 V run. Pure TK 
preparations including mutants often had a purity of >94%. The lysate 
preparations indicate the proportion of TK with regard to total protein 
concentration, which varied depending upon TK mutant and initial cell growth. 
Total protein concentration was determined by the Bradford assay where the 
absorbance shift between starting Coomassie solution and protein bound 
Coomassie is measured   (Bradford, 1976).  
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Figure 3.28: TK purification process. His x 6-tagged protein production and 
purification from fermentation and isolation using Ni-NTA columns, based on 
Nickel Chelate metal affinity chromatography.  
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Figure 3.29: SDS-PAGE gel photograph.  Lanes 1. Marker, 2. Pure WT-TK, 3. 
Pure D469T TK, 4. D469T lysate 33%, 5. D469L lysate 25%, 6. D469K (B6) 
lysate 35%, 7. F1 Lysate 19%, 8. WT 31%, 9. D469K (E2) Lysate 35% 10.  Pure 
TK D469T (x5) (See section 2.4.1 for details).  
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WT-TK expressed TK as 30% of its total protein, microwell F12 expressed 33% 
TK, B6 35% TK, B7 32%, D5 25% and F1 an average of 19% TK of total 
expressed protein. Further indication of an issue with the host cell or plasmid 
vector of microwell F1.  
 
Each batch of pure-TK and clarified lysate-TK preparations were analysed for 
activity with glycolaldehyde and HPA (Figure 3.8). The reaction products are L-
erythrulose and carbon dioxide rendering an irreversible reaction (Bolte et al., 
1987). The standard glycolaldehyde activity assay entails a 20 minute pre-
incubation of enzyme with a cofactor solution at room temperature to reconstitute 
the holoenzyme. An equimolar substrate concentration was performed, samples 
taken at regular intervals and a specific activity of 0.63 µmol.mg-1.min-1 was 
measured.  
 
Initial activity tests using substrate glycolaldehyde and protein measurements of 
purified WT-TK and D469T-TK showed significantly lower amounts of enzyme, 
with lower activities than expected. The purification was analysed at each step to 
determine any protein losses. It was found the filtration step using 0.2 µm 
cellulose acetate syringe filters prior to column equilibration caused a 70% loss in 
TK levels. The filtration step was not performed in subsequent purifications, and 
appeared to have no detrimental effects on the loading of the sample onto the Ni-
NTA column or on purity of the pure TK samples.  
 
Two shorter dialysis stages replaced one lengthy stage, after initial activity assays 
indicated potential activity losses at the dialysis stage of 16 hours. A larger 
volume of 50 mM Tris-HCl dialysis buffer also containing cofactors, TPP and 
Mg2+ was also used to increase removal of free EDTA and EDTA nickel 
complexes and maximise TK stability in solution (Matosevic, 2009).  
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3.3.7.1 Bioedit 
 
Bioedit is a biological sequencing alignment tool, allowing for a relatively simple 
visualisation of gene sequences. The tool permits both the analysis of sequences 
and useful manipulation functions, whereby simple single point mutations are 
easily determined. The sequence mutations were determined and are presented in 
table 3.3.  
 
 
 
 
 
Table 3.3: TK-Mutant Characterisation. Top performing mutants from D469 
library screen with HPA (50 mM) and DCHCA (50 mM) in Tris-HCl buffer (50 
mM pH 7.0). a Total activity measured using the colorimetric assay screen. 
Well 
Number 
Mutation Residue 
Relative 
Activitya 
(D469T = 1) 
TK 
expressed 
(% total 
protein) 
WT D469 Aspartic acid 0 31 ± 5.0 
F12 D469T Threonine 1 33 ± 2.9 
B6 D469K Lysine 0.82 35 ± 4.5 
B7 D469S Serine 0.81 32 ± 4.3 
F1 D469T Threonine 0.79 19 ± 7.6 
D5 D469L Leucine 0.76 25 ± 3.1 
E2 D469K Lysine 0.82 35 ± 4.3 
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The top performing mutant F12 was sequenced as D469T (threonine), the same as 
the mutant sequenced in microwell F1. The inconsistent growth ranging from 
OD600 levels of 1-5 A.U., significantly lower expressed TK levels, up to 50% less 
than WT, and inconsistent activity levels with acceptor aldehyde substrates 
DCHCA and glycolaldehyde, indicated the possibility of an additional mutation 
within the gene not present in F12 or problems with the host.   
 
Microwells E2 and B6, were both sequenced and confirmed to have the same 
mutation, D469K. Both microwells correlated well with regard to their TK 
expression levels and activity towards DCHCA, indicating that both mutants 
maintain the same mutation without any evidence of further mutations affecting 
these characteristics.  
 
Initial growth and activity studies indicated that microwell E2 was contaminated 
with multi variants, as activity was inconsistent with both substrates propanal and 
DCHCA however consistent with glycolaldehyde reactions. Sequencing of the 
mutants from microwell E2 confirmed the presence of at least two different 
mutants, namely, D469K (leucine) and D469N (asparagine). The mutants were 
separated with repeated streaking and growing up of individual E. coli colonies as 
described in Chapter 2. D469K showed enhanced activity with DCHCA whilst 
D469N was relatively inactive, with no improvement on WT-TK activity. 
 
 
 
3.3.8 Summary 
 
 
In this chapter, a potential novel acceptor aldehyde for application to the 
transketolase catalysed reaction was investigated. A chiral, bulky, hydrophobic 
aldehyde was considered for probing the effects of TK activity and selectivity. 
The far removed substrate, yet sequentially linked to natural substrates provided 
the basis of broadening the range of TK acceptor aldehydes beyond currently 
perceived limitations.  
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The aldehyde, 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde (DCHCA), was 
successfully synthesised using Diels Alder chemistry in a room temperature ionic 
liquid (RTIL) and the process assessed for optimal reaction conditions. The 
addition of water to the system was critical for the effective stirring of the viscous 
liquid magnetically. The water insensitive, catalyst/solvent system of zinc-
chloride/choline-chloride melt, gave excellent aldehyde yields of up to 91% and 
high purity of 98% without lengthy or complicated purification steps. 
 
Library D469X was selected for screening due to its relationship associated with 
substrate binding and substrate stereoselectivity. Initial screening with a range of 
cyclic aldehydes showed low but promising activity with WT-TK, however a 
number of D469X mutants showed considerable activity enhancement. A specific 
colorimetric assay was employed for its high sensitivity, rapid and relatively easy 
detection of a large number of mutants. Despite applying highly sensitive 
detection methods including thin layer chromatography, WT-TK indicated no 
activity towards the novel substrate. However, screening of TK-Mutants 
previously made through saturation mutagenesis highlighted several ‘hits’.    
 
The top six performing mutants towards the novel substrate were subsequently 
grown and their specific activity determined. Activity towards the novel substrate 
was demonstrated as infinitely enhanced with all mutants, due to the total lack of 
activity observed with WT-TK.  Small scale fermentations were performed for the 
isolation of DNA, and the TK gene sequenced for identification of the single point 
mutation at position 469. A range of mutations were observed, and Mutant D469T 
(threonine) was identified as the most improved active mutant towards the novel 
substrate. 
 
The identified D469T mutant was then subjected to a Histidine-tag purification 
process and analysed for optimal process conditions and storage stability. The 
purification process saw that eliminating a filtration step prior to his-tag binding 
improved protein yield and also identified the importance of maintaining 
consistently cool temperature (>4 °C where possible), particularly during 
sonication and centrifugation steps.  
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4 Synthesis of 1,3-Ketodiol and enantiomeric excess 
 
 
This chapter describes investigations into the enzymatic and biomimetic synthesis 
of the novel compound 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-
2-one (DCDHP). TK variants identified as having enhanced activity towards the 
cyclic, acceptor aldehyde 1,3-dimethyl-3-cyclohexene-1-carboxaldehyde 
(DCHCA), were applied to preparative scale reactions where products were then 
isolated, purified and subsequently characterised.  This chapter also describes the 
determination of the optical purity of the product from TK catalysed reactions and 
compares the enantioselectivities of enhanced mutants to that of the WT-TK. The 
absolute stereo-configuration of the product from TK variant catalysed reaction of 
HPA and 1,3-dimethyl-3-cyclohexene-1-carboxaldehyde was also determined 
from a recently modified Mosher’s ester methodology.  
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4.1 Introduction 
 
 
4.1.1 TK reaction with complex substrates 
 
A wide range of α-hydroxy and α-unsubstituted aldehydes have been previously 
reported as substrates accepted by transketolase from yeast (De La Haba et al., 
1955), spinach (Horecker et al., 1956), and E. coli (Racker, 1948; Hibbert et al., 
2008). The ability of TK from yeasts, plants and bacteria to achieve 
enantioselective carbon-carbon bond formation, and tolerance for a wide range of 
aldehyde acceptors to give (S)-α,α'-dihydroxyketones has made it an attractive 
enzyme for industrial applications (Bongs et al., 1997; Turner, 2000; Shaeri et al., 
2006). E. coli TK has been successfully over expressed (Lilly et al., 1996) and 
shown to give up to six times greater specific activity than yeast TK, and as much 
as thirty times greater specific activity than spinach TK, with donor substrate 
HPA (Sprenger and Pohl, 1999).  E. coli TK has also been successfully applied to 
a number of potentially commercial biocatalytic processes eg. the production of 
xylulose-5-phosphate (Shaeri et al., 2008; Hecquet et al., 1994).  
 
A number of TK reports have described the use of α-hydroxyaldehyde acceptors 
and HPA where it was stereospecific for the α-(R)-hydroxyaldehyde (Bolte et al., 
1987; Effenberger et al., 1992; Kobori et al., 1992; Hecquet et al., 1994; Mitra et 
al., 1998) and stereoselectively forms a ketodiol product with the S-configuration. 
Further TK investigations have also reported that it can accept several non-α-
hydroxylated aldehydes, although lower relative rates of reaction (typically 5-35% 
of hydroxylated substrates) were observed (Demuynck et al., 1991; Hobbs et al., 
1993; Morris et al., 1996). The activity of E. coli TK towards propanal as a 
substrate has been recently increased by directed evolution (Hibbert et al., 2008; 
Smith et al., 2008), paving the way for acceptance of other non-α-hydroxylated 
aldehydes. For example, 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-
2-one (DCDHP) was synthesised in Chapter 3 via a TK variant (Scheme 6).   
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Scheme 6: Transketolase catalysed reaction. HPA and 3,4-dimethyl-3-
cyclohexene-1-carboxaldehyde (DCHCA) for the synthesis of 1-(3',4'-
dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP). 
 
 
 
 
4.1.2  TK catalysed reaction conditions 
 
Optimal TK reaction conditions are well established due to the continued 
investigation of activity (Cazares et al., 2010) and the more recently studied 
structure and stability (Martinez-Torres et al., 2007). However, with altering 
process conditions, such as scale, reaction vessels, titre concentration, enzyme 
concentration and enzyme preparation used, optimal conditions may require 
further modification tailored to a specific substrate. Also, the use of novel reaction 
components, may lead to required changes to the process conditions such as 
temperature increases, stirring rate and the use of alternative solvents to improve 
substrate solubility. Temperature and pH are important reaction parameters 
requiring consideration with TK, as with the majority of biological catalysts. E. 
coli TK has been seen to possess very low activity in acidic and basic conditions, 
with a typical bell-shaped activity profile with optimal activity at close to neutral 
pH (Mitra et al., 1998).  
 
The stability of the enzyme under storage and biocatalytic reaction conditions is 
also an important consideration when investigating kinetic activity with novel 
TPP, Mg2+ 
DCHCA        HPA            DCDHP  
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substrates.  It is crucial that the biocatalyst maintains native activity over a period 
of time and that no destabilisation or degradation of the enzyme occurs. This is 
fundamental to ensure that measurements between separate reactions are accurate 
and in particular between separate batches of TK preparations. For example, it is 
known that wild-type E. coli TK is susceptible to deactivation by dissociation of 
the TPP cofactor (Brocklebank et al., 1999; Martinez-Torres et al., 2007), and 
irreversible inactivation by oxidation (Brocklebank et al., 1999). 
 
 
4.1.3 Biomimetic TK reaction 
 
The monitoring and characterisation of new enzyme-catalysed reactions requires 
that a product standard can be synthesised to enable assay calibration and also 
identification of the correct product peaks if HPLC assays are used. Previously 
reported syntheses of α,α’-dihydroxyketones include methods such as a 
ruthenium-catalysed oxidation of allenes (Laux and Krause, 1997) and the double 
hydroxylation of silyl enol ethers with m-chloroperbenzoic acid (Horiguchi et al., 
1989). A particularly useful and somewhat relevant approach however, describes 
a mimetic of the transketolase catalysed reaction (Smith et al., 2006). 
 
The biomimetic reaction successfully synthesises a racemate of the 1-(3',4'-
dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP), useful for 
analysing the enantiomeric excess (ee) of the TK reaction product, and 
deciphering the corresponding enantiomer and therefore absolute configuration. 
The reaction is also advantageous in synthesising a standard, prior to the 
identification of TK accepting mutants of this aldehyde, enabling a comparison of 
detection methods including TLC, HPLC and calibration of the colorimetric 
assay.  
 
The mimetic of the transketolase catalysed reaction was discovered during TK 
control experiments, where the formation of product was evident without the 
presence of the enzyme or cofactors.  The formation of a quaternary ammonium 
enolate is postulated as the mechanism in the atom efficient one pot synthesis. The 
substrates and products are analogous with the TK reaction however, the cofactor, 
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TPP relied upon by TK for conversion, is not required here. The mechanism is not 
fully understood, however, is proposed to follow a different pathway to TK and 
involves tertiary amine catalysis and quaternary amine enolate formation. This 
mimetic reaction was used as described in Section 4.2.5 to synthesise the racemic 
1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP) using 
N-methylmorpholine shown in Scheme 7. 
  
 
O
O
OH
OH
CO2O
O
OH
OH  
 
Scheme 7: The mimetic of the TK reaction. In the presence of tertiary amine, 
N-methylmorpholine the reaction is stirred in water at pH7.0 and monitored by 
TLC.  
 
 
4.1.4 Substrate solubility in biocatalysis  
 
For hydrophobic substrates, solubility is a challenge that potentially needs to be 
overcome amongst other process limitations to achieve both maximum 
productivity and accurate kinetic data.  Reduced accessibility of the substrate to 
the biocatalyst may severely inhibit activity and many approaches therefore exist 
to improve such situations. A number of measures are employed for altering 
substrate solubility in process chemistry and biocatalysis including co-solvent 
addition (Carrea, 1984; Seng Wong et al., 2004; Miyako et al., 2010), stirring, 
(Woodley et al., 1991; Michelletti et al., 2006) and increased temperature. All of 
these approaches subsequently generate considerations for process design and 
engineering, such as reaction vessel design, substrate feeding strategies and 
product isolation. All of these methods however, possess the potential to 
significantly affect the activity and / or stability of the biocatalyst. Some organic 
solvents as well as elevated temperatures may irreversibly cause protein 
N-methyl 
morpholine 
+ 
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degradation. This may occur through the penetration of the cosolvent to the 
aqueous microenvironment surrounding the protein, potentially altering its three 
dimensional structure or stripping tightly bound water from the enzyme crucial for 
catalytic activity (Deetz and Rozzell, 1988; Klibanov, 1997). However, on the 
other hand, some enzymes have exhibited increased stability in the presence of 
organic solvents (Kilbanov, 1989; Moore and Arnold, 1996; Hao and Berry, 
2004), such as porcine pancreatic lipase (Zaks and Klibanov, 1985) ribonuclease 
(Volkin et al., 1991) and α-chymotrypsin (Zaks and Klibanov, 1988) at 100 °C 
exhibits a half life of several hours in anhydrous solvents, compared to complete 
deactivation within seconds in water. 
 
The transketolase reaction has previously been performed in aqueous media and 
therefore all reaction components were characterised in water.  The use of 
alternative or additional solvents may also have adverse effects on reaction 
components other than the biocatalyst, potentially causing decomposition over 
periods of time. Selectivity of the enzyme may also be affected by organic 
solvents altering enantio- regio- and chemo- selectivity characteristics. Many 
reports over recent years have presented data that not only shows an improvement 
in the enantioselectivity of the enzyme but complete inversion of the 
enantioselectivity (Klibanov, 2001). For instance, the transesterification of 
methyl-3-hydroxy-2-phenylpropionate with propanol saw a 20-fold rate change 
with differing organic solvents. Additionally, the enantioselectivity was seen to be 
completely reversed, in that with cyclohexene as a solvent the S-enantiomer was 
preferentially transesterified compared to the R-anitpode in acetone (Wescott et 
al., 1996).  
 
 
4.1.5 Enantioselectivity of wild-type-TK and its variants 
 
The enantioselectivity of an enzymatic reaction if generating chiral compounds is 
one of the most significant factors determining the usability of a commercial 
biocatalyst. The direct synthesis of single enantiomer products is not only 
preferential but becoming more and more fundamental in most disciplines. 
Enantiomeric excess (ee) is a measure of the degree to which one or another 
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enantiomer is present in a greater quantity. WT-TK stereoselectivity towards 
glycolaldehyde and HPA was determined by chiral HPLC to be (S) 95% (Smith et 
al., 2008).    
 
C4-C8 linear aldehydes (non-α-hydroxyaldehydes) were recently investigated as 
aldehyde acceptors with a range of single-point mutant TK enzymes (Cazares et 
al., 2010). Several improvements in stereoselectivity were observed, ranging from 
0% to >99%. It is particularly interesting that the degree of stereoselectivity of the 
transformation varied with the length of the aliphatic chain of the aldehyde. High 
stereoselectivities were noted with mutant TK-D469E against butanal, pentanal 
and hexanal giving 97-98% ee and the highest ee was observed with aldehydes of 
a similar size to in vivo TK substrates. WT- TK stereoselectivity with propanal 
(PA) was noted as only 58%; however D469E-TK improved this stereoselectivity 
to 90% of (3S)-DHP. The overall product yield was also enhanced from 36% to 
70% (Smith et al., 2008).   
 
Mutant D469T- TK also exhibited both stereoselectivity and yield enhancement 
with PA, with the ee rising from 58% to 64% and yield improving from 36% to 
68% (Smith et al., 2010). TK residue D469 has previously also been noted as 
being involved in the enantioselectivity of the reaction when using α-
hydroxyaldehydes (Nillson et al., 1997). Remarkably, active-site single-point 
mutants Asp469Glu (D469E) and His26Tyr (H26Y) were identified and were able 
to both enhance and reverse the stereoselectivity from 58% (3S)-DHP to 88% 
(3R)-DHP (Smith et al., 2008). Stereoselectivity reversals were also noted 
throughout a range of linear aldehyde substrates C3-C8.  Mutant D469E-TK was 
also noted to possess high enantioselectivities with the cyclic aldehydes of the 
substrate walking approach, whereby cyclopropanecarboxaldehyde and 
cyclopentanecarboxaldehyde adducts were formed in 99% ee and 
cyclohexanecarboxaldehyde formed in 97% ee. Similarly D469T exhibited high 
enantioselectivities with these cyclic aldehydes forming the (1S)-isomer.  
 
The equivalent residue to E. coli TK D469 in yeast transketolase is D477 which 
has also been reported as a determinant of enantioselectivity. This residue is 
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located in the active site channel and forms a hydrogen bond with the C2-
hydroxyl group of the acceptor aldehyde. It was seen that substrates with an L-
configuration at the C2-atom had kcat/Km  values 3-4 orders of magnitude lower 
for the D477A mutant than with the wild-type enzyme (Nilsson et al., 1998). 
 
 
 
 
Table 4.1: Highly enantioselective biocatalysts reported in literature. 
Enzyme 
Source of 
Enzyme 
Product 
ee 
(%) 
Ref. 
(S)-specific 
Nitrilase 
Rhodococcus C311 
&MP50 
(S)-naproxen 
 
>99 
Layh et al., 
1994. 
(S)-specific 
Nitrilase 
Acinetobacter sp. 
AK226 
(S)-Ibuprofen 
 
90.8 
Goodhue and 
Schaeffer, 1971 
Ketoreductase Lactobacillus kefir 
(R)-tetrahydrothiophene-3-ol 
 
99.3 
Huisman et al., 
2010 
Hydantoinase Escherichia coli 
L-methionine 
 
90 May et al., 2000 
Epoxide 
Hydrolase 
Agrobacterium 
radiobacter 
Styrene Oxide 
 
>99 
Spelberg et al., 
1998 
Transketolase Escherichia coli 
L-Erythrulose 
 
95 
Smith et al., 
2008 
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4.1.5.1 Methods of enantiomeric excess (ee) determination 
 
The products of reactions such as the TK catalysed reaction are often analysed for 
their enantiomeric ratio through optical rotation, derivatisation and 
chromatography. X-ray crystallography and NMR spectroscopy by the use of 
lanthanide shift reagents (Wenzel et al., 1992) or chiral derivatising agents (Dale 
and Mosher, 1973; Pehk et al., 1993) are also widely used methods for the 
determination of ee and absolute configuration. 
 
A recent investigation has described the determination of absolute chemistry of 
1,3-dihydroxy ketones through acetate derivatisation and chiral HPLC and GC 
alongside Ender’s SAMP methodology to synthesise the products in high optical 
purity (Smith et al., 2008). Enders methodology involves the utilisation of chiral 
auxiliaries, temporary chiral compounds employed to introduce chirality into 
racemic compounds allowing for the asymmetric alpha-alkylation of aldehydes 
and ketones. However, the use of this lengthy, multistep procedure and the 
addition of chiral auxiliaries is not ideal in terms of time scale and is also not 
suitable for aromatic α,α’-dihydroxyketones (Enders et al., 1986). 
 
The method developed by Mosher, using 2-methoxy-2-(trifluoromethyl) 
phenylacetic acid (MPTA) has been utilised widely for the determination of 
absolute stereochemistry of both secondary alcohols and primary amines (Ohtani 
et al., 1991).  MPTA is a chiral molecule, available commercially as both the R 
and S enantiomers shown in Figure 4.1. The approach works by forming an ester 
or an amide with the compound of unknown stereochemistry, which may be then 
determined by 1H NMR spectroscopy of the ester or amide.  
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Figure 4.1: Mosher Conformers. (S)-MPTA and (R)-MPTA derivatives. 
 
 
 
 
The use of Mosher’s acid and 1H chemical shift to aid configurational assignment 
of chiral secondary alcohols has been demonstrated by two separate, analogous 
experiments using each Mosher’s acid enantiomer (Figure 4.1). The ester protons 
at R1 and R2 were assigned through the determination of the difference between 
their chemical shift, such that ∆δ=δS-MPTA – δR-MPTA.  The protons at R1 of the (R)-
MPTA diastereoisomer were observed upfield in relation to the (S)-MPTA ester 
due to current effects of the phenyl ring (Pehk et al., 1993).  
 
It was also recently demonstrated that application of a modified Mosher’s method 
for the determination of enantiomeric excess (ee) and also the absolute 
configuration of chiral 1,3-dihydroxyketones at C3 was possible (Galman and 
Hailes, 2010). The ee of a range of aliphatic α,α’-dihydroxyketones with 
lipophilic and polar R groups were demonstrated to be accessible within 5% 
accuracy of GC or HPLC methods. In this chapter this method was used to 
determine the absolute stereochemistry of the 1-(3',4'-dimethylcyclohex-3'-enyl)-
1,3-dihydroxypropan-2-one (DCDHP) product from a mutant TK-catalysed 
reaction. 
 
4.2 Materials and Methods 
 
O 
O H 
MeO Ph 
CF3 R 
R2\ 
R1 
O 
O H 
OMe Ph 
CF3 S 
 
R1 
R2\ 
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4.2.1 TK Catalysed synthesis of 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-
dihydroxypropan-2-one (DCDHP) 
 
TPP (22 mg, 48 µmol; 2.4 mM) and MgCl2 (39 mg, 180 µmol; 9 mM) were 
dissolved in H2O (10 mL) and the pH adjusted to 7 with 0.1 M NaOH. To this 
stirred solution, at 20 ºC, was added D469T-TK (clarified lysate or pure) (2 mL) 
and the mixture stirred for 20 minutes. In another flask, HPA (330 mg, 3 mmol; 
50 mM) and DCHCA (414 mg, 3 mmol; 50 mM) were dissolved in H2O (8 mL), 
sonicated and the pH adjusted to 7 with 1 M NaOH. Following the 20 minutes 
enzyme/cofactor pre-incubation, the substrate solution was added to the enzyme 
solution and the mixture stirred at 25 ºC for 24 hours. During this time, the pH 
was maintained at 7.0 by addition of 1 M HCl using a pH stat (Stat Titrino, 
Metrohm). Silica was added and the reaction mixture concentrated to dryness 
before dry loading onto a flash silica gel column (ethyl acetate) to give DCDHP 
(0.090 g, 15% ±2%).  [α]20D = +140 (c 0.5, CHCl3); 1H NMR (300 MHz; CDCl3) 
δ 1.38 (2H, m), 1.59 (3H, s, CH3), 1.61 (3H, s, CH3), 1.96 (4H, m), 2.12 (1H, m), 
2.98 (1H, m) 4.22 (1H, J 2.6 Hz, CHOH), 4.30 (1H, d, J 18.8 Hz, CHHOH) 4.48 
(1H, d, J 18.8 Hz, CHHOH); 13C NMR (125 MHz; CDCl3) δ 18.8 (CH3), 19.1 
(CH3), 23.3, 31.5, 34.3, 38.9 (CH), 66.1 (CH2OH), 78.2 (CHOH) 125.4, 130.4, 
211.6 (C=O) (see figure 4.2).  
 
The same protocol was followed with the addition of 5% EtOAc with the 
substrate solution for increased yields of the same product (19% (±2%).   
 
 
4.2.2 D469T-TK reaction pH dependence  
 
The reaction was performed exactly as described in section 2.5.4 using pH stat 
(Stat Titrino, Metrohm) at pH 3, 5, 7, 9 and 11. The pH was maintained at the 
corresponding pH by addition of 1M HCl or 1M NaOH. Samples were taken at 
regular intervals and analysed by HPLC.  
 
4.2.3  D469T-TK reaction temperature dependence  
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Reactions were performed exactly as described in section 4.2.1 however at both 
20 °C and 40 °C in a water bath and stirred magnetically. Samples were taken at 
regular intervals and analysed by colorimetric assay.  
 
 
4.2.4 Biomimetic reaction with propanal to give product 1,3-
dihydroxypentan-2-one (DHP) 
 
To a stirred solution of HPA (330 mg, 3.00 mmol) in water and THF (1:1, 60 mL) 
at room temperature, was added propanal (PA) (720 µL 3.00 mmol) and N-
methylmorpholine (0.33 mL). The reaction mixture was stirred at 20 °C for 48 
hours. The solvent was removed in vacuo and the crude product dry loaded onto 
flash silica chromatography column (EtOAc/hexene, 1:1) to afford (DHP) as a 
white solid (22% ± 3%).  
 
 
4.2.5 Biomimetic synthesis of 4-isomer mixture of (1RS,1'RS)-1-(3',4'-
dimethylcyclohex-3'-enyl) -3-hydroxy-2-oxo-propyl ester 
 
To a stirred solution of HPA (330 mg, 3.00 mmol) in water (60 mL) at room 
temperature, was added 3,4-dimethyl-3-cyclohexen-1-carboxaldehyde (DCHCA) 
(414 mg, 3.00 mmol) and N-methylmorpholine (0.33 mL). The reaction mixture 
was stirred at room temperature for 48 hours. The solvent was removed in vacuo 
and the crude product dry loaded onto a flash silica chromatography column 
(EtOAc/hexene, 1:1) to afford (1RS,1'RS) -1- (3',4'-dimethylcyclohex-3'-enyl) -3-
hydroxy-2 -oxo-propyl ester (racemic DCDHP) as a colourless oil (0.020 g, 3%).  
Rf = 0.49 (EtOAc/hexene, 1:1); νmax (KBr)/cm–1 3456br, 2893m, 1721s; 1H NMR 
(300 MHz; CDCl3) δ 1.40–2.08 (13H, m), 2.93 (1H, m), 4.26 (1H, m, CHOH), 
4.36 (1H, br d, J 19.3 Hz, CHHOH) 4.49 (1H, dd, J 19.3 and 4.2 Hz, CHHOH); 
13C NMR (75 MHz; CDCl3) δ 18.8, 19.1, 22.7, 23.5, 31.5, 34.3, 38.9, 66.1, 78.2, 
125.4, 130.4, 211.6 (C=O); m/z (+FAB) 221 (MNa+, 35%), 199 (MH+, 100); 
Found (+HRES) MH+ 199.13381. C11H18O3 requires 199.12895 (Figure 4.2a).  
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The 2-isomer mixture of (1RS,1'R)-1-(3',4'-dimethylcyclohex-3'-enyl)-3-hydroxy-
2-oxo-propyl ester was prepared using an identical method and (1R)-3,4-
Dimethyl-3-cyclohexen-1-carboxaldehyde (3-1R isomer) synthesis described in 
section 4.2.6.1. 
 
 
4.2.6 Enantioselectivity of D469T – TK 
 
4.2.6.1 Synthesis of (1R)-3,4-Dimethyl-3-cyclohexen-1-carboxaldehyde ((1R-
3)-DCHCA) 
 
2,3-Dimethyl-1,3-butadiene (1.13 mL, 10 mmol) and acrolein (2.0 mL, 30 mmol) 
were added to a solution of (5S)-2,2,3-trimethyl-5-phenylmethyl-4-
imidazolidinone monohydrate chloride as catalyst  (255 mg, 1 mmol) in 
acetonitrile/water (95:5, 40 mL). The reaction was stirred at 25 °C for 48 hours. 
The reaction was partitioned between diethyl ether (100 mL) and 0.3 M KHSO4 
(100 mL) and the aqueous phase extracted with diethyl ether (2 × 100 mL). The 
combined organics were dried (MgSO4) and the solvent removed in vacuo to give 
(1R)-DCHCA (1.10 g, 80%). [α]20D = +24.0 (c 1.0, CH2Cl2) (Benaglia et al., 
2002).  
 
 
4.2.6.2  Benzoylation of DCDHP for chiral HPLC (Benzoic acid (3'RS,1''RS)-
3'-(3'',4''-dimethylcyclohex-3''-enyl)-3'-hydroxy-2-oxo-propyl ester) 
 
The reaction was carried out under anhydrous conditions. To a stirred solution of 
DCDHP (0.030 g, 0.10 mmol) in dichloromethane (20 mL) was added 
triethylamine (20 µL, 0.20 mmol) and benzoyl chloride (28 µL, 0.20 mmol). The 
reaction was then heated under reflux for 6 hours, cooled and added  to 
dichloromethane (30 mL) and washed with 0.3 M KHSO4 (2 × 20 mL), sat. 
NaHCO3 (2 × 20 mL) and brine (2 × 20 mL). The organic layer was dried 
(MgSO4) and evaporated to obtain the crude product. The residue was purified 
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using silica gel column chromatography (EtOAc/hexane, 1:4) to afford the 
benzoate product as a colourless oil (0.040 g, 70%) (figure 4.2b) . Rf  = 0.34 
(EtOAc/hexane, 1:4); νmax (KBr)/cm–1 3429br, 2925s, 1785s, 1724s, 1452m; 1H 
NMR (300 MHz; CDCl3) δ 1.23–2.04 (13H, m), 3.00 (1H, br s, OH), 4.26 (1H, d, 
J 2.7 Hz, CHOH), 5.01 (1H, d, J 17.1 Hz, CHHOH), 5.15 (1H, d, J 17.1 Hz, 
CHHOH), 7.60 (3H, m, Ph), 8.13 (2H, m. Ph); 13C NMR (75 MHz; CDCl3) δ  
18.8 (signals superimposed), 19.2, 22.6, 31.6, 31.9, 34.5, 38.4, 38.5, 66.6, 78.3, 
78.7, 124.6, 128.5, 129.9, 133.6, 165.8 (C=O ester), 205.5 (C=O, ketone); Found 
(+HRFAB) M+ 303.15995. C18H22O4 requires 303.15963. Chiral HPLC: Chiracel-
AD column (Daicel); mobile phase, isopropanol/hexane (3/97); flow rate, 0.8 
mL/min, detection, UV 214 nm. Retention times; 28.6 min, 30.8 min, 34.0 min, 
43.1 min.  
a)     b)  
OH OH
O
C11H18O3
Exact Mass: 198.12560
Mol. Wt.: 198.25882
m/e: 198.12559 (100.0%), 199.12895 (12.2%)
C, 66.64; H, 9.15; O, 24.21   
OH O
O
O
Ph
C18H22O4
Exact Mass: 302.15181
Mol. Wt.: 302.36488
m/e: 302.15181 (100.0%), 303.15516 (20.0%), 304.15852 (1.9%)
C, 71.50; H, 7.33; O, 21.17  
 
   c) 
OH O
O
O
CF3
Ph
OMe
C21H25F3O5
Exact Mass: 414.16541
Mol. Wt.: 414.41541
m/e: 414.16541 (100.0%), 415.16876 (23.4%), 
416.17212 (2.6%), 416.16965 (1.0%)
C, 60.86; H, 6.08; F, 13.75; O, 19.30  
 
Figure 4.2: MS data for monobenzoylated DCDHP and Moshers acid.  
 
 
The 2-isomer mixture of benzoic acid (3'RS,1''R)-3'-(3'',4''-dimethylcyclohex-3''-
enyl)-3'-hydroxy-2-oxo-propyl ester (DCDHP-1'R isomer) was prepared using an 
identical method. Chiral HPLC as above, retention times 28.6 min, 34.0 min. 
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The D469T-TK product was also converted to the monobenzoate as described 
above. [α]20D= +7.6 (c 0.5, CHCl3). Chiral HPLC as above, retention times 28.6 
min (1%), 30.8 min (1%), 34.0 min (96.5%), 43.1 min (1.5%) to give a de for 
(1S,1'R)-DCDHP of 93%. 
 
 
4.2.6.3  Mosher’s Acid 
 
(2S,3'S,1''R)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionic acid 3'-(3'',4''-
dimethylcyclohex-3''-enyl)-3'-hydroxy-2-oxo-propyl ester. The reaction was 
carried out under anhydrous conditions. To a stirred solution of the 
biotransformation product (DCDHP, 0.010 g, 0.05 mmol) in dichloromethane (5 
mL) was added triethylamine (20 µL, 0.25 mmol) and (R)-MTPA chloride (15 µL, 
0.08 mmol) in CH2Cl2 (2 mL) and the reaction was stirred for 12 hours at room 
temperature. The product was dry loaded onto silica gel and purified using flash 
chromatography (EtOAc/hexane, 1:4) to afford product as a colourless oil (0.015 
g, 75%), (2S,3'S) >98% ee. Rf = 0.45 (EtOAc/hexane; 1:4) [α]20D= +7.6 (c 0.5, 
CHCl3); νmax (KBr)/cm–1 3429br, 2925s, 1758s,1734s, 1170s; 1H NMR (500 
MHz; CDCl3) δ 1.38 (2H, m), 1.60 (3H, s, CH3), 1.62 (3H, s, CH3), 1.98 (4H, m), 
2.12 (1H, m), 3.65 (3H, s, OMe), 4.23 (1H, m), 4.91 (1H, d, J 17.0, CHHO 
(2S,3'S)), 5.18 (1H, d, J 17.0, CHHO (2S,3'S)), 7.42 (3H, m, Ph), 7.63 (2H, m, 
Ph), (no 2S,3'R isomer detected); 13C NMR (125 MHz; CDCl3) δ 18.8, 19.1, 22.7, 
31.6, 34.3, 38.6, 55.8 (OCH3), 67.7, 78.6, 124.5, 125.5, 127.5, 128.5, 129.9, 
131.9, 166.2 (C=O ester), 204.2 (C=O, ketone); 19F NMR (282 MHz; CDCl3) δ -
71.0; m/z (+FAB) 437 (MNa+-H, 43%), 415 (M+, 56), 307 (65), 189 (100); Found 
(+HRFAB) M+ 415.17372; C21H26O5F3 requires 415.17322 (Figure 4.2c).  
 
 
 
4.3 Results and Discussion 
 
4.3.1 D469T-TK catalysed reaction with DCHCA 
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The indication in Chapter 3 that transketolase variants were able to accept a 
hydrophobic, bulky, cyclic substrate provided evidence of the versatility 
introduced through genetic modification of the enzyme. Initial activity tests 
followed by TK mutant screening highlighted several mutants capable of 
accepting DCHCA. Subsequent cell culture growth and bench-scale production of 
the highest performing mutant TK enzyme enabled the preparative scale D469T-
TK catalysed reaction for the synthesis and isolation of the reaction product 1-
(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP).  
 
 
4.3.1.1 Determination of optimum reaction conditions 
 
Reactions using both, clarified lysate and pure, D469T-TK preparations, were 
optimised using reaction substrates, HPA with GA and PA to synthesise L-
erythrulose and 1, 3-dihydroxypentan-2-one (DHP) respectively as described 
below.  
 
 
4.3.1.1.1 D469T-TK pH optimum  
 
The natural progression of the TK-catalysed reaction has a net increase on the pH 
of the reaction mixture due to the consumption of hydroxypyruvate. The synthesis 
of carbonates is offset to a small degree by the evolution of carbon dioxide, 
however to maintain a constant, optimal pH, some level of control is required. 
Larger volume reaction systems are performed in a pH stat which continually 
monitors and fine tunes the pH by controlled continuous titration of concentrated 
acid and base solutions. Smaller scale reactions systems for kinetics analysis, 
enantioselectivity and high throughput reactions, utilising small volumes of 
reagents, reactions are performed in the presence of buffers.  
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Figure 4.3: D469T-TK pH optimum investigation. D469T-TK with HPA (50 
mM) and glycolaldehyde (50 mM) in Tris-HCl buffer (50 mM, pH 7.0), 20° C, to 
afford L-erythrulose analysed by HPLC.  
 
 
The optimal pH of the D469T-TK reaction was analysed and found to peak at pH 
7.0 as observed previously for WT-TK reactions (Mitra et al., 1998). No activity 
was seen at all at pH 3, little activity at pH 5, and very little activity at pH 11 
dropping from 0.9 mM/min to less than 0.175 mM/min. The optimal pH of 
D469T-TK corresponds very well with WT-TK behaving in the same manner at 
low pH and high pH alike. Previously reported data also indicated that exposure to 
pH below 6.5 results in a decrease in activity of WT-TK, and was assumed to be 
the result of protein denaturation. Maintaining a pH within the range 6.5-8.0 lead 
to >90% of TK enzyme activity (Mitra et al., 1998). All biotransformations 
performed throughout the investigation were controlled at pH7.0 by automated 
titration of acid or by Tris-HCl buffer (50 mM, pH7.0).  
 
 
4.3.1.1.2 Investigation of temperature optimum 
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Higher temperatures are seen not to be detrimental to the stability of the enzyme, 
in fact it is reported that exposing it to temperatures reaching 55 °C actually 
shows an improvement in residual activity (activity determined at ambient 
temperature after the enzyme is exposed to increased temperatures and cooled). 
However, exposure to temperatures above 55 °C resulted in a significant drop in 
activity. The report suggested a potential denaturation and refold mechanism 
enabling a structural re-annealing at around 55 °C leading to a more highly active 
protein (Martinez-Torres, 2009). 
 
In this work a range of temperatures were investigated for its effect on D469T-TK 
activity, whilst attempting to improve the low solubility of the novel cyclic 
aldehyde substrate. In conjunction with pre-ultrasonication of the aldehyde stock 
solutions, reactions performed at 40 °C resulted in a slight initial reaction rate 
enhancement, however the overall yield remained the same (Figure 4.4).  This 
indicated an intrinsic ‘supply and demand’ process occurring whereby, as 
substrate was being consumed more substrate dissolved in solution, thus 
introducing a substrate solubility partitioning pre-equilibrium. The initial rate of 
the enzyme was greater at 40 °C compared to 20 °C by a phenomenon seen with 
the majority of both biological catalysts and chemical reactions, whereby the 
number of energetic collisions increases and therefore reaction rate is more rapid 
according to the Arrhenius equation (below). The transmission coefficient- ratio 
(k, rate constant) represents the probability that the activated complex (enzyme / 
substrate complex) will go on to form products rather than return to reactants.  
 
k = Ae-Ea/RT 
 
Where k is the rate constant, T is temperature, R is the gas constant, A is the pre-
exponential factor (Arthenius constant)  and Ea is the activation energy.  
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Figure 4.4: Effect of temperature on D469T-TK activity. Comparison of 
D469T activity against DCHCA and HPA at ( ○ ) 40 °C and ( ■ ) 20 °C over 10 
hours (HPA and DCHCA 50 mM and cofactors TPP 2.4 mM and MgCl2).  
 
 
 
 
The lack of effect on overall yield of the reaction at 40 °C compared to ambient 
temperature indicates temperature independent reaction issues. Potential substrate 
and / or product inhibition may cause this trend when a particular concentration is 
reached and is investigated further in Chapter 6. Additionally, the stability of all 
reaction components may be compromised at the elevated temperature. A more 
rapid degradation of substrates may be occurring shown by a drop in reaction 
activity.   
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4.3.1.1.3 Reaction component stabilisation 
 
 
4.3.1.1.3.1  Biocatalyst stability 
 
Pure enzymes D469T and WT-TK storage stability was investigated, to evaluate 
potential structural affects of the mutation within the active site. Samples of both 
biocatalysts were stored at room temperature (20 °C), in the fridge at 4 °C, and at 
-20 °C. No difference in activity between the mutant and WT-TK in the various 
storage situations was seen at all, indicating no immediate structural effect of the 
mutation, shown in Figure 4.5. It was found that storage at 4 °C was sufficient for 
up to two months with no significant drop in activity. Storage at ambient 
temperature saw a rapid drop in activity over 2 weeks, with negligible activity 
after 1 month. Samples stored at -20 °C also showed no significant drop in 
activity at all over 2 months.  
 
Each batch of protein purified for use in kinetic studies was therefore stored in the 
fridge at 4 °C. Batches were discarded after two weeks and new preparations 
made. GA and HPA activity tests established comparable activity of each batch 
prior to application to kinetic experiments.   
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Figure 4.5: Storage stability of D469T-TK His-tagged pQ412. L-erythrulose 
formation using enzyme stored at (■) Room Temperature (■) 4 °C (■)-20 °C. 
Reaction conditions as described in section 2.5.4. 
 
 
4.3.1.1.3.2 HPA 
 
HPA appears to maintain sufficient stability throughout a 2 hour reaction time 
scale, whereby no significant drop in HPA is detected in control experiments at 20 
°C and pH 7.0 (Figure 4.6). However with lengthier reaction time scales of up to 
72 hours, the stability of HPA appears to become compromised (Figure 4.7). A 
starting concentration of 50 mM, equal to the starting concentration in a standard 
activity assay with glycolaldehyde, propanal and DCHCA, is seen to drop to 
approximately 35 mM over 72 hours.  
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Figure 4.6: Stability of HPA during short time scale reactions.  Experiment 
conditions, HPA (50 mM) Tris-HCl buffer (50 mM pH 7.0), 20 °C, in the 
presence of cofactors (TPP, 2.4 mM and MgCl2, 9 mM).    
 
 
 
Figure 4.7: HPA stabilization during long time scale reactions. Experiment 
conditions, 50 mM Tris-HCl buffer, pH 7.0, 20 °C, in the presence of cofactors, 
(TPP, 2.4 mM and MgCl2, 9 mM).    
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4.3.1.1.3.3       DCHCA and R-isomer-DCHCA 
 
The storage stability of the racemic aldehyde and R-isomer aldehyde was 
investigated. 1H NMR analysis and mass spectrometry (figure 4.8 shows a typical 
spectra used for comparison) was performed fortnightly on the compounds which 
were stored under argon at 4 °C in glass screw top vials. No structural changes or 
oxidation of the aldehyde were evident indicating a stable compound throughout a 
period of 6 months.  
 
 
 
 
 
Figure 4.8: Mass spectrometry of DCHCA. MW 138 (m/z =mass to charge 
ratio).  
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4.3.1.1.4 Reaction vessels, plastic eppendorf or glass vials? 
 
The reaction vessel was examined for optimal reaction conditions and to establish 
any effect on the different material of the vessel surface when using the novel 
aldehyde substrate.  Figure 4.9, shows a fairly significant effect of two different 
reaction vessels, a closed top silanized glass vial and a closed top plastic 
eppendorf at 40 °C. Initially activity appears to follow a similar rate within the 
two different vessels, however at approximately 20-30 minutes reaction time, the 
rate of the reaction in the plastic eppendorf vial slowed significantly and after 50-
60 minutes of reaction time activity appeared to cease. A subsequent study 
indicated that the same effect was evident when using plastic microwell plates, 
and is thought to be caused by an adverse adhering of the aldehyde to the vessel 
walls. Glass vials were subsequently used throughout for all reactions.  
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Figure 4.9: Comparison of reaction vessel effect on DCDHP synthesis. (○) 40 
°C silianized glass vial (■) 40 °C plastic eppendorf vial. Reaction conditions, 40 
°C maintained in a water bath, 50 mM DCHCA and HPA and cofactors (TPP 2.4 
mM and MgCl2 9 mM).  
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Sealed reaction vials were also deemed necessary due to the volatile nature of 
propanal and potentially other substrates used with TK. Figure 4.10 indicates PA 
depletion within a closed vial compared to microwell plates without secure seals. 
An average of 75% loss was seen within the microwell plates with loose lid 
compared to 12% loss seen from the screw top vials, a significant improvement.   
The length of the reaction times make it crucial to ensure the reaction substrates 
remain within solution.    
 
 
 
 
 
 
 
Figure 4.10: Comparison of propanal depletion within screw top glass vials 
and microwells with plate lid. 50 mM propanal (PA) in Tris-HCL buffer (50 
mM, pH 7.0) measured by HPLC after 48 hours.  
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4.3.1.1.5 Impact of reaction scale for D469T-TK and WT-TK activities 
 
 
4.3.1.1.5.1  Kinetic assays at low reaction volumes (300 µl -1.2 mL) 
 
Small scale reactions were performed for glycolaldehyde activity assays, propanal 
activity assays and DCHCA kinetic analysis reactions. Small scales of 300 µL-
1.2 mL were sufficient to provide a solution of enzyme and substrate to allow 
effective diffusion through the mixture with reaction sampling. No significant 
difference in reaction rate was seen between the three different scales of 300 µL, 
600 µL and 1.2 mL. 
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Figure 4.11: Comparison of activity of D469T-TK at small assay scales. 
Substrates glycolaldehyde and HPA (50 mM, Tris-HCl buffer 50 mM pH7.0) at 
20 °C in 3 different small scale volumes, 300 µL, 600 µL and 1.2 mL and 
analysed by HPLC in triplicate.  
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A range of volumes (10% - 70% of reaction volume) of enzyme were investigated 
for the optimal level of reaction rate and balance of reaction components and 
solvent, whilst keeping substrate  (50 mM) and cofactor (TPP 2.4 mM, Mg2+ 9 
mM) concentrations constant and allowing for sampling at 300 µL scale. For the 
PA reactions 30% v/v clarified lysate was found to be optimal and for the 
DCHCA 50% v/v enzyme (pure and clarified lysate). A reaction with 70 % 
enzyme caused an issue with aldehyde solubility where substrate stock solutions 
required higher starting concentrations and so this was not considered for further 
investigation. A 10% reaction of DCHCA saw very little product formation over 
24 hours and 30% relatively low product formation. (Figure 4.12). All GA activity 
tests maintained 10% v/v enzyme which was found to be effective for the rapid 
reaction rate and determination of activity within 60 minutes.   
 
 
 
 
 
 
 
 
Figure 4.12: Comparison of enzyme concentration on product formation. 
D469T-TK mediated synthesis of DCDHP. DCHCA and HPA (50 mM) and 
cofactors TPP (2.4 mM) and MgCl2 (9 mM) in Tris-HCl buffer (50 mM, pH7.0) at 
20 °C for 24 hours.  
 
 
    10%    30%   50% 
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4.3.1.1.5.2 TK kinetics at preparative reaction scales (90 mL-500 mL) 
 
A 90 mL scale D469T-TK lysate reaction using a pH stat, at pH 7.0, 50 mM 
substrate concentration, in 100% water yielded 18% of DCDHP (± 3%). A Tris-
HCl buffered (50 mM Tris-HCl, pH 7.0) reaction with the same reaction 
conditions yielded very similar conversions of 15% DCDHP (±2%), in a 
magnetically stirred closed reaction vessel over 72 hours.  
 
Large scale volumes ranging from 90 mL up to 500 mL were performed for the 
preparation and isolation of 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-
dihydroxypropan-2-one (DCDHP), the analysis of enantioselectivity and 
determination of absolute configuration. All reactions scales corresponded well 
with regard to product yield and reaction rate.  
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Figure 4.13: Comparing effect of scale on initial rate of D469T-TK.   
Substrates DCHCA and HPA (50 mM, Tris-HCl buffer 50 mM pH7.0) at 20 °C at 
different scale volumes, 300 µL, 600 µL, 1.2 mL, 90 mL, 500 mL and analysed by 
colorimetric assay.  
 156
4.3.1.2 Investigation into improving substrate solubility 
 
4.3.1.2.1 Co-solvent addition to water 
 
A small yield improvement was seen with the addition of a co-solvent ethyl 
acetate (EtOAc) to the TK-catalysed reaction with DCHCA and HPA in water. 
The Tris-HCl buffered D469T-TK lysate reaction yield was improved from 15% 
(±2%) to 19% (± 2%) with the addition of 5% v/v EtOAc, due possibly to an 
improvement in substrate solubility.  This is also an indication of the tolerance of 
enzyme stability in organic solvents, as when using a 1:1 ratio of water and 
EtOAc there was no product formation seen at all. A 2:1 ratio of water and EtOAc 
also yielded no product. Reported data suggests an effect of the solvent on the 
activity of an enzyme catalysed reactions is due to differential Gibbs free energy 
of desolvation for the transition states of the reactants (Wescott and Klibanov, 
1993; Ke et al., 1996). 
 
The cosolvent was therefore added at a concentration of 5% v/v to subsequent 
preparative scale reactions. However, for activity and kinetic analysis the solvent 
remained 100% aqueous, to establish the native activity and provide a direct 
comparison to previous substrates. 
 
 
4.3.1.2.2 Comparison of shaking and non-shaking D469T reaction 
 
The effect of shaking on the TK reaction with the hydrophobic substrate was 
briefly investigated. To establish potential significant rate enhancement and to 
evaluate an improvement on solubility, shaken vessels were compared to non-
shaken reactions. No significant effects of shaking were seen at scales of 300 µL 
in glass screw top vials compared to non-shaken vials. Investigation of platform 
shaking at 200 rpm, at ambient temperature indicated no effect on the solubility of 
the substrates or on the mass transfer of solutes. The introduction of a magnetic 
stirrer bar into the kinetic assay reaction at such small scales was problematic. The 
aldehyde, as with the plastic vessels and microwells appeared to adhere to the 
plastic stirrer bar and cause slightly inconsistent reaction rates.  
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Stirring large scale reactions however, did have a significant effect and all 
preparative scale TK reactions and also biomimetic reaction were stirred 
magnetically. Unstirred preparative scale reactions produced very low yields of 
product <3%. The effect of the stirrer bar material did not appear to have an effect 
on reaction yields at larger scales, as the aldehyde loss (adhered to stirrer bar) was 
relatively less significant than the smaller scales.  
 
 
4.3.2 Biomimetic reaction for racemic ketodiol synthesis 
 
Biomimetic reactions using both PA and DCHCA were performed to synthesise 
standard racemic compounds of each. Initial chiral HPLC data, after conversion to 
the monobenzoate, indicated equals amounts of each of the four enantiomers, as 
shown in 4.14. Four peaks relating to each of the diastereoisomers was observed 
with a ratio of 1:1:1:1. Varying the reaction scales and use of co-solvents within 
the biomimetic reaction mixture did not affect the enantiomeric excess or 
distribution of diastereomers which in all cases were found in equal quantities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: Four possible ketodiol product diastereomers.  
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4.3.2.1 Co-solvent addition to the biomimetic reaction 
 
Initial preparative reactions in 100% water yielded very low conversions of 
racemic DCDHP, 3%. Co-solvents were assessed for their effect on reaction 
yields, in order to improve substrate solubility. The use of a co-solvent to improve 
precursor solubility in water was investigated using tetrahydrofuran (THF) and 
ethyl acetate (EtOAc). The use of EtOAc as a cosolvent did not lead to a 
significant improvement in productivity. The lower solubility of EtOAc in water 
may mean it is not suitable as a cosolvent possibly causing separation of reagents 
through a biphasic system. Ethyl acetate may also not be suitable due to potential 
hydrolysis. THF, a five membered ring containing an oxygen atom is soluble in 
water at the ratios used and due to the lone pair of electrons can hydrogen bond to 
reactants present in solution. 
 
 
 
 
 
Figure 4.15: Tetrahydrofuran, THF. Cosolvent used in the transketolase 
mimetic reaction.  
 
 
 
A 10% v/v addition of THF to the biomimetic reaction solution saw a small 
improvement from yields of <3% DCDHP, to 8 (±2%).  Increasing cosolvent 
concentration to 50% v/v, saw a significant yield enhancement from <3% to 22 
(±2%). A ratio of 1:1 water and THF was subsequently used in all biomimetic 
preparative reactions.  
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4.3.2.2 Scale 
 
Increasing the scale of the reaction from 100 mL solvent volume in a magnetically 
stirred RB flask at ambient temperature to 500 mL did not have any effect on the 
overall product yield. Larger volume reactions were more useful with regard to 
product yield and were performed regularly for synthesis of racemic DCDHP.  
 
 
4.3.3 Enantioselectivity of TK-D469T with DCHCA 
 
4.3.3.1 Cyclic aldehyde enantioselectivity and absolute configuration 
 
The methods described for determining ee vary depending on the compounds 
involved. The stereoselectivity and enantioselectivity were explored with this 
novel chiral substrate against mutant TK, D469T. Previously D469T-TK 
stereoselectivity against propanal was determined to be 90% for (S)-isomer 
compared to 58% for WT-TK (Hibbert et al., 2008).  
 
 
The product of the D469T-TK reaction alongside the product of the 
biomimetic reaction were subjected to the same benzoylation procedure in 
order to generate the D469T product and a four isomer mixture (racemate) of 
the same benzoylated compound (fig 4.16).  
 
The HPLC spectra of the benzoylated products, Figure 4.17 revealed that the 
D469T-TK product consisted of a single major diastereoisomer with traces of 
the remaining three isomers. Analysis of another variant, D469L-TK, was 
performed for comparison of the unusally high enantio- and stereoselectivity 
exhibted by D469T-TK. Both TK variants demonstrated the formation of the 
same major diastereoisomer, indicated by peak 3 in Figure 4.17.  
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Figure 4.16: Reaction sequence for chiral HPLC and ee assay.  Reaction 
conditions: (i) H2O, N-methylmorpholine, 10%; (ii) NEt3, PhCOCl, 70%; (iii) 
(5S)-2,2,3-trimethyl-5-phenylmethyl-4-imidazolidinone, CH3CN/H2O, 83%; (iv) 
D469T-TK, 4, TPP, MgCl2, 15% (rel. to 1RS-3), 30% (relative to 1R-3); (v) (R)-
MTPACl, NEt3, 75%. 
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a) 
 
 
 b) 
 
 
Figure 4.17: Chiral HPLC spectra. a) Comparison of the monobenzoylated 
reaction products from D469T and D469L reactions against DCHCA with 
racemic mixture formed biomimetically. (Four possible enantiomers indicated by 
peaks 1-4) b) S-MPTA DCDHP representative spectra, indicating a ∆L-∆H = > 0.2 
ppm.  
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The enantioselectivity of D469T-TK was determined and the absolute 
configuration of the product established through the preparation of the R-aldehyde 
and the recently modified Mosher’s acid method (Benaglia et al., 2002; Galman 
and Hailes, 2010).  To begin with, the Macmillan’s catalyst (5S)-2,2,3-trimethyl-
5-phenylmethyl-4-imidazolidinone was reacted with the Diels Alder substrates to 
form the R-isomer of DCHCA (Figure 4.16, (iii)) with a yield of 83%). The 
biomimetic reaction was performed with this aldehyde, to form DCDHP which 
was then benzoylated. HPLC peaks corresponding to the 1’R-isomers were 
assigned, indicating that the major product formed by D469T-TK possessed a 
1’R-centre in DCHCA (R-isomer). Also, the product (DCDHP) of the D469T-TK 
reaction was reacted with (R)-MTPACl to form the Mosher’s ester at C-1. A 
recent protocol to assign the absolute stereochemistry at C-3 of α,α'-
dihydroyketones, determined that the separation of the oxymethylene protons at 
C-2, derivatised as Mosher’s esters, differed with the trend that ∆δH2R,3'R and 2S,3'S > 
∆δH2R,3'S and 2S,3'R. Analysis of known stereocentres allows for the prediction that 
the ∆L-∆H = > 0.2 ppm shown in Figure 4.17b. Therefore, the stereochemistry at 
C-3 of the product formed by D469T-TK, was assigned as (1S). Considering the 
data from both the HPLC experiments and the Mosher’s ester derivatisations, the 
absolute stereochemistry of the major isomer of the product formed from D469T-
TK reaction was established as (1S,1'R). HPLC analysis of the benzoylated 
ketodiol product indicated that the D469T-TK product (1S,1'R) was formed in 
93% ee.  
 
 
 
 
 
 
Figure 4.18: Stereochemistry of the major diastereoisomer formed by D469T-
TK. (1'R,1S)-(3,4-dimethylcyclohex-3-enyl)-1,3-dihydroxypentan-2-one 
(DCDHP). 
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4.4 Summary 
 
In this chapter the preparative scale transketolase mediated synthesis of 1-(3',4'-
dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP) using TK 
variant D469T was performed and analysed. The optimal reaction conditions were 
investigated for the novel enzyme mutant and compared to previously reported 
data for WT-TK. The pH optimum of around neutral, corresponded well with 
current data for TK, despite altering the TK gene by single point mutation and 
addition of a His tag at the N-terminus.  
 
Alongside the TK catalysed reaction against DCHCA for the synthesis of the 
cyclic ketodiol product a very useful mimetic of the TK reaction was performed 
and optimised. The use of THF as cosolvent to improve solubility of the 
hydrophobic aldehyde, DCHCA, worked well and improved reaction yield almost 
10 fold. HPLC spectra of the biomimetic product which had been 
monobenzoylated highlighted an equal mix of all four possible diastereo-isomers. 
The racemic compound provides a useful standard for both the calibration of 
kinetic assays and the determination of enantiomeric excess and absolute 
configuration of the D469T-TK reaction product.  
 
A benzoylation procedure was applied to both the racemic cyclic ketodiol and the 
D469T-TK reaction product and analysed by chiral HPLC. Analysis of the HPLC 
spectra revealed the presence of a single major enantiomer with trace amounts of 
the other three enantiomers. Analysis of a further TK variant D469L also revealed 
the formation of the same single major enantiomer. An ee was calculated for the 
variant D469T and found to be in excess of 93%.  
 
A recently modified Mosher’s ester methodology was employed for the 
determination of the absolute chemistry of the single major enantiomer and was 
calculated by assigning protons of the compound. The absolute configuration was 
subsequently calculated and elucidated as the (1S,1'R) enantiomer.  
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5 D469T-TK and Wild-Type-TK kinetics 
 
 
 
This chapter describes investigations into the characterisation of the highest 
performing D469 library mutant D469T identified for activity towards the novel, 
bulky, hydrophobic aldehyde acceptor 3,4-dimethyl-3-cyclohexene-1-
carboxaldehyde (DCHCA). The enzyme kinetics of D469T–TK were analysed 
using a modified colorimetric assay and compared to WT-TK kinetics. The 
colorimetric assay, involving tetrazolium red, was further developed from a 
recently established assay for high throughput screening of 1,3-ketodiols, by 
modifying it for use as a quantitative kinetic assay. Michaelis-Menten kinetic 
parameters, Km, Vmax and kcat were determined for the mutant D469T transketolase 
variant against the novel chiral acceptor aldehyde.  
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5.1 Introduction 
 
 
5.1.1 Wild-type TK kinetics 
 
Transketolase follows a mechanism known as the ‘ping pong bi-bi’ mechanism, 
whereby a two substrate reaction forms two products. The enzyme reacts with a 
single substrate to release a single product and the subsequently modified enzyme 
then reacts with the second substrate to form the second, final product and renders 
a regenerated enzyme. For instance with TK, the ketol donor (HPA) is first bound 
to the enzyme, followed by the release of the first product (CO2) followed by the 
binding of the acceptor aldehyde (glycolaldehyde, propanal or 3,4-dimethyl-3-
cyclohexene-1-carboxaldehyde) and subsequently followed by the release of the 
second product (L-Erythrulose, 1,3-dihydroxypentan-2-one, or 1-(3',4'-
dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one, respectively) and the 
regenerated enzyme. 
 
Kinetic parameters for WT-TK overexpressed in E. coli host JM107 and plasmid 
pQR700 with substrates HPA and glycolaldehyde and product L-erythrulose have 
been reported. The enzyme was shown to be free from excess substrate inhibition 
up to 40 mmol 1-1 for HPA and 100 mmol 1-1 for glycolaldehyde. Inhibition by L-
erythrulose was found to be competitive, as in the predicted mechanism 
(Gyamerah and Willets, 1997).   
 
 
5.1.2 TK variant kinetics 
 
Transketolase has been subjected to a number of engineering procedures such as 
mutagenesis techniques and directed evolution (Hibbert et al., 2007; Hibbert et 
al., 2008). Transketolase variants have been identified to have enhanced activity 
towards non-phosphorylated substrates such as glycolaldehyde and the non-
natural aliphatic aldehyde propanal. Several mutants from a phylogenetically and 
structurally guided library were found to possess enhanced specific activity of up 
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to 3-fold higher than WT-TK under biocatalytically relevant conditions. These 
mutants were found to have substituted residues that differed from those found in 
nature. However, other mutants with conserved residues which are seen to be 
involved in phosphate binding also yielded mutants with almost 5-fold improved 
specific activity against non-phosphorylated substrates. The report suggests that 
the phylogenetically variant active-site residues are useful for modulating activity 
on natural or similar substrates and that conserved residues which no longer 
interact with modified target substrates are significant for application of saturation 
mutagenesis in order to improve activity (Hibbert et al., 2007).  
 
 
5.1.3 Colorimetric assay 
 
Finding alternative methods of detecting substrates and products of a reaction 
creates a method of validating new raw data.  A new specific technique for 
measuring reaction components is valuable for accurate data accumulation and 
may be simpler and quicker to perform than traditionally used assays. The method 
may also be modified for generic use.  
 
Using a colorimetric assay to determine kinetic data is a relatively novel and 
interesting method compared to standard detection methods such as HPLC and 
gas chromatography. It allows for compounds with low responsive chromophores 
to be detected with ease and relative simplicity. It provides a means of validating 
standard data from sources such as chromatography to gain more accurate and 
precise data. The HPLC methods used for transketolase-catalysed reactions with 
glycolaldehyde and propanal accurately detect one of the two substrates, HPA. 
The other substrates are not detected with the same method due to low absorbance 
extinction coefficients. The product is detectable but with a relatively low and less 
well resolved response. The colour assay allows a faster and potentially more 
accurate measurement of the reaction product, while the HPLC method is 
complementary to that of substrate depletion. 
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TK has also been measured by monitoring the residual HPA via an NADH-
dependent enzyme assay after the preparative scale isolation of the reaction 
product. However this method can prove costly due to large scales required and 
may also be prone to product losses through isolation and purification processes. 
Fluorescence has also been reported as a technique for in vitro TK activity 
producing D-threo aldoses and L-erythro ketoses, but is limited to particular 
substrates. Those containing an umbelliferone moiety were used, which could 
potentially affect the TK biotransformation (Sevestre et al., 2003; Simon et al., 
2009).   
 
Chromogenic compounds have been used as substrates for many enzymatic 
reactions in order to produce a coloured product for ease of detection (Erlanger et 
al., 1961; Wahler et al., 2001). Common chromogenic substrates include 5-
bromo-4-chloro-3-indolyl derivatives and p-nitrophenyl. The use of dyes or stains 
and colour indicators are integral for the detection of such compounds. The use of 
tetrazolium salts is often demonstrated, due to the sensitive nature of its signal 
compared to reduction equivalents. The detection of aromatic acyloins, such as 
(R)-phenylacetylcarbinol ((R)-PAC) a chiral intermediate of industrial ephedrine 
synthesis, was developed utilising tetrazolium red (Brèuer et al., 2002). The 
bioconversion of benzaldehyde by pyruvate decarboxylase is detected by the 
reduction of tetrazolium red by the product and measured spectrophotometrically.  
 
Development of the colorimetric assay initially for screening of 2-non-
hydroxylated aldehydes was based upon the reduction of 2,3,5-
triphenyltetrazolium (tetrazolium-red) (Smith et al., 2006). Whereby a colourless 
compound (tetrazolium-red) is reduced in the presence of diol products and 
becomes a red coloured formazane compound, providing a linear relationship 
between the formazane detection and transketolase cataysed reaction ketodiol 
product. In this chapter the screening assay is developed for use as a kinetic 
measurement detection assay, providing an alternative method besides HPLC.       
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5.2 Materials and methods 
 
5.2.1 TK activity at various substrate concentrations 
 
Pure TK (50% of reaction volume) (prepared as described in Section 3.2.11) was 
pre-incubated with cofactor solution (TPP 2.4 mM and MgCl2 9 mM as described 
in Section 2.5.2) for 20 minutes at 20 ºC. A range of substrate stock solutions 
were made with aldehyde concentrations of 10 - 50 mM and 50 mM HPA. 
Substrate solutions were sonicated to assist dissolution for 3 cycles of 10 second  
8 µ pulses with 10 second intervals using a Soniprep 150 sonicator (MSE, Sanyo, 
Japan). Substrate solutions are added to the enzyme preparation with pipette 
mixing and samples taken at regular intervals. Samples were quenched with 
methanol to stop the reaction and stored at -80 °C. The colorimetric assay is 
performed as described in Section 5.2.3.2 
 
 
5.2.2 TK Kinetic assay reaction quenching methods 
 
Kinetic assay reactions were performed as described in Section 5.2.4 and 20 µL 
samples taken at regular intervals, however quenched with either 200 µL ethanol, 
200 µL 0.2% TFA, or the samples were placed immediately in plastic eppendorf 
vials and immersed into an acetone and dry ice bath for rapid freezing and all 
samples stored at -20 °C. The flash frozen samples were diluted with 200 µL Tris-
HCl buffer (50 mM, pH 7.0). The colour assay performed as in section 5.2.3.2.  
 
 
5.2.3 Colorimetric assay for kinetic analysis 
 
5.2.3.1 Carbonate resin quenching 
 
100 µl of a 2.5 mM stock solution of HPA was added to 10 wells of a 96 
microwell plate. Twenty µg MP-carbonate resin beads were added to the 
microwell at t0, and samples taken from wells in order 1-10 (so as not to alter the 
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level of HPA within solution-due to sample taking) at regular intervals over 3 
hours. The automated colour assay was performed as described in Section 5.2.3.2 
to all samples and the OD measured at 485 mM.  
 
 
5.2.3.2 Colorimetric assay 
 
Samples were taken (50 µL) and transferred onto a microwell plate containing 10 
mg MP-Carbonate resin (Biotage AB) and 50 µL Tris-HCl buffer (50 mM, pH 
7.0) and incubated at 20 °C for 2 hours. A 50 µL sample of the quenched reaction 
was transferred without resin into a microwell plate. Automated injection of 20 µL 
tetrazolium red solution (0.2% 2,3,5-tripheyltetrazolium chloride in methanol) and 
10 µL 3 M NaOH (aq) with shaking by FLUOstar Optima plate reader (BMG 
Labtechnologies GmbH), was followed by immediate measurement at OD485nm. 
 
 
5.2.3.3 Calibration curve  
 
Stock solutions of DCDHP were made at concentrations of 50, 40, 30, 20, 10, 5, 
2.5 mM in Tris-HCl buffer (50 mM, pH 7.0). For each concentration 50 µL was 
diluted with 50 µL of Tris-HCl buffer (50 mM, pH 7.0). The colorimetric assay 
was performed as in section 5.2.3.2. The calibration curve is shown in figure 5.1. 
 
 
5.2.4 TK Kinetics Assay 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (0–50 mM, Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (0–50 mM Tris-HCl buffer 50 mM, pH 7.0) 
were added to the reaction mixture. HPA was kept constant at a concentration of 
50 mM, while DCHCA ranged, 0, 5,  20 30, 40, 50, mM and then DCHCA was 
kept constant at 50 mM while HPA ranged from 0 – 50 mM.  Samples of the 
reaction mixtures were taken at regular intervals (20 µL) and the reaction 
quenched in 200 µL methanol. The samples were then taken (50 µL) and 
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transferred onto a microwell plate containing 10 mg MP-Carbonate resin (Biotage 
AB) and 50 µL Tris-HCl buffer (50 mM, pH 7.0) and incubated at 20 °C for 2 
hours.  Fifty µL of the quenched reaction sample was transferred without resin 
into a microwell plate. The automated colour assay was performed as described in 
section 5.2.3.2.  
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Figure 5.1: Calibration curve for formazane after addition of 1-
(3’,4’dimethylcyclohex-3’enyl)-1,3-dihydroxypentan-2-one, DCDHP (r2= 
99.3%).  
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5.3 Results and discussion 
 
 
5.3.1 Kinetic assay development  
 
The development of the kinetic assay was required for the application of a novel 
substrate with greatly differing properties than previous aldehydes such as 
glycolaldehyde and propanal. The reaction profile shown in Figure 5.10 indicates 
a reaction time of up to 48 hours, compared to the 60 minutes for glycolaldehyde 
and 24 hours for propanal. 
 
 
5.3.1.1  Kinetic assay optimisation 
 
The differing characteristics of the novel substrate compared to the well 
established substrates used previously in this TK assay, including in particular the 
much lower solubility in water, demands modifications. In order to improve this 
solubility limitation for the kinetic assay without the use of previously discussed 
co-solvents in preparative scale reactions (Chapter 4), substrate solutions were 
subjected to ultra sonication. The solubility of HPA is not limiting at the 
concentrations used here for kinetic analysis, however the industrial-scale 
economic requirements for high titres may find the solubility in water of 0.65 M 
to be problematic.  
 
Cyclic aldehyde substrate stock solutions were sonicated using an ultra-sound 
probe (Soniprep 150 sonicator) in order to maximise solubility of the aldehyde 
within the buffer solution. The solution was placed within an ice jacket during 
sonication to counteract any heating affect of the procedure. In conjunction with 
the use of an ice jacket, ‘pause’ intervals were introduced between 10 second 
pulses to allow intermittent cooling of the solution. The ultra sonication of the 
aldehyde appeared to temporarily improve solubility in water turning the 
hydrophobic globules of the aldehyde into a homogenous ‘milky white’ solution. 
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The ultrasonic waves will cause a periodical compression and rarefaction of the 
buffer and aldehyde solution, potentially and significantly causing an increase in 
mass transfer (Mason, 1997). The increase in mass transfer may be attributed to a 
sonochemical effect, whereby the reactants are transformed into more water-
soluble reaction products by the formation and rapid collapse of gas bubbles 
within solution. In addition, the microcurrents induced by the ultrasound 
procedure reduce diffusion layer differences between phases, promoting faster 
mass transfer in solution (Mason, 1999).  .   
 
The sonication method appeared to offer a more accurate transfer of substrate 
from stock solution into reaction solution, and was therefore performed before 
each reaction. 1H NMR analysis of the sonicated aldehyde indicated no immediate 
effect on chemical structure, however stock solutions were discarded after one use 
and fresh solutions prepared for each separate reaction. HPA was added to the 
substrate solution following sonication to avoid any destabilization of the ketol 
donor compound. The solution was applied to the pre-incubated TK cofactor 
mixture immediately. 
 
 
 
 
 
 
 
 
Figure 5.2: Optimisation of dilutions in the colorimetric assay.  A range of 
dilutions of the solubilised 25 mM DCDHP product stock solution were 
investigated for optimal sensitivity, linearity and the limit of detection in kinetic 
experiments. Actual concentrations after assay dilution: the six wells containing 
from left to right 2.5 mM, 2.5 mM, 0.25 mM, 0.25 mM, 0.025 mM and 0.025 mM 
DCDHP. 
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A number of dilutions were analysed for optimisation and evaluation of the 
colorimetric assay for use in quantitative kinetic measurements. Concentrations 
that lay within the detection limits of the assay were investigated. Dilutions were 
required to provide product levels above the lower limits of the colour assay 
where traces of HPA are detected as shown in control experiments (Figure 5.7). 
Also, dilutions were required to remain within the lower maximum capacity range 
of the MP-carbonate resin beads, 2.5-3.5 mmol.g-1 (based on nitrogen elemental 
analysis, Biotage, AB), otherwise the HPA substrate would saturate the resin and 
not be entirely removed from the reaction, thus causing inaccurate measurement. 
Dilutions were investigated to avoid signal saturation of the colour assay and also 
to optimise the sensitivity and ability to measure very low level concentrations 
and thus low reaction conversion levels. The assay was previously reported as 
capable of detecting as little as 2.5 mM (actually 12.5 nmol after assay protocol 
dilutions), however slight improvements in sample handling and dilution control 
provided a limit of detection (LOD) of just 0.5 mM. Comparable detection levels 
of DCDHP were detected here (Figures 5.2). It was found that it was absolutely 
crucial that samples were pipette-mixed at each transfer and particular attention to 
pipetting accuracy was fundamental when measuring such low product 
concentrations.  
 
 
5.3.1.2 Reaction quenching methods  
 
The standard method for sampling and quenching TK-catalysed reactions against 
GA and PA for detection by HPLC is by the addition of 0.2% trifluoroacetic acid 
(TFA) causing denaturation. The same method however, proved problematic 
(Figure 5.3) for samples of the reaction against DCHCA despite neutralisation, 
due to the new colorimetric detection method, as data was inconsistent and did not 
correspond well with HPLC data of the same reaction. Several alternative 
methods were investigated for reaction quenching including methanol addition 
and flash freezing in an acetone and dry ice bath (Figure 5.3).  
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Figure 5.3: Enzyme reaction quenching methods. Comparison of quenching 
by: (∆) Methanol (50% v/v); (■) Flash freeze (acetone and dry ice); and (●) TFA 
0.2%. Activity assay performed as described in section 5.2.4. 
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Flash freeze quenching was not a successful method for initial rates experiments 
of this particular reaction. Results indicated it may have been possible that on 
thaw of the frozen samples the enzyme continued to transform the substrates 
within the sample during the 3 hour MP-carbonate resin adsorption for removal of 
the HPA. Therefore a method that instantly and irreversibly inhibited the enzyme 
(deprotonated or denatured) and therefore prevented the reaction from proceeding 
was required, due to the length of the HPA quench time relative to the short 
sample times of a matter of minutes.  
 
The use of methanol as a quenching agent was based upon the high concentration 
of an organic solvent causing irreversible degradation to the enzyme within the 
sample. At a concentration of 50% methanol, Figure 5.3 indicates an effective 
quench (reaction inhibition) of the reaction and no adverse effect on the 
colorimetric detection assay.  Using methanol within the system was simplified by 
its presence already within the colorimetric assay (solvent for tetrazolium red) 
reducing further potential complications of the presence of numerous organic 
solvents.  
 
 
5.3.1.3  Resin quenching  
 
The removal of HPA from the reaction system prior to tetrazolium red addition 
was fundamental. The presence of the hydroxyketone functionality within HPA 
reduces tetrazolium red in the same way as the dihydroxyketone products of TK 
to form the red coloured formazane, therefore, masking the effect of the TK 
reaction product on the formazane levels within the sample. Removal by an ion-
exchange resin was developed (Smith et al., 2006) and a quaternary amine 
functionalised MP-carbonate resin (Biotage) was found to be effective (Figure 
5.4). The resin ‘quench’ required optimisation to ensure complete HPA removal 
from the system.  
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Figure 5.4: MP-Carbonate resin (Biotage). Used for scavenging acids, such as 
lithium hydroxypyruvate (HPA).  
 
 
The length of time that the HPA is reacted (quenched and removed from the 
sample) with the MP-carbonate resin was investigated. It was found that two 
hours was adequate for removal of HPA, however three hours was optimal for 
complete confidence of removal of all traces of HPA. It is critical that the HPA is 
properly removed so as not to interfere with the relatively low ketodiol 
concentrations within the samples.  
 
Shaking of the system was also investigated to assess potential increases in the 
adsorption rate of HPA to the resin beads, whereby the microwell plates were 
subjected to a 200 rpm platform shaker. However, shaking did not significantly 
reduce quenching time and it was considered unnecessary also due to the potential 
contamination caused between microwells. It was found, however, that volumes 
of sample solution greater than 200 µL for 10 mg resin did not effectively remove 
all of the HPA. The larger ratio of sample volume to resin bead mass was found to 
insufficiently quench the HPA possibly due to insufficient mass transfer rather 
than due to reaching the limit in chemical capacity of the resin. Mixing of the 
samples could potentially improve mass transfer throughout the solution of larger 
volumes (>200 µL), however as previously mentioned using a SWR-96 microwell 
format, contamination between wells was an issue.  
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Figure 5.5: Time-dependence of Li-HPA quench using quaternary amine MP 
carbonate resin. 50 mM HPA solution (actual concentration 2.5 mM) to remain 
within resin maximum capacity and in line with actual kinetic reaction conditions, 
20 °C, 10 mg MP-carbonate resin, assay performed as in section 3.2.8.   
 
 
5.3.1.4 Colorimetric assay development for kinetic analysis 
 
The tetrazolium-red colorimetric assay was initially developed for use as a high 
throughput screening assay for TK mutant libraries (Smith et al., 2006). Here the 
assay has been modified for use as a kinetic assay for detection of the products of 
the transketolase reaction, including DCDHP. Modifications developed here 
includes the TK reaction times, sampling over time, reaction sample dilutions, 
reaction quenching method and assay component concentration. The assay 
provides an alternative, simpler and more rapid detection method of numerous 
samples at one time, and is also applicable to several TK products from non- α-
hydroxylated aldehydes.  Here, the 2-hydroxyketone TK reaction product reduces 
colourless 2,3,5-triphenyltetrazolium to red coloured formazane and the 
corresponding oxidised product, diketone.  
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Scheme 8: Colorimetric assay mechanism. Reduction of colourless a)  
tetrazolium red  to b) red coloured formazane by oxidation of D469T-TK product 
c) 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one (DCDHP) to d) 
two possible oxidised products.  
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5.3.1.4.1 Colorimetric assay calibration curve 
 
The ketodiol product (DCDHP from biotransformation and racemic biomimetic 
reactions) proved to be very difficult to re-dissolve in water after isolation and 
purification.  Although kinetic experiments indicated solubility in water of up to 
~12 mM, it seems that once the compound had been isolated it was very difficult 
to re-dissolve into water even using ultra-sonication. Therefore, a cosolvent was 
considered possible candidates included methanol (CH3OH), ethanol (C2H5OH), 
ethyl acetate (EtOAc), and tetrahydrofuran (THF). The selected solvents were 
assessed for both their improvement on solubility and the possible effects on the 
colorimetric assay chemistry.  Due to the presence already within the colorimetric 
assay, methanol was selected as cosolvent for the standard DCDHP solution for 
calibration curves. Methanol had no effect on the fundamental chemistry of the 
assay and also proved particularly effective as a cosolvent for the hydrophobic, 
cyclic, 1,3-ketodiol. The additional methanol within the system did, however, 
cause a very slight alteration in colour, from the distinctive pink/red seen during 
screening experiments, to a red/orange (λmax  = 485 nm) shown in Figure 5.6.  
 
 
 
 
 
          1                 2           3                4  
 
 
 
Figure 5.6: Effect of addition of methanol into colorimetric assay samples.  
Wells 1 and 2 show the additional methonal compared to original assay 
components in wells 3 and 4.  Use of cosolvent to improve solubility and 
therefore accuracy of calibration curve of TK product DCDHP.  
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5.3.1.4.2 Limit of detection and control assay 
 
Control TK-reaction experiments analysed with the colorimetric assay indicated a 
small interaction between HPA and TK might occur, where despite quenching of 
the HPA from reaction solution, traces of HPA were still measured (Smith et al., 
2006). Where HPA was present (prior to resin quench) not in the presence of TK, 
no traces of HPA were measured. The detection limit is the mean of the blank and 
the lower detection limit is the lowest quantity of a substance that can be 
distinguished from the absence of that substance within a confidence limit.  The 
limit of detection here was found to be 0.5 mM comparable to the signal of a WT-
TK against DCHCA and HPA over 48 hours.  
 
 
 
 
 
 
 
                                         
 
 
 
Figure 5.7: Evaluation of the colorimetric assay on TK reaction control 
experiments. 1: 24 hour reaction with TK, Cofactors, HPA. 2: 24 hour reaction 
with cofactors, DCHCA and HPA 3: 24 hour reaction with TK, cofactors and 
DCHCA. (Cofactors: TPP and MgCl2) and 3 hours quenching on MP-Carbonate 
resin at 20 °C (Biotage, AB).  
1                        2       3  
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5.3.2 D469T kinetic parameters 
 
The colorimetric assay for product formation was used to obtain kinetic data of 
mutant D469T-TK against DCHCA, in addition to mutant screening, as it was 
found to quantitatively compare with HPLC.  The analysis of enzyme kinetics is 
vital to the development of new biotechnologies, such as screening for drug 
candidates and the identification of useful biocatalysts. The knowledge of kinetic 
parameters allows for the effective integration of individual enzymes or 
biocatalysts into current chemical syntheses or the development of new pathways 
with optimal productivity.  
 
The depletion of HPA was monitored using the same HPLC-based method 
developed for assaying the glycolaldehyde reaction, and compared to the 
formation of DCDHP as monitored by the colorimetric assay. The Pearson 
correlation was calculated to be 0.98 indicating comparable data from the two 
different detection methods. To further initially validate the colorimetric assay the 
formation of DHP from the bioconversion of propanal (PA) and HPA was 
monitored by both HPLC and the colorimetric assay (fig 5.8). The Pearson 
correlation value calculated between the two sets of data was 0.9808.  
 
His-tagged D469T-TK was purified and characterised using DCHCA at a 
range of concentrations (0–50 mM) and 50 mM HPA. Complete two substrate 
anaylsis was not performed due to the inhibition seen by HPA of WT-TK with 
a Ki of 42 mM and also to concentrate on the aldehyde pathway only. The 
enzyme was first incubated with cofactors, Mg2+ and TPP to ensure formation 
of the holoenzyme, found to be crucial for the transketolase reaction to proceed 
(Sprenger et al., 1995).  The lack of pre-incubation was previously seen to 
slow intial reaction rates, due possibly to competitve binding between 
substrates and cofactors when prepared and applied to the enzyme 
simultaneously.  Reaction volumes of 600 uL were performed in order to 
provide sufficient sample for the larger volumes required for accurate 
measurment by the colorimetric assay.  
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Figure 5.8: Colorimetric assay validation. A)  HPA (●) depletion measured by 
HPLC and DCDHP (□) formation detected by colorimetric assay. 50 mM 
DCHCA and 50 mM HPA in Tris-HCl buffer (50 mM pH 7.0) 20 °C. B) DHP 
formation detected by HPLC (□) 15 min isocratic assay as described in section 
2.6.2.3 and colorimetric assay (●) performed as described in section 3.2.8. 
Reaction, 50 mM propanal and 50 mM HPA, in Tris-HCl buffer (50 mM, pH 7.0) 
at 20 °C.   
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Figure 5.9: Comparison of colorimetric assay wells from different TK 
catalysed reactions. Comparison of reactions over 48 hours for A) D469T with 
propanal (PA); B) D469T-TK with DCHCA; and C) WT-TK with DCHCA. 
Reactions contained 50 mM substrates, 2.4 mM TPP, 9 mM MgCl2, 1.0 mg.mL-1 
TK, in Tris-HCl buffer (50 mM, pH 7.0) at 20 °C.   
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The reaction profile over 48 hours for activity of both WT-TK and D469T against 
the novel acceptor aldehyde DCHCA is shown in both figure 5.9 and 5.10.  It may 
be seen that the activity of WT-TK against DCHCA is negligible which is also 
demonstrated by the sensitive TLC plate photograph, Figure 5.11.  
 
 
 
 
 
 
 
Figure 5.10: Comparison of TK reaction profiles for WT-TK and D469T-TK 
towards DCHCA. Reactions were analysed over 48 hours in triplicate, 10 mL 
reaction scale, 0.6 mg.mL-1 in the presence of cofactors (TPP 2.4 mM and MgCl2 
9 mM), stirred magnetically and controlled in a pH stat at pH 7.0. (●) WT-TK 
(▲) D469T-TK 50 mM DCHCA and 50 mM HPA for the synthesis of DCDHP.  
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Figure 5.11: Typical TLC plate for the conversion of DCHCA to DCDHP by 
TK. TK reaction product (F12=D469T) by resolution with 1:1 EtoAc and hexane 
mobile phase on silica TLC plates and visualisation by phosphomolybdic acid 
(PMA) and heat.  
 
 
 
The reaction profile indicates the level of product formation attainable, and it is 
obvious no product formation at all was possible from WT-TK, while D469T- TK 
reached levels of approximately 12 mM. Preparative scale WT-TK reactions 
yielded no DCDHP at all and pH stat preparative scale reactions of WT-TK 
indicated negligible pH changes within reaction solution by the lack of HCl 
consumption, normally seen with TK reactions to maintain constant pH 7.0. For 
kinetic analysis, the initial rate of the reaction is used to accurately measure and 
provide comparable data for previous TK substrates and other TK variants. Initial 
rate WT-TK is represented by Figure 5.12, further indicating the lack of activity 
of WT-TK with this cyclic, hydrophobic substrate.  
 
Ketodiol 
Aldehyde 
Excess HPA 
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Figure 5.12: Initial rate of WT-TK against DCHCA. Reaction scale 600 µL 
pH 7.0 in 50 mM Tris-HCl buffer with cofactors TPP (2.4 mM) and MgCl2 (9 
mM) (TK 0.4 mg.mL-1) at 50 mM equimolar substrate concentration and 
measured colorimetrically.   
 
 
Figure 5.13: Initial reaction progress curves for D469T-TK catalysed 
reactions of DCHCA. HPA (50 mM) and DCHCA at (○) 10 mM (● ) 15 mM (◊ ) 
20 mM (X) 25 mM (∆) 30 mM (♦) 40 mM (□) 50 mM were reacted with the 
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enzyme using conditions as described in section 5.2.4. The data were fitted by 
linear regression.  
 
 
The data obtained colorimetrically (Figure 5.10) from the D469T-TK reaction 
with HPA and DCHCA, was fitted to the standard Michaelis-Menten model 
(below) utilising the Lineweaver-Burk plot to determine the kinetic parameters, 
Vmax , kcat and Km. The following equation describes the basic model where, Vmax 
is the maximum initial rate of synthesis of the product,  v is the initial rate of 
product formation, Km is the Michaelis–Menten constant, and [S] is the substrate 
concentration.   
 
 
 
 
 
 
Although transketolase has two substrates, it was assumed that the reaction would 
be limited by only one (HPA) and that the substrate concentrations were in excess 
of previously measured activity profiles.  
 
v  =  
Vmax[S] 
Km + [S] 
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Figure 5.14:  Michaelis Menten standard.  
 
 
 
The basic Michaelis-Menten model shown in Figure 5.14 illustrates that the 
Michaelis –Menten constant, Km is equivalent to the substrate concentration when 
the rate of conversion is half of Vmax. Vmax is equivalent to the product of the 
catalyst rate constant (kcat) and the concentration of the enzyme. As described by 
Michaelis and Menten in 1913, the Km of a particular enzyme allows for the 
prediction of how the formation of product will be affected by the availability of 
the substrate, if at all. A substrate with a small Km indicates high affinity which 
will saturate the enzyme more and thus advance closer to Vmax at lower substrate 
concentrations. In order for a reaction to actually even approach Vmax, a significant 
excess of [S] is required, where the enzyme becomes completely saturated.  
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The kinetic parameters can only be read approximately from a direct plot of the 
kinetic substrate concentration and initial velocity data. For accuracy the data can 
be fit to the Michaelis-Menten equation either by a linear or non-linear regression 
analysis. Such linear regression analysis methods including, Eadie-Hofstee, 
Hanes-Woolf and Lineweaver-Burk possess varying degrees of error distortion or 
exclusion within the data. The insensitivity to errors inherent in all inverse plots is 
taken into consideration and the Lineweaver-Burk plot is complemented by the 
Hanes-Woolf plot here. The Lineweaver-Burk (Figure 5.16) is particularly useful 
for representing the kinetic data graphically as a double reciprocal plot first 
described by Hans Lineweaver and Dean Burk in 1934 (Lineweaver and Burk, 
1934). 
 
                      
 
 
 
 
It is useful for analysis of the Michaelis Menten equation and although it 
adversely distorts error-prone data, particularly by placing greater weighting upon 
the less accurately measured lower substrate concentrations, it is also useful for 
graphically determining the type of competitive inhibition that may be present.  
The Hanes-Woolf plot (Figure 5.17) further represents Michealis-Menten data and 
an equation can be written: 
 
 
 
 
 
 
 
 
 
 
A basic drawback of the use of Hanes-Woolf analysis is that the ordinate and 
abscissa are both dependent on substrate concentration and therefore do not 
represent independent variables resulting in error on both axes, as the correlation 
coefficient R becomes redundant.  
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Figure 5.16: Lineweaver-Burk Plot for the D469T catalysed reaction of HPA 
and DCHCA. Reaction conditions: 20 °C, HPA (50 mM), 0–50 mM 3,4-
dimethyl-3-cyclohexene-1-carboxaldehyde and 50 mM Tris-HCl buffer, pH 7.0, 
2.4 mM ThDP, 9 mM MgCl2, pH 7.0 (TK 0.5 mg.mL-1)  (R2 = 0.9962).  
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Figure 5.17:  Hanes-Woolf Plot.  (The same data from figure 5.16 is used here). 
(R2=0.9332). 
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For D469T-TK with DCHCA, we observed a Vmax of  0.07 mM min-1, an 
apparent Km of 69.9 mM, and a kcat of 17.5 s-1.  Taking WT-TK activity to be 
at the limit of detection (0.5 mM at 48 hours), this represents a minimum of 
18,000-fold improvement in substrate specificity (kcat/Km) for D469T-TK 
compared to WT-TK. The Km value calculated is relatively high compared to 
previous measurements of WT-TK with a range of other aldehyde substrates, 
such as 0.16 mM for xylulose-5-phosphate and 1.1 mM for glyceraldehyde 
(Sprenger et al., 1995). However it corresponds well with the increase in Km 
seen for non-phosphorylated substrates, where D-ribose gave a Km of 45 mM, 
L-xylose 55 mM, L-arabinose 250 mM and D-xylose 230 mM (Villafranca and 
Axelrod, 1971). The D469T mutant has previously been shown to have 8.5-
fold improved specificity towards propanal relative to glycolaldehyde when 
compared to WT-TK, highlighting that the conversion of an acidic residue to 
threonine (Thr,) may favour conversions with more lipophilic substrates 
(Hibbert et al., 2007; Hibbert et al., 2008).  
 
 
5.4 Summary 
 
Product detection of kinetic assays for the determination of kinetic parameters are 
measured using a number of different methods such as chromatography, 
colorimetry and fluorescence. The transketolase catalysed reaction has been well 
reported to be measured, by a convenient and accurate HPLC assay, however is 
not time effective for the screening of numerous samples. A SRW-96 microwell 
format can take up to 24 hours for analysis. Previously a time-consuming and 
somewhat less sensitive method involving the coupling of an additional enzyme 
was used. The development of more specific and highly sensitive assays is 
therefore preferential, particularly for high-throughput procedures measuring a 
large number of samples, in the case of numerous enzyme variants.  
 
Here, the recently developed tetrazolium red colorimetric assay for the high 
throughput screening of mutant TK libraries was modified for use as a kinetic 
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assay detection system. Alternative reaction quenching methods were analysed to 
improve compatibility with the colorimetric assay. As a replacement for the 
standard acid quench (0.2% TFA for deprotonation) for the transketolase 
catalysed reaction, flash freezing and methanol were analysed, and methanol was 
found to be the most effective and had the least impact on the colorimetric assay.   
 
Michaelis-Menten kinetic parameters were determined for the novel TK mutant 
D469T against novel substrate 3,4-dimethyl-3-cyclohexene-1-carboxaldehyde 
(DCHCA). Solubility proved to be an issue with the novel substrate with very low 
solubility in water at room temperature. Attempts were made in order to overcome 
this for the kinetic analysis, however as for large scale preparative reactions, 
additional solutions will be required such as mixing and the use of a co-solvent, as 
discussed in Chapter 4 (Matosevic et al., 2008). The kinetic parameters were 
characterised as having a significant 18,000-fold improvement in substrate 
specificity (kcat/Km) for D469T-TK compared to WT-TK. The activity 
enhancement further encourages the suggestion that the conversion of the acidic 
aspartic acid residue to the less polar and uncharged residue threonine, may prefer 
more lipophilic substrates such as propanal and now DCHCA (Hibbert et al., 
2008).   
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6 Product inhibition, substrate inhibition and product 
extraction 
 
 
 
 
This chapter describes initial investigations into the transketolase reaction with 
DCHCA, including both substrate and product inhibition. The use of a novel 
substrate with additional functionalities, introduces problems that affect the 
enzyme in ways that require further characterisation. The chapter also looks 
initially at the compatibility between the Diels Alder reaction and transketolase 
for a chemo-enzymatic reaction. Initial identification of product inhibition and 
potential methods of product removal including the use of another enzyme 
transaminase (TAm) and phenylboronic acid are presented. Transaminase has 
been previously identified as an appropriate candidate for a multi-enzyme 
pathway following transketolase (Ingram et al., 2007), as it has been seen to 
effectively transform ketodiol products of the transketolase reaction forming 
chiral amines (Matosevic et al., 2010).  
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6.1 Introduction 
 
The use of biocatalysis in place of conventional chemical syntheses maintains a 
number of significant advantages such as selectivity and operation under ambient 
conditions (described in section 1.4.1). However, due particularly to inherent 
mechanisms of biological enzymes, drawbacks include both substrate and product 
inhibition or even toxicity towards the enzyme (Dalby et al., 2007) and limited 
substrate solubility in aqueous media.  
 
Previously reported data regarding the stability of TK in the presence of the other 
reaction components, highlighted the requirement to perform a pre-incubation of 
the enzyme with its essential cofactors, TPP and Mg2+ (Mitra et al., 1998). It was 
seen that in the absence of the reaction cofactors, the donor substrate HPA caused 
irreversible enzyme inhibition, however in their presence no inhibition was 
exhibited. TK is also susceptible to oxidation (Brocklebank et al., 1999), 
irreversible inactivation at pH <6.5 (Mitra et al., 1998), and dissociation of TPP 
upon removal of excess of TPP (Mitra et al., 1998). It is significant therefore to 
establish the effect of novel substrates and other components on enzyme activity 
such as components of potentially integrated reactions.  
 
 
 
6.1.1 Enzyme substrate inhibition 
 
The phenomenon of substrate inhibition is described by the reduced activity of an 
enzyme-catalysed reaction in the presence of excess substrate. The relationship 
between substrate concentration and enzyme reaction rate can be quantitatively 
modelled by the Michaelis-Menten theory.  Glycolaldehyde has been reported to 
show substrate inhibition towards transketolase (Mitra et al., 1996; Woodley et 
al., 1996; Bongs et al., 1997; Vasic-Racki et al., 2003; Chen et al., 2007) and 
HPA indicated some inhibition without the pre-incubation of cofactors. The 
inherent effect of aldehydes on proteins has been widely identified as the aldehyde 
potentially forming Schiff bases with the primary amine groups on the surface of 
the enzyme (Snell and Di Mari, 1970).  
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Several methods have been employed to overcome substrate inhibition issues 
throughout industrial biocatalysis. For example, keeping substrate concentrations 
at around the Km for maximum potential activity whilst maintaining a 
concentration low enough to eliminate substrate inhibition and yield high 
productivities overall is often the objective. Substrate feeding strategies provide 
solutions for such situations, where industrially relevant titre concentrations are 
not feasible due to substrate inhibition, substrate solubility or both.    
 
 
6.1.2 Enzyme product inhibition 
 
Inhibition often refers to a reversible loss of activity while toxicity further 
represents an irreversible and time-dependent loss of activity.  The products of 
enzyme reactions have been seen in many biological reactions to be inhibitors of 
their corresponding enzyme (Walter and Frieden, 1963). Although commercially 
undesirable, this is an inherent feature of enzymes relating back to their natural 
environment in which it often provides a negative feedback loop for metabolic 
pathway regulation. In other words, an enzyme may synthesise product until a 
critical concentration is reached, at which point the product becomes inhibitory (at 
this critical concentration) to stop the enzyme from synthesising more product, as 
in the regulation of in vivo metabolic pathways (Hutson et al., 1979). The negative 
feedback inhibits flux through the metabolic pathway and is significant in 
homeostasis mechanisms of biological organisms.  
 
Forms of reversible and irreversible inhibition may be present within an 
enzymatic reaction, whereby the enzyme may become temporarily inactivated or 
where the enzyme may become truly incapacitated by the covalent bonding of an 
inhibitor. Competitive inhibition occurs, in simple terms, when the product of the 
reaction is ‘mistaken’ for the substrate, making the active-site unavailable for 
substrate conversion. Non-competitive inhibition occurs when the product 
adversely interacts with the enzyme by binding to it and causing an alteration in 
its three dimensional structure therefore preventing the substrates from interacting 
with the enzyme. Irreversible degradation may also occur by the structural 
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alteration of the enzyme caused by the product. Inhibition in any form is 
detrimental to the productivity of an enzymatic reaction and must first be 
characterised to establish the appropriate approach for subsequent solutions.  
 
In addition to the direct toxic or inhibitory effects that reaction products may have 
on biocatalysts, is the effect the products have on the composition of the reaction 
mixture. The physio-chemical changes to the solution such as pH fluctuations, 
changes in ionic strength and solution viscosity necessitate the development of 
processes accordingly. For instance, the formation of CO2 in the transketolase 
reaction, dissociating into carbonate and bicarbonate ions as the CO2 dissolves 
into the aqueous media, causing a net increase in pH. 
 
 
6.1.3 Approaches to overcome inhibition issues 
 
 
6.1.3.1  Substrate feeding strategies 
 
In addition to controlling substrate concentrations because of inhibitory effects at 
critical concentrations and limited solubility of target substrates, a relationship 
between high substrate concentrations and enantiomeric excess (D’Arrigo et al., 
1998; Houng and Liau, 2003; Kim et al., 2007) has been reported indicating low 
substrate concentrations giving high selectivity. Fermentations have employed 
substrate feeding strategies to closely control the culture environment and yield 
higher product concentrations (Qureshi et al., 1992) such as, ethanol production 
by s. cerevisiae (Hong, 1986) and the avoidance of oxidoreductive metabolism in 
bakers yeast production (Wang et al., 1977). The supply of substrates to 
enzymatic bioconversions has also been described (Carragher et al., 2001; 
Rojanarata et al., 2004) although not as comprehensively as the removal of 
products from biocatalytic reactions. Commonly, fed-batch stirred tank reactors 
(STRs) are utilised to maintain low substrate concentrations. The 
biotransformation of toxic substrate, toluene to toluene cis-glycol (cis-1,2-
dihydroxy-3-mthylcyclohexa-3,5-diene,TCG) by Pseudomonas putida UV4 was 
shown to follow Michaelis-Menten kinetics until toluene concentrations reached 
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2.4 mM, above which irreversible denaturation of the biocatalyst was observed. In 
order to overcome the low aqueous solubility of the substrate and highly toxic 
nature, an STR with a feed-back control algorithm based on a mass balance 
system was used (Hack et al., 2001). Fed-batch modes are commonplace in 
substrate feeding strategies and have shown to be useful in bioconversions that 
require low aqueous substrate concentration for higher yields and/or higher ee 
(Phumathon and Stephens, 1999). Syringe pumps or peristaltic pumps simplify the 
fed-batch methodology for bench scale investigations.  
 
The use of auxiliaries, such as water immiscible solid phase resins (Simpson et 
al., 2001) and multiphases such as gas (Letisse et al., 2003), or water-miscible 
organic solvents (Collins and Daugulis, 1997) have been reported as a means of 
substrate supply to eliminate substrate inhibition issues. Amberlite XAD 2 resin 
was reported to improve a Saccharomyces cerevisiae asymmetric reduction of 
ethyl-4- chloroacetoacetate (ECA) to S-4-chloro-3-hydroxybutyric acid ethyl 
ester. A yield improvement from 88% to 93%, alongside the optical purity 
increasing from 75 % to 84 % was observed when the substrate (ECA) was pre-
absorbed onto resin and slowly released into solution. Mass transfer of the 
substrate from the solid-phase resin into the liquid phase is the driving force for 
release of the substrate into solution. The use of the resin within the reaction 
solution reduced substrate inhibition affects as well as preventing the spontaneous 
chemical hydrolysis of ECA, demonstrating stabilising effects of such an 
approach (Houng and Liau, 2003). Amberlite (IRA 400), another adsorbing resin, 
was utilised for the controlled release of benzoylformate in an aminotransferase 
bioconversion to synthesise D-phenylglycine. In order to improve the otherwise 
unfavourable equilibrium constant and the presence of substrate inhibition the 
resin was adsorbed with benzoylformate substrate and slowly released throughout 
the reaction on a demand-based supply, resulting in a four fold improvement in 
product yield (Rojanarata et al., 2004). 
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6.1.3.2 Product removal 
 
Product removal strategies traditionally occur as a separate batch operation once 
the reaction is complete by filtration, centrifugation or precipitation. This 
however, does not address product inhibition issues and therefore the product 
requires removal during the reaction. Multi-phasic strategies have been employed 
for such a process including, solid-phase resins and two-liquid phase reactors 
(Woodley and Lilly, 1990).  As well as substrate feeding, resins have been largely 
used as tools for product removal in an approach named ISPR (in situ product 
removal) (Freeman et al., 1993; Roddick and Britz, 1997; Lye and Woodley, 
1999; Stark and von Stockar, 2003; Woodley et al., 2008). Continuous removal of 
the reaction product is advantageous for removing inhibitory and toxic products 
but it also acts to drive the reaction equilibrium forward aiding completion of the 
reaction. A biocatalytic synthesis of 3-tert-butylcatechol by an E. coli variant 2-
hydroxybiphenyl-3-monoxygenase was reported by the hydroxylation of toxic 
substrate, 2-tert-butylphenol which was supplied via a limited feed to the reaction 
mixture (Meyer et al., 2003). In addition to the substrate control the product was 
removed from culture by a continuous in situ product removal with the 
hydrophobic resin Amberlite XAD-4, which was seen to stabilize the otherwise 
labile product. Boronates have also been investigated as a means of removal of 
cis-diols, such as the products of the transketolase reaction (Chauhan et al., 1996; 
Chauhan and Woodley, 1997). 
 
Simultaneous substrate feeding and product removal techniques (figure 6.1) 
represents a step further in the complete control of reaction component 
concentration for optimal reaction process conditions affording subsequent 
maximal yields and ee when toxic substrates form toxic products (Straathof, 
2003). An example of such a concept is demonstrated by a preparative scale 
asymmetric Bayer-Villiger oxidation, where an in situ SFPR (substrate feed 
product removal) resin is used (Hilker et al., 2004).  
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Figure 6.1: SFPR concept (substrate feeding product removal).  
 
 
 
The use of a second enzyme is similar to the concept of ISPR.  However, the 
removal process is not only designed to prevent product inhibition or to isolate the 
product, but also feeds a subsequent step in a useful pathway without the need for 
purification or isolation steps. A two-step transketolase and transaminase pathway 
has been previously investigated and is described below.  
 
 
6.1.3.2.1 Transaminase 
 
The compounds produced from transketolase catalysed reactions are potentially 
useful building blocks for conversion to other chiral synthons such as aminodiols. 
Another transferase enzyme, transaminase (TAm) is able to accept products of the 
transketolase reaction to form these chiral aminodiols. Previous investigation into 
dual strain recombinant E. coli for the ‘one-pot synthesis’ of chiral amino diols 
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has been performed (Ingram et al. 2007) by coupling of native transketolase and a 
β-alanine: pyruvate aminotransferase, transaminase. It demonstrated the 
integration of separate reactions establishing a symbiotic relationship whereby, 
the potentially toxic product of the first reaction (TK) feeds the second reaction 
(TAm). It provides a means of product removal, equilibrium driving force and 
synthesis of optically pure commercially interesting compounds in significantly 
reduced process steps.   
 
In vivo transaminase has a molecular weight of 51.2 kDa and is involved in the 
synthesis of non-essential amino acids and also in the tricarboxylic acid and urea 
cycles. Like transketolase, the action of transaminase may be described by the 
‘ping-pong’ mechanism. In the first half of a model TAm reaction (Scheme 9), 
binding of the amino-donor to the enzyme is followed by amination of the 
coenzyme pyridoxal 5’-phosphate (PLP) to pyridoxamine 5’ phosphate (PMP) 
causing a release of the keto product.  The second half of the mechanism transfers 
the amino group from the enzyme-bound PMP to the acceptor substrate, releasing 
a recycled cofactor PLP (Kaulmann et al, 2007).  
 
 
 
 
NH2 O
HO
O
OH
OH
+
PLP
β-A: P TAm HO
NH2
OH
OH
+
 
 
 
 
 
Scheme 9: Model TAm reaction. Synthesis of optically active L-2-amino 1,3,4-
butanetriol catalysed by β-alanine: pyruvate transaminase enzyme and cofactor 
pyridoxal 5’-phosphate (PLP) from L-erythrulose (synthesised by TK) and the 
amine donor L-methylbenzylamine.   
 
 
L-MBA                 L-erythrulose                        Acetophenone                  ABT 
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6.1.3.2.2 Boronates 
 
Boronic acids have been widely recognised as useful compounds for the 
derivatisation and protection of sugars, amino acids and hydroxamic acids with 
1,2- or 1,3-diols within carbohydrate chemistry (Springsteen and Wang, 2002). 
The interaction of boronic acids and diols has been described as unique in 
supramolecular chemistry in that a reversible pair of covalent bonds is formed 
(Bromba et al., 2009). The simple and straightforward reaction of boronic acids 
with diols has led to wide spread application in many processes including product 
removal in biotransformations. The removal of transketolase reaction products 
with boronic acid derivatives has been demonstrated by specifically extracting the 
ketodiol product from the reaction mixture (Chauhan et al., 1997).   
 
Boronic acids are alkyl or aryl substituted boric acids containing a carbon-boron 
bond such as phenylboronic acid (Figure 6.2). The compounds are able to rapidly 
and reversibly bond by a covalent pair-wise interaction to 1,2- and 1,3-diols in 
aqueous media in ambient conditions, making them excellent candidates for the 
removal of transketolase reaction products.  
 
 
 
 
 
 
Figure 6.2: Phenylboronic acid  
 
 
An investigation for the optimal removal of ketoses from aldose-containing 
reaction mixtures, illustrated that 3-amino phenylboronic acid (PBA) should be 
coupled to a polymeric carrier via alkylamino chemistry instead of an amido 
derivative. The effect of immobilisation chemistry on the preferential binding of 
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ketoses on PBA derivatives was shown previously (Dukler and Freeman, 2001), 
and indicated an increase in selectivity of xylulose and fructose binding 
throughout isomerisation at pH7.0 - 8.0.   
 
 
6.1.4 Compatibility between biological and chemical processes  
 
Biological processes within industry face many complications, particularly the 
stability of the enzyme. The integrity of the enzyme may be compromised by the 
effects of stirring such as shearing, lengthy reaction times and high ionic 
environments. High substrate titres required for industrial scale processes often 
cause proteins to become denatured. Solutions to overcome these limitations 
include strategies to increase enzyme stability, such as immobilisation to solid 
interfaces, films or coatings. The attachment of the protein to solid phases can 
result in a more stable protein structure and therefore more active and efficient 
biocatalysts. Several studies have reported reduced thermal denaturation of 
immobilised enzymes (Brocklebank et al., 1999), and this is often thought to be 
due to the rigidification of the protein tertiary structure when bound to the resin 
support, or upon chemical cross-linking of the enzymes. 
 
Similar to the effects of the industrial processing, the combining of processes with 
differing optimal conditions or the use of toxic components implores the 
development of compatible processes. For example, the optimal pH or 
temperature for the enzymatic reaction may not be the favourable optimum for the 
preceding synthesis step or the proceeding isolation and purification steps. In 
addition, the components of separate reactions may be detrimental to components 
of another such as aldehydes forming Schiff bases with proteins, or the 
competitive inhibition of one reaction substrate on the biocatalyst.  
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6.2 Materials and Methods 
 
6.2.1 Substrate inhibition studies 
 
6.2.1.1  Addition of neat aldehyde 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM final) in 50 mM 
Tris-HCl buffer, pH 7.0) was added to the reaction mixture. Simultaneously 2.07 
mg of neat, undiluted, DCHCA was added to the reaction mixture and samples of 
the reaction mixtures were taken at regular intervals (20 µL) and the reaction 
quenched in 200 µL methanol. The colour assay was performed as described in 
section 5.2.3.2.  
 
The reaction was also performed without a pre-incubation of the enzyme and 
cofactor solution. Pure D469T-TK, cofactor solution, HPA stock and neat 
aldehyde were combined simultaneously and samples taken at regular intervals 
and colour assay performed.  
 
A further substrate feeding simulation experiment was performed. A preparative 
scale assay was carried out as described however, the neat volume of aldehyde 
was added drop wise at regular intervals throughout the reaction. However, 
samples were not taken and the end point of the reaction analysed by TLC and 
colorimetric assay.  
 
 
6.2.1.2  Increased substrate concentrations of 200 mM DCHCA 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM in Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (200 mM in Tris-HCl buffer 50 mM, pH 
7.0) were added to the reaction mixture with 5 % v/v EtOAc. Samples of the 
reaction mixtures were taken at regular intervals (20 µL) and the reaction 
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quenched in 200 µL methanol. The automated colour assay was performed as 
described in section 5.2.3.2. 
 
The same reaction was performed with 50 mM DCHCA with 5% EtOAc for 
comparison.   
 
 
6.2.2 Product inhibition study 
 
6.2.2.1 D469T-TK reaction spiked with product at t0 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM in Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (50 mM in Tris-HCl buffer 50 mM, pH 7.0) 
and DCDHP (10 mM, Tris-HCl buffer 50 mM, pH 7.0) were added to the reaction 
mixture. Samples of the reaction mixtures were taken at regular intervals (20 µL) 
and the reaction quenched in 200 µL methanol. The automated colour assay was 
performed as described in section 5.2.3. The addition of 10 mM product was taken 
into consideration on analysis of data.  
 
 
6.2.2.2 D469T-TK reaction spiked with product at t5 
 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM in Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (50 mM in Tris-HCl buffer 50 mM, pH 7.0) 
were added to the reaction mixture. Samples of the reaction mixtures were taken 
at regular intervals (20 µL) and the reaction quenched in 200 µL methanol. At 
reaction t5, DCDHP (10 mM, Tris-HCl 50 mM, pH 7.0) was added to the reaction 
with pipette mixing. The automated colour assay was performed as described in 
section 5.2.3.2. The addition of 10 mM product was taken into consideration on 
analysis of data.  
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6.2.2.3 Enzyme product complex experiment 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM in Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (50 mM in Tris-HCl buffer 50 mM, pH 7.0) 
were added to the reaction mixture and left to react for 48 hours. The reaction 
mixture was micro-dialysed (due to the small sample volume) in Tris-HCl buffer 
(50 mM, pH 7.0) and cofactors, TPP (2.4 mM), and MgCl2 (9 mM) for 8 hours, 
then transferred into fresh buffer containing cofactors and dialysed for a further 8 
hours (see Figure 6.3 for microdialysis). The dialysed solution was analysed by 
spectophotometry at OD280nm for protein concentration. The solution was then 
applied to a TK catalysed reaction with glycolaldehyde and DCHCA as described 
and analysed by HPLC and colorimetric assay.  
 
 
Hole in lid
Dialysis 
tubing
Reaction 
mixture
Eppendorf
 
 
 
Figure 6.3: Micro-dialysis. Dialysis for small sample volumes. A hole is made in 
the lid of the eppendorf or microfuge tube by melting. The reaction mixture is 
placed in the bottom of the tube and a section of dialysis tubing trapped on closing 
of the tube, creating a tight seal. The sealed tube is inverted and attached (making 
sure the reaction mixture is in contact with the dialysis tubing) to the side of a 
vessel containing dialysis buffer and stirred magnetically at 4 °C for 16 hours.   
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6.2.3 Transaminase (TAm) preparation and purification 
 
Purification of his-tagged β-A:P transaminase TAm (pQR801) was performed 
using a HisBind Quick 900 cartridge (EMD Biosciences, Darmstadt, Germany), 
packed with a pre-charged large-diameter cellulose matrix with tethered Ni2+ 
complex immobilised on NTA. Following fermentation, the broth (in LB-
glycerol) was centrifuged for 10 minutes at 4000 rpm and the supernatant 
decanted. The pellet was resuspended in binding buffer (500 mM NaCl, 20 mM 
Tris-HCl buffer, 5 mM imidazole; pH 7.95; 0.1 mM PLP) and then sonicated to 
disrupt the cells. Following sonication, the lysate was centrifuged at 4000 rpm at 4 
°C. The supernatant was recovered, filtered through a 0.45 and 0.1 µm Whatman 
syringe filter. Purification was carried out by equilibrating the cartridge with 
binding buffer, after which the cell extract was loaded and the cartridge washed 
with the same buffer. Elution was carried out with buffer containing 1 M 
imidazole, 500 mM NaCl, 50 mM HEPES and 0.1 mM of PLP. 
 
 
6.2.4 Transaminase reaction 
 
β-A:P TAm activity (with plasmid pQR801) was measured using an assay with 
(S)-α-methylbenzylalamine (MBA) and DCDHP as substrates. Substrates MBA 
(10 mM) and DCDHP (50 mM) were added to the reaction and incubated at 22 °C 
for 48 hours. Reactions were performed in 1.5 mL clear glass vials. Heating was 
provided by an Eppendorf Thermomixer Comfort shaker (Cambridge, UK). 
Reactions were monitored for MBA depletion and acetophenone (AP) production 
by sampling at t0 and end point and analysed by HPLC. Samples were quenched 
by 0.2% TFA and centrifuged briefly at 2000 rpm to remove any precipitate prior 
to HPLC.  
 
 
6.2.5 Transaminase HPLC analysis 
 
AP and MBA were analysed using a CE 5 C18 reverse phase column (150 mm x 
4.6 mm, 5 mm particle size; Advance Chromatography Technologies, Aberdeen, 
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UK). A gradient was run from 15% acetonitrile/85% 0.1% (v/v) trifluoroacetic 
acid (TFA) to 72% acetonitrile/28% TFA over 8 minutes, followed by a re-
equilibration step for 2 minutes (oven temperature 30 ºC, flow rate 1 mL.min-1). 
UV detection was carried out at 210 nm and 250 nm. The retention times (in min) 
under these conditions were: MBA 3.59 and AP 7.39. 
 
 
6.2.6 Phenylboronic acid reaction with ketodiol products 
 
6.2.6.1 L-erythrulose and phenylboronic acid 
 
Phenylboronic acid (0.5 g) was added to separate, 5 mL L-erythrulose, 500 mM 
and 100 mM and stirred magnetically at room temperature at pH7.0 for 48 hours 
on pH stat.  The solution was filtered and analysed by HPLC.  
 
 
6.2.6.2 DCDHP and phenylboronic acid 
 
Phenylboronic acid (0.5 g) was added to 5 mL DCDHP (10 mM) and stirred 
magnetically at room temperature at pH 7.0 for 48 hours at pH 7.0 controlled on a 
pH stat . The solution was filtered and analysed by colorimetric assay 
 
In addition, 33 mg DCDHP was added to 1.7 mL water sonicated by 6 cycles 8 
second pulses and 8 second pauses, stirred and heated to 40 °C until dissolved.  
0.17 g phenylboronic acid was added to the solution and stirred at 40 °C for 48 
hours at pH 7.0 controlled on a pH stat. The solution was filtered and analysed by 
colorimetric assay.   
 
 
6.2.7 Compatibility studies 
 
Purified D469T-TK, 300 µL was incubated with 50 µL cofactor solution, TPP (2.4 
mM), and MgCl2 (9 mM) for 20 minutes at 20 °C. HPA (50 mM in Tris-HCl 
buffer, 50 mM, pH 7.0) and DCHCA (50 mM in Tris-HCl buffer 50 mM, pH 7.0) 
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and one reaction with acrolein (50 mM in Tris-HCl buffer 50 mM, pH7.0) one 
with 2,3-dimethyl-1,3-butadiene (50 mM) and one with acrolein and 2,3-
dimethyl-1,3-butadiene (50 mM each in Tris-HCl buffer 50 mM, pH7.0) added to 
the enzyme mixture. The automated colour assay was performed as described in 
section 5.2.3.2. 
 
A separate reaction was performed in the same way however, with acrolein (50 
mM in Tris-HCl buffer, 50 mM, pH7.0) in place of DCHCA. Control reactions 
were performed as set out in Table 6.1.  
 
 
 
 
 
Table 6.1: Control reactions for compatibility studies. Reaction conditions: 20 
°C in Tris-HCl buffer (50 mM substrates, pH 7.0) 0.5 mg/ml TK, cofactors TPP 
(2.4 mM) and MgCl2 (9 mM) over 48 hours measured colorimetrically. 
1Additional buffer was added to reactions to maintain consistent reaction volumes 
and component concentration between reactions. 2 The OD measurements were 
below detection limit.  
Control TK Buffer1 
Co-
factors 
(TPP 
and 
MgCl2) 
DCHCA 
50 mM 
Acrolein 
50 mM 
2,3-
dimethyl-
1,3-
butadiene 
50 mM 
Li-
HPA 
Activity 
detected2 
1  ■ ■ ■   ■ 
2 ■ ■ ■ ■    
3 ■ ■ ■   ■  
4 ■ ■ ■  ■   
5 ■ ■ ■    ■ 
6 ■  ■  ■  ■ 
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6.3 Results and discussion 
 
6.3.1 Investigation into substrate inhibition 
 
Substrate inhibition was previously reported for transketolase, particularly in the 
absence of the pre-incubation step with the cofactors to reconstitute the holo-
enzyme (Mitra et al., 1996). Schiff base formation is widely known as a 
complication of the interaction between aldehydes and proteins, whereby the 
amino acid residues form imines in the presence of aldehyde functionality, 
potentially altering the protein structure and active site composition. Initial 
substrate inhibition experiments were performed and found that greater than 50 
mM substrate saw a decline in enzyme activity. Figure 6.4, represents the effect of 
higher substrate concentration on TK. The use of 5% ethyl acetate enabled the 
dissolution of the higher aldehyde concentration and was compared to the same 
conditions as the standard 50 mM substrate reaction. The yield improvement in 
the presence of cosolvent ethyl acetate, is indicated in Figure 6.4, and further 
represented by the yield improvement in preparative scale reactions (Chapter 3).   
 
There was no significant difference in reaction rate when 50 mM DCHCA was 
added prior to the incubation of the enzyme with cofactors. This was considered 
to be due to the already relatively slow reaction rate, and the expected lag time 
was lost, compared to the reaction of glycolaldehyde occurring within just 
minutes. The affect of adding neat aldehyde to the reaction also indicated no 
difference in reaction rate, in experiments where total concentration was added at 
the start and also as a substrate feed simulation experiment. Small scale substrate 
feeding experiments yielded product levels no greater than previous preparations 
(Chapter 3) thought to be due to the low solubility in the aqueous media. A 
combination of increased temperature, use of cosolvent and feeding strategy may 
be beneficial here.  
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Figure 6.4: Varying reaction conditions of TK catalysed DCHCA and HPA 
reaction. ○ 50 mM substrates with 5% v/v EtOAc ■ 50 mM substrates ∆ 200 mM 
DCHCA with 5% v/v EtOAc ♦ WT-TK 50 mM substrates. All in the presence of 
cofactors (TPP 2.4 mM and MgCl2 9 mM and TK 0.5 mg.mL-1).  
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6.3.2 Investigation into product inhibition 
 
The addition of fresh reconstituted transketolase to the reaction after 7 hours 
appeared to have a dramatic effect on the normal progression of the reaction 
(Figure 6.5). The reaction seems to continue at a similar rate to the first 7 hours of 
reaction, unlike the normal reaction which begins to plateau at around 7 hours.  
The slowing of the normal reaction in comparison to the spiked reaction indicates 
some inhibition whether it be competitive inhibition by the reaction product or a 
non-competitive toxicity towards the enzyme for instance.  
 
 
 
 
 
 
Figure 6.5: Enzyme spike reaction. The effect of spiking a 50 mM substrate 
reaction with fresh, pre-incubated enzyme at the point the reaction usually begins 
to plateau (□) spiked at t7 with TK (indicated by arrow) (●) normal progression of 
50 mM D469T-TK reaction. Reaction conditions: 20 °C, 50 mM HPA and 
DCHCA (Tris-HCl buffer 50 mM, pH7.0 and TK 0.5 mg.mL-1).    
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Figure 6.6: Effect of reaction product on reaction. □ DCDHP solution (10 mM, 
Tris-HCl buffer, 50 mM, pH7.0) added with reaction substrates ■ no product 
added. Reaction conditions 20 °C, 50 mM HPA and DCHCA in Tris-HCl buffer 
(50 mM pH7.0), cofactors (TPP 2.4 mM and MgCl2) and TK 0.5 mg.mL-1.  
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Figure 6.7: Effect of spiking TK reaction with product at 5 hours. (□) spiked 
at 5 hours with 10 mM product solution (■) no product added.  Reaction 
conditions, 20 °C, 50 mM HPA and DCHCA in Tris-HCl buffer (50 mM pH7.0), 
cofactors (TPP 2.4 mM and MgCl2) and TK 0.5 mg.mL-1. 
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The transketolase catalysed reaction of DCHCA was subjected to product addition 
at both the beginning of the reaction and at 5 hours reaction time to determine any 
product inhibition issues. Both Figures 6.6 and 6.7 indicate some level of product 
inhibition. The rate reduction in the presence of DCDHP from the beginning of 
the reaction is significant confirmed by the spiking of the reaction later in reaction 
time.   
 
The effect of the reaction on transketolase was investigated by recycling of the 
enzyme from a previous reaction. A DCHCA and HPA reaction was left to 
proceed for 48 hours, and analysed by TLC, to ensure product formation. The 
solution was subjected to a microdialysis (Figure 6.3) in order to remove the 
reaction components from the protein portion of the mixture. The mixture was 
dialysed against Tris-HCl buffer alongside cofactor solution (TPP and MgCl2) at 
reaction concentrations to maintain TK stability through dialysis. The enzyme was 
then applied to a glycolaldehyde reaction and a DCHCA reaction. Activity was 
severely retarded as no product formation was seen at all for the DCHCA 
reaction, with detection by TLC and colorimetric assay and very low levels of L-
erythrulose were detected by HPLC, <10% conversion. The dialysis may have 
caused protein destabilisation, the product may have been irreversibly bound to 
the enzyme or Schiff base formation between the aldehyde and protein may have 
caused considerable denaturation over 48hr reaction time. Further characterisation 
is required to provide a clearer picture of the possible causes of inhibition.  
 
 
6.3.3 Product Removal 
 
6.3.3.1  Phenylboronic acid 
 
Free phenylboronic acid was reacted with L-erythrulose, the product of a 
transketolase reaction with glycolaldehyde, to form a boronic ester-ketodiol 
complex. The reactive tetrahedral phenylboronate anion is converted to a trigonal 
phenylboronic acid structure. HPLC analysis of the reaction saw that 76% (± 3%) 
of a 0.5 M solution of L-erythrulose was removed by the boronic acid. Lower 
concentrations, 0.1 M of the product solution saw lower levels of complexation 
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with the boronic acid, around 11 ± 2% corresponding well with previous 
investigations (Chauhan, 1996).  Similar reactions with phenylboronic acid and 
the product of the DCHCA D469T-TK reaction, DCDHP, proved less effective 
due to the very low solubility of the product in aqueous solution at ambient 
temperature. Product solutions of 10 mM were made and stirred with the 
phenylboronic acid for 48 hours, the solution was filtered initially through filter 
paper followed by syringe filtration to remove the boronic ester-diol solid 
complex. No reduction in ketodiol concentration was evident after detection by 
colorimetric assay indicating no interaction between the boronic acid and 
ketodiol. It was considered that the low product concentration was preventing an 
effective interaction, and so the reaction was repeated at an elevated temperature 
in order to improve aqueous solubility. At 40 °C, DCDHP was dissolved to 100 
mM and reacted with phenylboronic acid and stirred for 48 hours. After 
elimination of the binding component the colorimetric assay indicated a 9%  ± 2% 
reduction in DCDHP in solution, indicating a positive reaction between the 
boronate and the novel TK product. The removal of the ketodiol product for future 
investigation is a simple alteration in pH, effectively stripping the covalent bonds. 
Lowering the pH causes the reactive tetrahedral phenylborate anion to be reverted 
back to the original structure. The seemingly generic reactivity of boronic acids 
with such diol products and the simplicity of removal firstly from reaction mixture 
by filtration and then separation of the complex by simple change in pH, lend 
themselves well to an in situ product removal tool for TK reactions.   
 
 
6.3.3.2  Transaminase (TAm) 
  
A transaminase (TAm) reaction was performed with the ketodiol product 
(DCDHP) of the transketolase reaction product towards DCHCA and HPA. The 
reaction was performed to establish the potential of product removal technique 
utilising a second enzyme and also to determine potential future work involving a 
‘one pot synthesis’ integration of a chemical synthesis step (DA) and 2 enzyme de 
novo pathway (TK and TAm).  Previously, work has been reported regarding the 
use of an E. coli hosted dual plasmid strain expressing both TK and TAm (Ingram 
et al., 2007). Initial detection of product by HPLC indicated some low level 
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acceptance of less than 5% (data not shown), and so this investigation was 
discontinued.   
 
6.3.4 Compatibility studies between DA and TK reactions 
 
The lack of a purification step for the cycloadduct of the Diels Alder reaction 
(DCHCA), despite 98% purity, called for an investigation into the effect of the 
other Diels Alder reaction components on the subsequent transketolase step. The 
potential for traces of acrolein, 2,3-dimethyl-1,3-butadiene, water and ionic liquid 
was high due to the simple decanting of the aldehyde from the reaction mixture. 
The effect the reaction components of each step have on other steps is also an 
indication of the potential ‘one- pot synthesis’ approach.  
 
 
 
 
 
 
 
Scheme 10. Two step reaction sequence. Diels Alder reaction with substrates 
2,3-dimethyl-1,3-butadiene and acrolein to afford 3,4-dimethyl-3-cyclohexene-1-
carboxaldehyde (DCHCA). Followed by the second step, transketolase catalysed 
reaction of DA reaction cycloadduct (DCHCA) and lithium hydroxypyruvic acid 
(HPA) to afford 1-(3',4'-dimethylcyclohex-3'-enyl)-1,3-dihydroxypropan-2-one. 
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The dienophile substrate was analysed for activity with both WT-TK and D469T-
TK, due to the compound possessing aldehyde functionality. The aldehyde group 
of the dienophile substrate of the cycloaddition reaction is present to afford a 
cycloadduct with the corresponding aldehyde group, essential for activity with 
TK. The colorimetric assay is applicable to the reaction of acrolein and HPA as it 
is a non-α-hydroxylated aldehyde unlike that of glycolaldehyde shown in the 
control reaction 6 of Table 6.1 This shows that the aldehyde is not accepted as an 
acceptor substrate and optical density measurements were in line with the limit of 
detection. WT-TK indicated the same negligible activity with acrolein. The effect 
of the diene component of the DA reaction on TK was also investigated. Control 
reactions confirmed the applicability of the colorimetric assay in the presence of 
the diene and dienophile shown in Table 6.1. 2,3-Dimethyl-1,3-butadiene 
appeared to have no adverse effects on the transketolase reaction when added at a 
concentration of 50 mM. The reaction proceeded as normal in the same way the 
reaction was unaffected in the presence of acrolein and also a mixture of the two 
DA substrates.  
 
 
The presence of even traces of ionic liquid in the transketolase reaction saw 
completely toxic consequences, whereby the reaction did not proceed at all. The 
detrimental effect of ionic liquid on the enzyme indicates that further development 
of this system is required to be used as a model for ‘one- pot syntheses’. The 
catalysis of the DA reaction has been widely reported by numerous methods 
including aqueous systems (Diego-Castro and Hailes, 1998; Otto et al., 1998; 
Marchàn et al., 2006; Windmon and Dragojlovic, 2008) and organic solvents 
(Laszlo and Lucchetti, 1984) or in the presence of a catalyst. An aqueous medium 
would be ideal in terms of compatibility with the biotransformation and also 
because water is an abundant and often cost effective solvent.  
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Figure 6.8: Effect of ionic liquid on D469T-TK reaction. Traces of the ionic 
liquid present appeared to completely prevent the TK reaction from proceeding.  
 
 
6.4 Summary 
 
 
Preliminary experiments were performed to investigate potential inhibition issues 
associated with the use of the novel, cyclic hydrophobic substrate for 
transketolase. The presence of product inhibition was indicated by spiking 
reactions with the product at various points of the reaction progression curve. 
Previously L-erythrulose was observed to similarly inhibit TK-catalysed reactions, 
and was presumed to be a competitive inhibitor of TK. It was also suggested that a 
futile reaction can exist where L-erythrulose and glycolaldehyde react to form the 
same compounds, indicating that the ketodiol can mimic the ketol donor substrate 
(Hobbs et al., 1993). This could potentially occur with other aldehyde substrates 
including DCHCA.  
 
The presence of substrate inhibition was also briefly investigated and the reaction 
found to be inhibited in concentrations of 200 mM DCHCA compared to 50 mM. 
Substrate feeding experiments were not significantly different and considered to 
be due to the low substrate solubility. Where standard, unfed, unstirred, batch 
reactions were possibly simulating the substrate ‘supply and demand’ effect of 
substrate feeding, through a hydrophobic/aqueous phase interface.  
 
   no IL                    IL 
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The compatibility between the two steps of the novel chemoenzymatic reaction, 
DA and TK, were also briefly analysed. The presence of even small traces of ionic 
liquid completely stopped the TK reaction preventing any product formation 
shown in figure 6.8. The presence of the other DA reaction substrates on the TK 
reaction however indicated no detrimental effects and the aldehyde did not appear 
to be accepted as a substrate by TK. These findings indicate good compatibility 
between the DA substrates and the biotransformation steps, however alternative 
solvent and catalyst for a single pot approach will be required.  
 
The transketolase catalysed product of DCHCA and HPA reaction, with 
phenylboronic acid was investigated and found to positively interact. Although 
relatively low removal levels from solution were measured in comparison to L-
erythrulose. The low solubility of the compound in water reduced the potential for 
higher levels as reactions with similar concentrations yielded similar levels of 
interaction. The possible conversion of the DCDHP compound by further 
biocatalyst, transaminase was also briefly investigated as potential synthesis of 
commercially valuable chiral amine intermediates. Unfortunately, conversion 
levels were low and insignificant, however, alongside reaction optimisation, 
processes such as the substrate walking approach and directed evolution methods 
used for transketolase may improve such activity.   
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7 Summary and final discussion 
 
 
 
The integration of two separate fields is not only an attractive means of synthesis 
but it is becoming more of a necessity. The demand for optically pure 
pharmaceuticals is a hard task for a solely chemical synthesis to remain cost 
effective and to be developed within a feasible time scale. The integration of two 
different processes such as a chemical reaction and a biocatalytic step requires 
numerous considerations including process design, reactor design, and 
compatibility studies. The engineering of enzymes provides a closer link, whereby 
the biocatalysts are engineered to possess more desirable characteristics. For 
instance, to improve the biocatalyst activity over a wider range of pH or 
temperature to be compatible with chemical reaction conditions or with a broader 
range of more complex substrates to afford commercially valuable, structurally 
demanding, compounds.  
 
The model reaction pathway designed for chemoenzymatic synthesis of optically 
pure compounds involved a DA cycloaddition which is a well established 
synthetic chemistry step, and an extensively investigated biotransformation with 
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the transferase enzyme, transketolase. The utilisation of a well established 
reaction is crucial to enable characterisation of the issues arising upon integration, 
as it is advantageous to already have established detection methods, knowledge of 
optimal reaction conditions, and the potential to achieve high yields. 
 
Target compounds for the transketolase reaction were examined via a substrate 
walking strategy, whereby sequentially linked cyclic aldehydes with increasing 
complexity were investigated for activity with both WT-TK and TK variants. 
Positive results were obtained from screening experiments where several ‘hits’ 
were highlighted. The use of a further complex cyclic aldehyde with additional 
functionalities, including a double bond and two methyl groups was useful for 
probing TK activity and selectivity. The differing characteristics of previously 
examined substrates, particularly the low aqueous solubility, introduced factors 
for consideration, including the use of co-solvents and alternative reaction quench 
methods. The synthesis of the cyclic aldehyde acceptor substrate via a DA 
cycloaddition provided a point of integration for analysis and characterisation of a 
chemoenzymatic reaction sequence, such as enzyme kinetics and 
enantioselectivity. 
 
The synthesis of a novel acceptor aldehyde by a well studied chemical synthesis 
was optimised here for application to a biocatalytic step to demonstrate the 
integration of the two processes. The acceptor aldehyde was synthesised by a 
Diels Alder cycloaddition reaction using a room temperature ionic liquid in 
ambient conditions (Abbott et al., 2002). Ultimately with various scales and 
reaction optimisation experiments, very high purity of 98% and particularly high 
yields of around 91% were established without the need for separate purification 
techniques. The lack of additional purification steps however, did have potential 
knock-on effects for the following biological enzymatic step.  
 
Previously produced, phylogenetic and structurally defined transketolase libraries 
(Hibbert et al., 2007) were screened for activity with the sequentially linked cyclic 
aldehydes providing evidence for TK ability to accept such compounds. The DA 
cycloadduct was subsequently applied to the library with potential for activity, 
namely the D469X structural library, previously indicated for involvement with 
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stereoselectivity. Utilising a sensitive colorimetric assay that was specifically 
optimised for transketolase catalysed reaction products, a number of D469X 
mutants showed considerable activity enhancement. Subsequent selection and 
culture of the highest performing mutants enabled gene sequencing and 
identification of the sequence mutation. Corresponding well with a previous 
observation (Hibbert et al., 2008), D469T was highlighted as having the highest 
level of activity enhancement towards the DA cycloadduct. A common pattern 
was seen throughout all the cyclic aldehyde screens including that for the simpler 
compound propanal, indicating some variants inability to accept such compounds 
in contrast to the more ‘promiscuous’ variants, for example D469T-TK. 
 
Analysis of the initial rates of the cyclic aldehydes compared to propanal 
indicated a slight drop in reaction rate as ring size increased from cyclopropane 
7.45 mM.h-1 to cyclohexane 3.46 mM.h-1.The potentially lower conformational 
flexibility of the cyclic aldehyde structures within the active site of the enzyme 
compared to less complex substrates including propanal and linear chain 
aldehydes, may explain the lower initial rates. Also the increasing ring size may 
have increasing steric hindrance within the active site or increasing Van der Waals 
interactions with residues reducing the flexibility of the substrate further for 
correct orientation.   
 
Large scale preparations of D469T-TK followed by purification using an N-
terminal His-tag and a Ni-NTA resin, enabled preparative scale 
biotransformations with DCHCA and HPA. The use of co-solvents for improving 
aldehyde solubility saw an increase in product yield and novel compound 3',4'-
dimethylcyclohex-3'-enyl-1,3-dihydroxypropan-2-one was synthesised, isolated 
and analysed. Chiral HPLC techniques and modified Moshers’ ester method 
permitted the determination of the enantioselectivity of the novel TK catalysed 
reaction. It was calculated that an ee in excess of 93%, for the single point 
mutation transketolase towards a cyclic, bulky, hydrophobic aldehyde was 
produced. The absolute configuration was subsequently calculated and the single 
major enantiomer elucidated as the (1S,1'R) enantiomer, corresponding well with 
previous observations that TK is stereospecific for (R)-hydroxyaldehydes and 
stereoselectively synthesises ketodiol products with the S-configuration.  
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The colorimetric assay for screening was successfully adapted for use as a kinetic 
measurement assay to complement HPLC analysis and Michaelis-Menten kinetic 
parameters were determined. For D469T-TK with DCHCA, we observed a Vmax of 
0.07 mM min-1, an apparent Km of 69.9 mM, and a kcat of 17.5 s-1, representing at 
least an 18,000-fold improvement in substrate specificity (kcat/Km) for D469T-TK 
compared to WT-TK. The mutation from a polar, charged, aspartic acid residue 
(Figure 6.9 1) previously highlighted as potentially being involved with 
enantioselectivity (Nilsson et al., 1998), to a less polar and uncharged residue 
threonine (Figure 6.9 2) appears to be preferential for activity with more lipophilic 
substrates. Corresponding well with previously reported data (Hibbert et al., 
2008) D469T-TK exhibited enhanced activity with the lipophilic, aliphatic 
aldehyde propanal and here the lipophilic DA cycloadduct. Further emphasising 
this potential relationship, TK variant D469L, a conversion from aspartic acid to 
the non-polar, hydrophobic leucine (Figure 6.9 3), indicated enhanced activity 
towards the cyclic aldehyde. In addition, the top five performing mutants 
highlighted in library screening experiments, all possessed residues uncharged at 
neutral pH unlike the wild type TK residue aspartic acid, which indicted 
negligible activity towards the novel substrate. The well known phenomenon that 
the chemical property of an amino acid determines the substrate specificity of the 
enzyme is demonstrated here.   
 
 
 
 
 
           1                                2    
 
 
 
        
    
   3  
Fig.6.9. Amino acid side chain comparison. 1) aspartic acid 2) threonine and 3) 
leucine.  
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The physical integration of the two-step reaction was briefly investigated 
alongside inhibition issues towards the enzyme, transketolase with aldehyde 3,4-
dimethyl-3-cyclohexene-1-carboxaldehyde. Substrate inhibition became evident at 
concentrations above kinetic analysis concentrations and solutions to resolve this 
issue were briefly considered. Reported data regarding transketolase inhibition 
and also general enzyme inhibition, indicated the tendency for aldehyde substrates 
to induce Schiff base formation with the side chains of lysine residues lying on the 
surface of the protein. This may adversely alter the enzyme structure including the 
active site and therefore potentially affect enzyme activity, particularly at higher 
concentrations.  
 
Product inhibition was also investigated for the D469T–TK catalysed reaction 
affording 3',4'-dimethylcyclohex-3'-enyl-1,3-dihydroxypropan-2-one. A futile 
reaction was seen previously with wild type transketolase between glycolaldehyde 
and the reaction product L-erythrulose synthesising the same compounds, 
suggesting the reaction of the product was acting as a competitive inhibitor 
(Hobbs et al., 1993). The product of the reaction here may also be mimicking the 
cyclic aldehyde substrate causing product inhibition. In addition, at critical 
concentrations the product may be exhibiting toxicity towards the enzyme 
possibly causing an irreversible degradation of the protein structure. Further, more 
in depth analysis will be required to determine the nature of the product inhibition.  
 
Compatibility between two processes upon integration is a significant issue 
requiring characterisation prior to establishing process design requirements. Initial 
experiments indicated the detrimental effect of the DA solvent/catalyst room 
temperature ionic liquid on the progression of the transketolase reaction. No 
contamination of ionic liquid in aldehyde preparations was evident at any point 
through decanting, however in the event that even traces of the ionic liquid was 
transferred from one step to the next the transketolase reaction was completely 
inhibited. This indicated the need for development of DA catalysis which is a 
topic widely discussed throughout literature, including aqueous catalysed 
cycloadditions (Diego-Castro and Hailes, 1998) for further development of a 
‘one-pot’ strategy. The effect of the DA reaction substrates however, appeared to 
be insignificant with no activity differences shown in their presence at 
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concentrations of 50 mM. The dienophile substrate was also shown to have no 
enzymatic activity with transketolase given the aldehyde functionality possibly 
acting as acceptor substrate.  
 
Many solutions exist to overcome process limitations such as substrate and 
product inhibition, low substrate solubility, pH fluctuations, etc. The feeding of 
substrates though pump fed or resin fed strategies, enable the continuous supply 
of substrate below critical inhibitory concentrations and also to aid solubility 
limitations. Product removal was approached using similar techniques including 
resin adsorption via methods known as in situ product removal (ISPR). A well 
known interaction of compounds synthesised by transketolase catalysed reactions, 
1,2- and 1,3-diols and boronic acids was demonstrated here as a potential method 
of product extraction. Although relatively low yields were recovered compared to 
other cis-diol products, increased product concentrations and pH optimisation may 
positively influence interaction.  
 
The ultimate objectives of the project were achieved whereby, a novel 
chemoenzymatic reaction, integrating a chemical reaction and biotransformation 
was performed to potentially synthesise novel, optically pure compounds. A 
transketolase variant able to accept a markedly different acceptor aldehyde 
substrate, synthesised by a DA cycloaddition reaction was identified and 
subsequently analysed. The enantioselectivity and absolute configuration were 
determined alongside Michaelis-Menten kinetic parameters, utilising a 
colorimetric assay formerly developed for screening high-throughput 
transketolase variant libraries.  
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8 Future work 
 
 
 
The successful integration of a chemical synthesis and biotransformation has been 
demonstrated in this project. However, despite an excellent enantiomeric excess 
the enzyme reaction rate remains relatively low. The stability of the enzyme was 
demonstrated to be compromised at room temperature after even three days 
(Figure 4.5). It was evident, however, that the reaction equilibrium had not been 
reached, as indicated by further product synthesis upon addition of fresh holo-
enzyme to the reaction at a point where activity began to diminish (Figure 6.5). 
The reaction rate and yield could therefore be optimised by improving the stability 
of the enzyme by immobilisation, possibly by a His-tag, Ni-NTA interaction, also 
utilised for the purification of the enzyme.    
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Further investigation for improving TK product yield could involve overcoming 
the issues associated with both substrate and product inhibition. The 
immobilisation of the enzyme would potentially improve the issue of substrate 
inhibition by rigidifying the enzyme so it becomes less susceptible to the 
formation of Schiff bases, also due to the fact that less surface residues of the 
enzyme are accessible. In addition, improvements could be made through 
substrate feeding strategies with pump-fed control systems, or by the use of resin 
pre-adsorbed with the substrate which then gets released through mass transfer 
kinetics. Simultaneous substrate delivery and product removal techniques are 
valuable tools for overcoming the additional effects of product inhibition, evident 
with the reaction demonstrated here. The implementation of boronates or other 
specific resins for product removal of cis-diols may be further characterised and 
improved by increasing the reaction and hence product concentration, and by 
examining the optimal pH for interaction as well as trials of different boronate 
resins.  
 
Removal of product could also be achieved using a second enzyme step. The 
further integration of an additional enzyme step to the pathway for removal of TK 
product from reaction and synthesis of commercially valuable chiral amines could 
involve the transaminase (TAm) enzymes. Previously transaminases have been 
demonstrated to accept TK products and have also been investigated in a dual 
strain enzyme system (Ingram et al., 2007). TAm activity was examined briefly 
with the product of the sequence described in this project and low activity was 
detected (> 5%). Development of a range of mutant libraries like the phylogenetic 
and structural libraries constructed for TK would potentially provide mutant TAm 
enzymes with enhanced activity. However, unlike transketolase, a high resolution 
crystal structure is not available for all transaminases so random mutagenesis 
approaches would be required as opposed to rational mutagenesis design 
approaches.  
 
Building of the ‘one-pot synthesis’ concept for the ultimate integration of a 
chemoenzymatic synthesis would require an alternative DA reaction solvent or 
catalyst. The cycloadduct synthesis here used a room temperature ionic liquid 
consisting of a zinc chloride and choline chloride complex which was detrimental 
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to the progression of the TK reaction. The performance of DA cycloaddition 
reactions in aqueous media has been well investigated throughout the literature 
and would provide a sound basis for identifying a compatible solvent system for 
the two-step pathway.  
 
Automation of the process at microwell scale could also enhance the process 
whereby, alternative process options could be evaluated within a reduced time 
frame ustilising less, often costly reagents such as HPA. A direct link between the 
process performance in varying conditions at small scale and modelling of the 
catalyst would potentially aid in achieving higher productivities.   
 
 
In summary, possible extensions to this project to further optimise the 
chemoenzymatic reaction: 
 
♦ Immobilisation to improve stability of TK throughout lengthy reaction 
times.  
♦ Further investigation into substrate inhibition and substrate feeding 
strategies at scale.  
♦ Characterisation of product inhibition and determination of suitable 
solutions such as in situ product removal using boronates or an 
additional enzyme such as, transaminase (TAm).  
♦ Performance of Diels Alder reactions in aqueous media.  
♦ Automation of the process for rapid analysis of compatible reaction 
and process options enabling prediction of the parameters at larger 
scales.  
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Appendix  
 
 
 
 
 
 
 
 
 
Appendix 1: Standard chromatogram for transketolase reaction detecting HPA, 
GA and L-erythrulose (UV).  
 
 
 
 
 
 
 
 
Appendix 2: Standard chromatogram for transketolase reaction. HPA and DHP 
and PA (ECD).  
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Appendix 3: Chromatogram for DCHCA (ECD).  
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Accurate Mass performed on a VG70-SE 
 
Instrument Resolution: 7000 
Mass Calculated for: C11H19O3 
Theroetical Mass: 199.13341 
Measured Mass: 199.13381 
Error: 2.01 ppm 
 
OH OH
O
C11H18O3
Exact Mass: 198.12560
Mol. Wt.: 198.25882
m/e: 198.12559 (100.0%), 199.12895 (12.2%)
C, 66.64; H, 9.15; O, 24.21  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 6. Mass spec DCDHP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 7.  Cyclopropanecarboxaldehyde screen of TK library D469.  
 
 
 
 
 255
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 8: Cyclopentanecaboxaldehyde screen of TK library D469.  
 
 
 
 
 
 
 
 
 
 
Appendix 9: Cyclohexanecarboxaldehyde screen of TK library D469.   
 
 
